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ABSTRACT OF THESIS
BACKGROUND: Calcium (Ca) has a central role in the mechanical and electrical 
properties of cardiac myocytes. This thesis examines cellular' Ca handling in a rabbit 
infarct model of heart failure (8 weeks after coronary artery ligation), which exhibits 
left ventricular dysfunction (LVD), pulmonary and hepatic congestion and a propensity 
to arrhythmias.
AIMS: The main aims of this thesis were (i) to determine the properties of Ca handling 
in single cells from different transmural regions in sham-operated (Sham) and post­
infarction animals, and (ii) to identify the underlying mechanisms behind any 
differences seen.
METHODS: Voltage clamp studies were performed at 37 °C on enzymatically-isolated 
single cells from the sub-endocardium (Endo) and sub-epicardium (Epi), loaded with 
the Ca indicator Fura-2. Baseline Ca transient characteristics were determined at 
different stimulation frequencies. Sodimn-calcium exchanger (NCX) activity was 
estimated from the rate constant (RC) of Ca decay during 10 mmol/L caffeine 
application. Sarco(endo)plasmic reticulum Ca ATPase (SERCA) function was 
estimated from the RC of Ca decay after brief caffeine application in the presence of 10 
mmol/L Ni. SR Ca content was calculated from the integral of the NCX current 
induced by caffeine application, and further analysis was used to quantify Ca buffering. 
These measures were each performed at steady state and were corrected for non-NCX 
Ca removal mechanisms. NCX current density was measured as the Ni-sensitive 
current in response to a ramp protocol, with major interfering currents blocked and 
intracellular [Ca] buffered to -250 nmol/L. Allosteric regulation ofNCX was studied
iii
by examining the outward NCX cuiTent through a range of [Ca], using a voltage step 
protocol. Finally, integrative analysis was used to determine Ca fluxes during systole 
and diastole, and separate protocols were used to perturb excitation-contraction (E-C) 
coupling to give further insights into cellular' Ca handling.
RESULTS: For both Sham and LVD animals, transmural differences in NCX were 
found, with higher current densities in Endo cells. In Sham animals, SERCA activity 
showed the converse, with greater Ca uptake in Epi cells, and this was associated with a 
higher SR Ca content in this region. In LVD cells, Ca transients were, in general, 
smaller compared to Sham, and exhibited a slower Ca decay. For both Endo and Epi 
regions, these findings were associated with reduced SR Ca content in LVD, and lower 
NCX current density and activity. For Epi cells, SERCA activity was also reduced in 
LVD. Studies of allosteric regulation of NCX by Ca showed that in LVD cells the 
exchanger was more sensitive to [Ca]. When Ca fluxes were studied, no difference in 
Ca entry via L-type Ca chamiels was found in LVD, but the gain of E-C coupling was 
reduced. This was likely to be due to the changes in SR Ca content. By studying E-C 
coupling in the presence of low concentrations of caffeine, there was some evidence of 
regional differences in SR Ca release.
CONCLUSIONS: Ca handling in the rabbit heart shows a number of differences 
between sub-endocardial and sub-epicardial cells. Following myocardial infarction, 
significant changes occur which may contr ibute to the impaired contraction and 
relaxation observed in this model of LVD.
IV
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CHAPTER 1
GENERAL INTRODUCTION
1.1 Chronic heart failure in the human
1.1.1 Definition and clinical consequences of heart failure
Heart failure (HF) is a syndrome which, at the most basic level, is caused by the 
inability of the heart to provide sufficient cardiac output to meet the metabolic demands 
of the tissues. Under these conditions, changes occur at a cell, tissue and organ level 
leading to the clinical “phenotype” of heart failure. The altered haemodynamic state 
has a number of consequences, including pulmonary and systemic congestion, causing 
amongst other things, breathlessness, fatigue and dependent oedema. A diagnosis of 
HF carries a poor prognosis -  figures based on the Scottish population in 1991 gave a
5-year survival rate of 25% after a first admission with the condition (Stewait et a l, 
2001), and a later study showed that for those over the age of 65, two thirds would die 
within 3 years (Cleland et a l, 1999).
To make the diagnosis of heart failure, clinical symptoms and signs should be 
accompanied by objective evidence of cardiac dysfunction (e.g. on echocardiography 
or radionuclide studies; Task force for the diagnosis and treatment of chronic heart 
failure, 2001). In cases where diagnostic doubt exists, then response to appropriate 
treatment can be taken into consideration. The typical finding on imaging studies is of 
impaired left ventricular (LV) function, although it is recognised that the clinical 
syndrome of heart failure can exist in the presence of preserved LV function. In the 
latter case, symptoms may be secondary to impaired LV relaxation / filling during 
diastole, and the condition has been termed “diastolic dysfunction”. Some controversy 
still exists regarding the diagnosis and the treatment of patients who are felt to have this 
condition (reviewed in Zile & Brutsaert, 2002).
1.L2 Aetiology of heart failure
It is important to realise that “heait failure” should not be regarded as a final diagnosis 
-  the underlying cause of the condition should also be sought. This is critical for 
tailoring appropriate treatment and can have a bearing on estimating prognosis. In the 
Western world, heart failure is most commonly due to coronary artery disease, where 
LV dysfunction (LVD) is a consequence of myocardial ischaemia and/or infarction 
(McMurray & Stewart, 2000). This may be accompanied by changes secondary to 
hypertension. Other aetiological factors include valvular heart disease, 
cardiomyopathies and arrhythmias. Of course, a number of these factors may coexist, 
and can be additive in producing heart failure. The importance of coronary disease in 
the aetiology of HF is relevant when considering appropriate animal models to study 
the condition (reviewed further in Chapter 2).
LI,3 Burden o f heart failure
Numerous studies have examined the epidemiology of heart failure and the results are 
reviewed by McMun ay & Stewart (2000). The reported overall prevalence of HF in the 
community is around 3-20/1000 population, with an annual incidence rate of around 
1-4/1000. Such figures increase mai'kedly with age, and the prevalence rate of 
symptomatic HF may exceed 10% in those aged over 65 years. With an ageing 
population and more patients surviving after myocardial infarction (MI), the burden of 
heart failure is increasing with time. This has significant implications for resource 
utilisation and healthcare expenditure, with over 5% of medical admissions being due 
to HF, and 1-2% of the overall healthcare budget being spent on the condition 
(McMurray & Stewart, 2000). These facts emphasise the ongoing need for studies into
the pathophysiology and treatment of HF, to reduce the individual and population 
impact of the condition.
1.2 Excitation-contraction coupiing in cardiac myocytes
Before considering the cellular changes which occur in heart failure, it is worth briefly 
reviewing relevant aspects of cardiac myocyte physiology. The discussion below will 
emphasise the central role that calcium (Ca) plays in the cellular processes occurring 
during the cardiac cycle and it will be seen that altered Ca handling affects both 
contractile function and the propensity for arrhythmias.
1.2,1 Calcium entry & calcium-induced calcium release
Figure 1.1 summaiises the events occuiring during systole in the cardiac myocyte. 
During the cardiac action potential (AP), depolarisation of the cell membrane 
(sarcolemma) is rapidly earned deep into the cell via the transverse tubule (T-tubule) 
network, resulting in a coordinated opening of Ca channels (mainly L-type Ca 
channels, also known as dihydropyridine receptors, DHPRs). This allows Ca to enter 
the cell down its concentration gradient (around 2 mmol/L in the extracellular space 
compared to 80-250 nmol/L in the cytoplasm at rest; see Bers, 2001). This initial entiy 
o f Ca in turn leads to Ca release from its intracellular store, the sarcoplasmic reticulum 
(SR), via intracellular Ca release channels termed ryanodine receptors (RyRs, 
principally RyR isoform 2 in cardiac cells; see Fill & Copello, 2002). This process is 
known as Ca-induced Ca release (CICR) and leads to amplification of the initial Ca 
signal, such that a peak intracellulai’ Ca concentration ([Ca]i) of around 0.5-2 pmol/L is 
achieved. At this concentration, cytoplasmic Ca activates the myofilaments, causing 
contraction.
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Figure 1.1 Ca entry and release in the cardiac myocyte. 1: Depolarisation 
of the sarcolemma during the action potential (AP) causes opening of L-type 
Ca channels (DHPR) and entry of Ca down its concentration gradient. 2: 
This activates clusters of ryanodine receptors (RyR), which are coupled by 
FKBP12.6 (see text), leading to release of Ca from the sarcoplasmic 
reticulum (SR). 3: This amplifies the Ca signal and cytosolic Ca acts on the 
myofilaments to cause contraction (4). For other abbreviations see Figure 
1.3.
7.2.2 Functional architecture o f  the dyadic cleft
The above brief outline mentions some of the critical players in the process of 
excitation-contraction (E-C) coupling, and the relationship between them is central to 
determining the characteristics of the systolic rise in [Ca],. The stage on which these 
events take place is the junctional, or dyadic, cleft -  the space of around 10-15 nm 
between the sarcolemmal membrane (mainly at T-tubule sites) and the specialised 
junctional membrane of the SR (reviewed by Brette & Orchard, 2003; Weir & Balke, 
1999; Fill & Copello, 2002). Evidence from recent studies suggests that the spatial 
arrangement of Ca channels and RyRs in this microdomain facilitates amplification of 
the Ca signal and allows a graded response to varying concentrations of trigger Ca. In
rabbit ventricular myocytes, each L-type Ca channel in the T-tubule membrane is 
associated with a cluster of around 4 RyRs (Milnes & MacLeod, 2001; Bers & Stiffel,
1993). The latter are lai’ge molecular complexes consisting of a tetramer of 564 kDa 
proteins, which display cooperative gating. In skeletal muscle there is evidence of a 
regular lattice-like array of RyR tetrads in the SR membrane, and in cardiac muscle a 
similar, although perhaps less strict, arrangement may be present (reviewed in Fill & 
Copello, 2002; Guatimosim et a l, 2002). This also has functional consequences -  as 
discussed in section 1.2.3.2, there is evidence that coupling exists between adjacent 
teti'ads (Marx et a l , 2001).
1,2,3 Regulation of RyR function
1.2.3.1 Luminal regulation hy Ca
Ca is the principal activating ligand for the RyR on the cytoplasmic side of the SR 
membrane, but there is also evidence that the concentration of Ca within the SR affects 
the function of the channel. Early studies using RyR channels reconstituted into lipid 
bilayers showed that the channel open probability was dependent on luminal [Ca] in a 
voltage-dependent manner (Sitsapesan & Williams, 1994; Tripathy & Meissner, 1996). 
In similar studies, Gyorke & Gyorke confirmed the activating effects of Ca on the 
cytoplasmic side of the channel, demonstrating a bell-shaped dependence on [Ca], with 
inhibition of channel conductance at higher [Ca] (>-100 pmol/L; Gyorke & Gyorke, 
1998). They then altered [Ca] on the luminal side of the channel, between 0.2-20 
mmol/L, and showed that the open probability of the channel increased as [Ca] 
increased within this range. This appeals to involve an allosteric site on the luminal 
side of the channel, rather than being due to an action on the cytoplasmic Ca binding 
site, since exposure to trypsin on the luminal side of the bilayers abolishes the effect
(Ching et a l,  2001). Other work has shown that luminal [Ca] has a similar effect on 
RyR function in intact ventricular myocytes (Lukyanenko et a l,  1996). Thus, altered 
SR Ca content, for example in heart failure, can have a direct effect on the functional 
properties of the RyR.
1.2.3.2 Phosphorylation o f  RyR and binding ofFKBP
Several molecules associated with the RyR have been described, whose functions 
include stabilisation of the RyR structure and regulation of its activity. Marks’ group 
have produced several papers documenting the association of various proteins with the 
RyR (see Marx et a l,  2000; reviewed in Marks et a l, 2002). These include protein 
kinase A (PKA) and protein phosphatases 1 & 2, which can alter the phosphorylation 
state of the RyR channel. Increased phosphorylation (e.g. through sympathetic 
stimulation) has been shown to activate the channel, increasing its sensitivity to [Ca]. 
Another molecule, one of the FK-506 binding proteins (FKBP12.6, in cardiac muscle), 
also associates with the RyR, with one molecule of FKBP12.6 able to bind to each 
subunit of the tetramer. FKBP12.6 appears to stabilise RyR gating and couple the 
gating of individual RyR tetramers with their neighbours, such that channel opening 
and closing can occur in a coordinated fashion during CICR (see Marx et a l,  2001; 
discussed below).
Marx et al. recorded single RyR channel activity under baseline conditions and with 
phosphorylation by PKA (Marx et a l,  2000). They demonstrated that phosphorylation 
of RyR markedly increased the open probability of the channel and also lead to the 
appearance of subconductance states, including long-lasting partially open states. The 
latter resembled previous findings when FKBP12.6 was dissociated from the RyR, and
Marx et al. concluded that hyperphosphorylation of the channel lead to loss of 
FKBP12.6, causing destabilised channel gating (Marx et a l,  2000). Under such 
conditions of increased Ca sensitivity, the channels would become “leaky”, resulting in 
loss of Ca from the SR during diastole, depleting the pool of Ca available for 
contraction, and potentially being arrhythmogenic. Work by Prestle et al is in support 
of this contention (Prestle et a l,  2001). They specifically overexpressed FKBP12.6 in 
rabbit ventricular myocytes using an adenoviral vector and demonstrated reduced 
RyR2-dependent Ca leak and increased SR Ca content. These changes were associated 
with increased fractional shortening. There remains some controversy as to the 
importance of altered FKBP12.6 binding in vivo and the role that it might play in heart 
failure (discussed in section 1.4.1.4).
1.2.3.3 Other proteins associated with RyR
Other proteins have been shown to co-localise and interact with RyR molecules, on 
each side of the SR membrane (see Fill & Copello, 2002; Bers, 2001 for reviews). 
Calmodulin binds on the cytoplasmic side and appears to have inhibitory effects on 
RyR2, although whether this is relevant at physiological [Ca] is unclear (Maier & Bers, 
2002). Sorcin also appears to act on the cytoplasmic side of the SR membrane, and 
there is some evidence that it prolongs the RyR closed time and reduces burst 
frequency (discussed in Seidler et a l,  2003). On the luminal side of the membrane, 
calsequestrin, a high-capacity Ca-binding protein, can also affect RyR activity, 
although again its physiological role is yet to be clarified. Finally, the two luminal 
proteins junctin and triadin are also associated with the RyR, and there is some 
evidence that there is a Ca-sensitive interaction between these proteins, and also 
calsequestrin (discussed in Bers, 2001, Chapter 7).
1.2.3.4 Pharmacological manipulation o f  RyR function
A large number of pharmacological agents can be used to alter SR Ca release, as 
summarised by Bers (2001, Table 23) and reviewed by Eisner et al. (2000). One such 
compound used extensively in this thesis is the methylxanthine caffeine, whose effects 
are outlined in Chapter 5 (section 5.1.1).
1.2.4 “Local control” theory of CICR
The physical arrangement of channels and receptors in the dyadic cleft means that 
RyRs are placed to respond to changes in [Ca] within the small space between the T- 
tubule membrane and that of the SR (termed “fuzzy space” by Lederer et a l, 1990). 
There is increasing evidence that this is of critical importance in the normal process of 
CICR. This “local control” theory, where RyR senses [Ca] in the immediate 
environment o f its subcellulai* compartment rather than the bulk cytoplasm, was first 
outlined by Stem (1992), and work since then has examined in detail the events 
involved in this process (reviewed by Weir & Balke, 1999; Bers, 2002; Guatimosim et 
a l,  2002). Current evidence suggests that Ca entry through one or two DHPR produces 
a sufficient local [Ca] to activate an adjacent cluster o f RyRs. The resulting localised 
release of Ca has been termed a “spark” and was first visualised and described by 
Cheng et al. (1993). It was initially felt that a spark was due to release through a single 
RyR, but, as discussed in section 1.2.3.2, it now seems more likely that it is the result of 
the opening of a cluster of RyRs (perhaps 4-20). At resting diastolic [Ca], spontaneous 
sparks can be seen at a low rate within the cell, but this rate increases dramatically 
when Ca entry through DHPRs occurs. It has also been known for some time that 
under conditions of elevated SR Ca content, Ca sparks can activate neighbouring
clusters, causing a “wave” of Ca release to spread through the cell (Cheng et a l, 1996). 
Under these conditions, RyR [Ca] sensitivity may be increased so much (e.g. through 
activation by SR luminal [Ca]) that even resting diastolic [Ca] is sufficient to trigger a 
release. Similar events can also occur at normal levels of SR Ca content if RyR [Ca] 
sensitivity is abruptly increased by other means -  e.g. through the application of 
caffeine (see section 5.1.1). Such spontaneous release events can generate 
airhythmogenic inward currents and are discussed further in section 1.3.3.
Elegant, and technically demanding, experiments by Wang et a l demonstrated influx 
of Ca through single DHPRs, correlating local changes in [Ca] at the patch pipette with 
single Ica channel events (Wang et a l, 2001a). These events were termed “sparklets”, 
and they further examined the relationship between these sparklets and RyR activity / 
sparks. Using a “loose-seal” configuration (where there is less defonnation of the 
sarcolemma, and therefore a more preseiwed spatial relationship between DHPRs and 
RyRs than with a GO-seal) they showed that if Ica was blocked with nifedipine, or if 
Ca was substituted with Ba, then triggered sparks could not be activated. This provides 
evidence against the possibility of voltage-dependent Ca release (rather than CICR) in 
cardiac cells, which has been the subject of some debate (see Weir & Balke, 1999; 
Bers, 2001, Chapter 8; Piacentino III et a l,  2000 for discussion). In the absence of 
blockers, the latency between a sparklet and a spaik was described well by a single 
exponential function with a time constant of 6.7 ms, and the coupling fidelity between a 
sparklet and a spark was around 0.71 -  i.e. not all sparklets lead to activation of a RyR 
cluster. These properties suggest that the coupling relationship between DHPR and 
RyR is stochastic, or probabilistic, rather than deterministic. This fits well with the 
diffusion properties of the local microdomain and with coupled gating of RyRs.
10
Calculations by Bers based on the buffering and diffusion properties of the dyadic cleft 
suggest that within a 15 nm radius of the mouth of an open Ca channel there may be as 
little as one free Ca ion (and -100 bound; Bers, 2001, Figure 118). Again, this fits with 
a stochastic DHPR-RyR relationship, and indeed, previous work has shown that a 
single Ca ion can be sufficient to activate the RyR complex (Fan & Palade, 1999).
1.2.4.1 Grading o f CICR and “gain ” o f  E-C coupling
There is an increasing acceptance that Ca sparks are the elementary events of SR Ca 
release, and that the cardiac action potential leads to a synchronised summation of 
several thousand such sparks through CICR, to produce the global Ca transient (see 
Guatimosim et a l,  2002). The properties of the system must be able to explain the 
graded natuie o f CICR, where changes in trigger [Ca] (amplitude or temporal 
properties), or pharmacological manipulation of the system, is reflected by altered SR 
Ca release. The details of how this comes about remain under some debate, as does the 
question of how a system with inherent positive feedback properties is limited from 
emptying the SR of Ca through a regenerative process. One factor contributing to both 
these issues may be the physical separation of RyR clusters, such that if trigger [Ca] is 
low then a sufficient concentration to activate RyR opening may only occur" at the 
adjacent cluster. The rapid fall in [Ca] away from the mouth of the DHPR would 
prevent activation of neighbouring clusters, and would similarly limit Ca release from 
one RyR cluster from spreading to activate the next. Higher trigger [Ca] could recruit 
more clusters, leading to a larger overall Ca release. This is depicted in Figure 1.2, 
along with some other possible methods for producing a graded response. These 
different theoretical ways of altering SR Ca release are by no means mutually 
exclusive, and several may act in conceit under physiological conditions. These factors
11
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Figure 1.2 Potential mechanisms for grading of CICR. 1: Baseline situation 
(outlined) where, for the purposes of illustration, a single DHPR causes 
opening of a coupled cluster of 2 RyRs. To achieve a graded response of 
CICR to increasing trigger Ca, a number of possibilities can be considered.
2: Increased coupling fidelity, or increased RyR sensitivity to [Ca]. 3:
Recruitment of RyRs within a cluster. 4: Recruitment of adjacent clusters.
5: Recruitment of additional DHPRs or altered DHPR properties, e.g. 
reduced Ca-dependent inactivation. 6: Increased SR Ca content (causing 
increased SR-cytoplasm Ca gradient and also activation of RyR by raised 
luminal [Ca]). Several mechanisms may act in concert to bring about the 
observed effect (discussed further in text). For abbreviations see Figure 1.1.
are also relevant when considering the situation in heart failure, where E-C coupling 
efficiency is often reduced (see sections 1.4.1.5 & 4.4.5).
The efficiency of E-C coupling is often expressed as the “gain” of the system. This 
compares the size of the “response” (SR Ca release) with that of the trigger {Ica flux) to 
give an amplification factor. Technical aspects of this calculation are outlined in 
section 4.3.6. Given the importance of SR Ca content in determining the magnitude of
12
Ca release, it is not surprising that E-C coupling gain is heavily dependent on this 
factor (e.g. Bassani et a l,  1995; Janczewski et a l, 1995). Shannon et al studied this 
relationship in rabbit ventricular myocytes, along with the related measure of SR 
fractional release (Shannon et a l, 2000). They demonstrated that E-C coupling gain 
showed a non-linear dependence on SR content, with an increasingly steep relationship 
at higher SR loads. This implies some effect on the release process itself, rather than 
simply being due to increased Ca available for release (and increased SR-cytoplasm 
[Ca] gradient). This is in keeping with studies demonstrating regulation of RyR 
function by luminal [Ca] (see section 1.2.3.1).
1.2.4.2 Termination o f  SR Ca release
The local environment around a cluster of RyRs, and the properties of the receptors 
themselves, seem important in terminating the potentially regenerative process of 
CICR. A number of different mechanisms have been proposed, including local 
depletion of SR Ca, inactivation or adaptation of RyR, and “stochastic attrition” (Stern, 
1992), the chance simultaneous closure of both DHPR and RyR intenoipting the 
process of release. It seems unlikely that depletion of SR Ca is the only mechanism 
involved, since significant Ca stores still remain after SR release (Vano et a l, 1993; 
Negretti et a l, 1995; Bassani et a l, 1995), and long-lasting sparks can be demonstrated 
(Cheng et a l, 1993). Stochastic attrition may occur to some extent, but does not appeal" 
to be a robust enough method alone to terminate SR Ca release when a cluster of 
several RyRs is present (discussed by Sobie et a l,  2002).
The work of Wang et a l contributed some information to the debate (Wang et a l, 
2001a). They examined the coupling latency between consecutive sparklets (DHPR Ca
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fluxes) and resulting triggered sparks. They showed that if the first sparklet did not 
trigger a spark then the coupling latency for the subsequent sparklet was unchanged, 
however if the first sparklet did trigger a spark then the coupling latency was reduced 
for the second sparklet. This suggests some fonn of use-dependent inactivation or 
adaptation of the RyR cluster. This is also supported by experiments examining the 
collision characteristics of intracellular Ca waves. These studies have shown that when 
two waves meet they annihilate each other, suggesting a refractory period in the wake 
of each wave (e.g. Ishide et a l, 1990). Such mechanisms are discussed in detail by Fill 
& Copello (2002) and Bers (2001, 2002).
Sobie et a l devised a mathematical model of spark generation and termination, which 
included recent findings regarding RyR function and accounts for a number of 
experimental observations (Sobie et a l , 2002). They used the term “sticky cluster” to 
describe the behaviour of a number o f coupled RyRs, with a cooperativity factor 
incorporated into the equations. When this was combined with the stochastic properties 
of individual RyR tetramers and modelling of [Ca] in the microdomain of both the 
dyadic cleft and the local junctional SR, the simulation matched experimentally 
observed spark behaviour well. It was also possible to mimic the effects o f altered RyR 
coupling, as might be seen with changes in FKBP12.6.
1.3 Calcium removal mechanisms
During the diastolic period, the calcium released into the cytoplasm to cause 
contraction must be removed from the cell or re-sequestered into the SR. This enables 
relaxation of the cell and filling of the cardiac chambers. Several mechanisms allow 
this to take place (see Figure 1.3), the two main ones being the sodium-calcium
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Figure 1.3 Removal of cytoplasmic Ca. 1: Ca is actively resequestered into 
the SR by the sarco(endo)plasmic reticulum Ca-ATPase (SERCA), which is 
modulated by phospholamban (PLB). 2: The sodium-calcium exchanger 
(NCX) leads to Ca efflux from the cell, utilising the transsarcolemmal [Na] 
gradient. NCX appears to be present on the cell surface as well as in the T- 
tubules (discussed in text). 3: “Slow pathways” also operate, including the 
sarcolemmal Ca ATPase (SLCaATPase) and uptake via the mitochondrial 
uniporter. For other abbreviations see Figure 1.1.
exchanger (NCX), which utilises the Na gradient to remove Ca from the cell, and the 
sarco(endo)plasmic reticulum Ca-ATPase (SERCA), which actively pumps Ca back 
into the SR. Given their importance to normal Ca handling, and the role they play in 
heart failure, these two mechanisms will be discussed in more detail.
1.3.1 Sodium-calcium exchanger
1.3.1.1 Discovery
It has been known for over 50 years that the relationship between the concentrations of 
external Ca and Na has significant effects on the function of cardiac tissue (Wilbrandt 
& Roller, 1948), and it was demonstrated in 1958 that depletion of extracellular Na 
could bring about contraction of frogs’ hearts (Lüttgau & Niedergerke, 1958). Further
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work on cardiac, skeletal and smooth muscle demonstrated that changes in intracellular 
[Ca] could be brought about by manipulating external [Na] (Niedergerke, 1963; 
Cosmos & Harris, 1961; Briggs & Melvin, 1961; Goodford, 1967). Reuter and Seitz, 
in 1968, were the first to demonstrate that the efflux of Ca from mammalian cardiac 
muscle was dependent on the external concentrations of Na and Ca (Reuter & Seitz, 
1968). They measured the rate of loss of "^ C^a from guinea-pig, sheep and calf cardiac 
tissue in the presence of external solutions with varying ionic composition and 
postulated the presence of a transport mechanism “very effective in reducing the 
intracellular Ca concentration ... without metabolic energy consumption”. Subsequent 
experiments showed that intracellular' [Na] also influenced Ca fluxes (Glitsch et a i, 
1970), providing further evidence for a Na-Ca exchanger mechanism. Around the 
same time, such mechanisms were also reported in invertebrate neurones (Baker et a l , 
1967; Baker & Blaustein, 1968; Blaustein & Hodgkin, 1969) and rat small intestine 
(Martin & DeLuca, 1969). Since then there has been considerable research on the 
stmcture, mechanism of action, distribution and physiological role of the sodium- 
calcium exchanger.
13.1.2 Structure, molecular aspects and tissue distribution
NCX was first cloned in 1990 from the cardiac sarcolemma (NCXl, Nicoll et a l, 1990) 
and since then two other mammalian isoforms have been found (NCX2 & NCX3). 
Recent modelling of NCXl suggests that the final protein consists of 938 amino acids, 
with 9 transmembrane domains and a large intracellular loop with important regulatory 
functions and a site where alternative splicing can occur (Nicoll et a l,  1999; reviewed 
in Philipson & Nicoll, 2000). Mammalian NCX shows marked sequence homology 
across several species and cDNA probes derived from the human exchanger have been
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used to study the tissue distribution of NCXl in humans and rats (Kofuji et a l, 1992). 
Such studies, and others, have determined that NCXl is present at high levels in heart 
and brain, with reduced expression in all other tissues tested. NCX2 and NCX3, 
however, have a more limited distribution, e.g. found in brain but not heart (reviewed 
by Shigekawa & Iwamoto, 2001; Blaustein & Lederer, 1999).
1.3.1.3 Distribution o f  NCX in cardiac cells
Immunofluorescence studies in cardiac myocytes have shown that NCX is located 
throughout the external surface of the cell, including within the T-tubules, but there is 
some debate regarding its relative distribution, Kieval et a l showed a relatively 
imiform distribution (Kieval et a l,  1992). Frank et al reported only patchy labelling of 
the peripheral membrane in guinea-pig and rat, with staining concentrated in the T- 
tubules (Frank et a l, 1992), however a later study in rabbits showed a more even 
distribution (Chen et a l, 1995). A quantitative analysis suggested that in guinea-pig 
ventricular myocytes 52-55% of NCX has an intracellular (presumed T-tubule) location 
(McDonald et a l, 2000).
A recent paper by Yang et a l made a functional assessment of NCX activity in rat 
ventricular cells which were detubulated by osmotic shock with formamide (Yang et 
a l, 2002). The results showed that détubulation reduced cell capacitance by around 
one third, consistent with loss of T-tubule area, and this was accompanied by an almost 
complete loss of NCX cunent. These effects were not seen in atrial cells, which lack 
T-tubule structure, and suggest that in ventriculai* cells NCX function is localised 
almost entirely to the T-tubules.
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1.3.1.4 Kinetics o f  NCX: stoichiometry
In early studies on squid giant axon, Blaustein & Hodgkin suggested that to maintain 
the gradient of [C a]i:[C a]o , the exchange of two Na ions for each Ca ion would be 
insufficient, but an exchange of 3Na:lCa would theoretically suffice, and this was 
supported by their experiments (Blaustein & Hodgkin, 1969; Baker et a l,  1967). Early 
studies by Pitts on cardiac sarcolemmal vesicles examining the influx or efflux of Ca 
and Na radioisotopes suggested that 3 Na were exchanged for every one Ca (Pitts, 
1979). Reeves & Hale confirmed this finding in a series of elegant experiments 
(Reeves & Hale, 1984). Studies on ventricular' tissue and Purkinje fibres reported a 
stoichiometry in the range 2.4->3 N a:lCa (Bers & Ellis, 1982; Sheu & Fozzard, 1985). 
Axelsen & Bridge re-interpreted the data of Sheu & Fozzard and, using thei-modynamic 
considerations taking account of Ca leak across the membrane, suggested that the 
stoichiometry was close to 3Na;lCa (Axelsen & Bridge, 1985). Using whole perfused 
rabbit hearts Axelsen & Bassingthwaighte concluded that the stoichiometi-y was 3:1, 
and could not be > 4:1 (Axelsen & Bassingthwaighte, 1988). In a comprehensive set of 
experiments on single guinea-pig ventricular cells, Noma and co-workers also found a 
3Na:lCa exchange (Kimura et a l,  1986; Kimui'a et a l, 1987; Ehara et a l,  1989), as 
have other investigators (Wakabayashi & Goshima, 1981; Crespo et a l,  1990).
In an interesting recent paper, Fujioka et a l have reported a stoichiometry of around 
4Na:lCa, with some variation in the relationship when intracellular [Na] and [Ca] were 
altered (Fujioka et a l, 2000). Their experiments were perfonned on large “inside-out” 
excised patches from guinea-pig ventricular cells, allowing tight control of ionic 
conditions on either side of the patch -  an important consideration, since relatively 
small changes in [Na] or [Ca] close to the membrane can have large effects on the
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apparent kinetics of the exchanger. It should be noted that many of their conclusions 
are based on membrane patches pre-treated with trypsin to prevent Nai-dependent 
inactivation of the current. They did not feel that trypsin treatment significantly altered 
their results, but examination of their data shows that the stoichiometiy obtained from 
non-treated patches was generally less than that obtained from treated ones, and in 
particular at physiological levels for resting [Na]i it was closer to 3:1. In non-cardiac 
forms of NCX, stoichiometries of 4:1 have been established and in some cases K is co­
transported with Ca (reviewed in Blaustein & Lederer, 1999). However, the weight of 
evidence on cardiac NCX, gathered under many different experimental conditions, 
supports an exchange of around 3 Na for each Ca. Potassium does not appear to be co­
transported in cardiac NCX (Crespo et a l, 1990; Yasui & Kimura, 1990).
1.3.1.5 Kinetics o f  NCX: electrogenicity & reversal potential
With a stoichiometry for the exchanger of 3Na:lCa, if  Na and Ca ai’e the only ions 
transported then the pump will be electrogenic, with a net gain of one positive charge 
for each Ca ion extruded. Early voltage clamp experiments in intact cells did show 
hyperpolarisation induced by removal of external Na (Coraboeuf et a l, 1981), a 
transient inward current on repolarisation (/„; Kass et a l,  1978) and a current on 
application of caffeine (Clusin et a l,  1983b; Clusin, 1983). However it was difficult to 
conclude that these currents were unequivocally due to NCX due to the possibility of 
contaminating currents and the lack of specific blockers (reviewed in Eisner & Lederer, 
1985).
Two reports in the same issue of Nature in 1986 gave more definitive evidence of NCX 
currents. Kimura et a l  used voltage ramp protocols with other significant currents
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blocked, and altered internal and external [Na] and [Ca] (Kimura et a l, 1986; see also 
Kimura et a l,  1987). They showed that the cuiTents obtained depended on the ion 
gradients and also the membrane potential in a manner predicted for NCX. Mechmann 
& Pott showed that Ca release from the SR (either spontaneous or induced by caffeine) 
generates an inward current which is consistent with NCX (Mechmann & Pott, 1986), 
see section 1.3.3.1. Since then, with refinements in experimental technique and 
acceptance that the stoichiometry of the exchanger is around 3:1, it has been 
established that the exchanger is electrogenic.
Studies have determined that operation of the sodium-calcium exchanger is bi­
directional -  depending on conditions it can either extmde calcium from the cell 
(“forward mode”) or bring calcium in (“reverse mode”). Thermodynamic 
considerations dictate that the direction in which the exchanger operates will depend on 
the gradients of [Na] and [Ca] and also on the membrane potential. Assuming a 
stoichiometry of 3Na:lCa, the equilibrium potential of NCX, Ej^ a,Ca, can be derived 
fr om the equation:
ENa.Ca = 3 Eno ~2 E ca  Equation 1.1
where E^a and Eca are the equilibrium potentials for Na and Ca calculated using the 
Nemst equation. At 37 “C, with physiological concentrations of ions ([Na], = 10 
mmol/L, [Na]o =140 mmol/L, [Ca]i =100  nmol/L, [Ca]o =1.8 mmol/L), Emq.co will be 
around -49 mV.
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1.3.2 Physiological role of NCX in the heart
1.3.2.1 Calcium extrusion & inward NCX current
In resting cardiac cells, the membrane potential {Em, around -80 mV), is negative to 
E}^ a,Ca and extrusion of Ca will be favouied. Studies have shown that under 
physiological conditions, NCX plays a crucial role in the extrusion of Ca from the cell 
(e.g. Bers & Bridge, 1989; Crespo et a l, 1990). Under steady-state conditions, the 
amount of Ca entering the cell, principally via L-type calcium channels, must be 
removed during the diastolic period. This is mainly brought about by NCX, with a 
small contribution from the sarcolemmal Ca ATPase (Bridge et a l, 1990). The relative 
contribution of different systems in the removal of Ca from the cytoplasm is discussed 
in more detail in sections 1.3.6 & 4.4.6.
The inward cunent generated by Ca extrusion may have a significant effect on the 
shape of the cardiac AP. In conditions where Incx is blocked, or [Ca]i is buffered, the 
AP plateau and duration are much reduced (Janvier et a l,  1997a; reviewed in Janvier & 
Boyett, 1996). Computer modelling also supports a role for inward Incx ^a maintaining 
the AP plateau (Noble et a l,  1991). Recovery of inward Ij^cx may also contribute to 
the time course of electrical restitution (Janvier et a l,  1997b).
1.3.2.2 Reverse-mode l^cx during the action potential
Determining N C X  function during the cardiac A P  is complicated, given the 
simultaneous changes in membrane potential, [N a], and [C a]i. In theory, during the 
early part of the A P  where the membrane potential is positive, subsarcolemmal [N a]i is 
elevated and [C a]i has yet to peak, conditions favour C a  entry via reverse-mode N C X .
21
There has been considerable debate in the literature as to whether reverse-mode N C X  
can trigger significant C a  release from the SR. In a study of rabbit ventricular 
myocytes, Litwin et a l provided evidence of putative reverse-mode Incx (sensitive to 
voltage, [N a]i, [Ca]o and nickel) with other significant currents blocked (Litwin et a l, 
1998). Sepai'ate experiments showed that the gain of SR C a  release was also dependent 
on voltage and [Na]i, as predicted if reverse-mode N C X  was contributing to C IC R . A 
previous paper from Bridge’s group also suggested that significant C a  entry could occui' 
on reverse-mode N C X  and that this could trigger SR release (Levi et a l, 1994), and 
similar findings have been reported elsewhere (Wasserstrom & Vites, 1996; Lipp & 
Niggli, 1994; Leblanc & Hume, 1990). Experiments such as these have supported the 
presence of a restricted (“fuzzy”) space beneath the sarcolemma where ion 
concentrations much higher than those in the bulk cytoplasm can be achieved (Lederer 
e ta l ,  1990).
Using an action potential clamp, Grantham & Cannell suggested that Ca influx via 
NCX was less than 30% of that via Ica, but may be enough to contribute to CICR 
(Grantham & Cannell, 1996). Subsequent experiments by the same group failed to 
show significant Ca influx or release due to reverse-mode NCX when Ica was blocked 
(Evans & Cannell, 1997). Furthermore, they suggested that in other published work 
supporting a contribution of reverse-mode NCX to E-C coupling, failure of adequate 
voltage control over the cell (due to large I^a cuirents), particularly within the dyadic 
clefts, might have allowed activation of Ica- Sham et al. reported similar results and 
conclusions (Sham et a l, 1992).
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Sipido et al. showed that Ca entry via NCX could trigger SR Ca release, but with low 
trigger efficiency and only after a significant delay (Sipido et a l,  1997). In the 
presence of Ica they could not detect a contribution of reverse-mode NCX to CICR at 
potentials below +60 mV. Thermodynamic constraints and modelling of the dyadic 
cleft also suggest that reverse-mode NCX is unlikely to be a significant trigger under 
physiological conditions (Cannell et a l, 1996).
Weber et a l recently presented an elegant approach to the problem (Weber et a l,
2002). Since I^cx will depend on submembrane (SM) [Ca], rather than bulk 
cytoplasmic [Ca], they derived a method for inferring [Ca]sM fi'om Ij^cx under 
controlled conditions. They then used this relationship to calculate [Ca]sM &t different 
times in the AP, using an inteiTupted AP clamp. This demonstrated that [Ca]sM is 
significantly higher than bulk [Ca] (peak of 3-4 pmol/L in their Figure 4) until 
repolarisation has occuiTed and bulk [Ca] is decaying. Ij^cx during the AP could then 
be modelled, based on [Ca]sM, and this suggested that very little reverse mode NCX 
occurred during the AP (perhaps only for the initial 19 ms of their 250 ms AP). Shnilar 
findings were obtained in non-failing human cardiac myocytes, however a greater 
contribution from reverse-mode NCX was found in failing human myocytes (Weber et 
a l,  2003).
1.3.3 Role of NCX in arrhythmogenesis
Two aspects of NCX function have raised interest in the fact that it could contribute to 
arrhythmic events: 1) the current it carries can potentially depolarise the membrane and 
if this depolarisation is sufficiently large it could trigger an action potential; 2) NCX 
activity can influence the amount of calcium in the SR and calcium overload is known
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to predispose to arrhythmias (Clusin et a l, 1983a). There is increasing evidence that 
NCX does indeed play a role in arrhythmogenesis, in particular it has been implicated 
in the phenomenon of “afterdepolarisations”. These are abnormal depolarisations 
occurring during or after the AP. Those occurring after the cell has ftilly repolarised 
are termed delayed afterdepolarisations (DADs), while those occuiTing during the 
plateau or repolarisation phases of the AP are known as early afterdepolarisations 
(EADs; Cranefield, 1975).
1.3.3.1 Delayed after depolarisations
It has been known for some time that manoeuvres which increase cellular Ca loading 
(e.g. cardiac glycosides or p-adrenergic stimulation) can lead to the appearance of 
DADs (see January & Fozzard, 1988 for review of early studies). Under voltage clamp 
conditions it was shown that these events were due to a transient inward current (///), 
and three potential charge-carriers were suggested: Incx, ^ Ca-activated chloride current 
{Ici(Ca)), and a Ca-activated non-specific cation current {Ins(Ca))- It was also realised that 
DADs were correlated with the intracellular release of Ca from the SR (either 
spontaneous or induced by caffeine application), and that if  SR function was disabled 
(e.g. with ryanodine) or if  [Ca], was heavily buffered, then they did not occur (Marban 
et a l, 1986). Early studies with imaging cameras (Miura et a l, 1993) or by analysis of 
sarcomere length (Capogrossi et a l, 1987) showed that these release events tended to 
spread as waves through the cell. With the advent of modern fluorescence imaging 
techniques, such as confocal microscopy, it has been possible to examine in detail the 
subcellular events which occur during spontaneous Ca release (e.g. Cordeiro et a l, 
2001). Such studies have shown spatially heterogeneous Ca release events at the
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periphery of the cell, which could propagate as waves and were accompanied by lu and, 
at times, triggered action potentials.
The current responsible for lu has been extensively investigated (reviewed by January 
& Fozzard, 1988; Schlotthauer & Bers, 2000; Bers, 2001). Ins(Ca) appears to have an 
insignificant role in most prepar ations studied, and the relative importance of In cx  and 
Icï(Ca) seems to vary depending on the species and origin of the myocytes used (atrial, 
ventricular or Purkinje cells). Both In cx  and Ici(Ca) were shown to contribute to lu  in 
canine (Zygmunt et a l,  1998) and sheep (Verkerk et a l, 2000) myocytes. In rat cells 
In cx  accounted for the majority of the current in control cells, but there was a greater 
contribution from Ici(Ca) in hypertrophied myocytes (Mészaros et a l,  2001). In rabbit 
ventricular myocytes, Schlotthauer & Bers found that lu was almost eliminated by 
removal of external Na, or in the presence of Ni (to block NCX), but was changed little 
by blocking Ici(Ca) with niflumic acid (Schlotthauer & Bers, 2000). They estimated that 
In cx  accounted for >90% of lu.
Thus, NCX plays a central role in the genesis of DADs and has therefore been 
implicated in triggered arrhythmias, such as the non-reentrant initiation of ventricular 
tachycardia (VT; January & Fozzard, 1988; Pogwizd et a l, 1999; Pogwizd et a l, 2001; 
Schillinger et a l,  2002). Additional factors which have been shown to be relevant in 
arrhythmogenesis include the SR Ca content, other cunents which tend to stabilise En, 
(e.g. the inward rectifier potassium cuirent, 1ki\  the profile of In (rapid or slow change 
in current; Pogwizd et a l,  2001), and diastolic [Ca] (Baartscheer et a l,  2003; Edgell et 
a l, 2000) and [Na] (Diaz et a l, 1996; reviewed by Bers, 2001), Arrhythmogenesis in 
heart failure is discussed further in section 3.4.
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When considering the causes of arrhythmias in vivo, it should also be remembered that 
changes at the single cell level must be related to the situation in the 3-dimensional 
syncytium of cells that exists in the heart. Neighbouiing cells can act as current 
“sinks”, reducing the effect, for example, of spontaneous Ca release in one cell. Thus, 
it may require simultaneous events in several cells for an arrhythmogenic 
afterdepolarisation to lead to a triggered arrhythmia (see Schlotthauer & Bers, 2000; 
Bers, 2001, Chapter 10).
1.3.3.2 Early after depolarisations
EADs tend to occur in situations where the AP is prolonged, and in a clinical context 
this would coiTespond to a prolongation of the QT interval, as seen in congenital or 
acquired long-QT syndromes. Patients with such conditions are prone to episodes of 
polymorphic VT (“torsade de pointes”), and EADs are implicated in this phenomenon. 
Volders et al. recently reviewed the literature on EADs, and the theories regarding 
which ionic currents are involved (Volders et a l, 2000). During the appropriate 
voltage “window” of the AP plateau and initial repolarising phase, sodium currents 
(Tva) aud L-type Ca cunents {Icaù niay be reactivated when a long AP has allowed 
sufficient recovery from channel inactivation (see Marban et a l,  1986; Volders et a l, 
2000). This can cause significant depolarisation of the membrane and triggering of a 
further arrhythmogenic AP. Beyond this phase, late EADs appear to be caused by a 
similar mechanism to DADs, i.e. through spontaneous release of Ca from the SR, with 
resulting inward currents (see Szabo et a l,  1995; Ming et a l, 1994). Thus, /yvcxhas 
also been implicated in EADs. Volders et al. postulated a further role for Incx, in that it
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provides inward current during the normal AP, which can prolong the plateau phase, 
making the reactivation of “window currents” more likely (Volders et a l,  2000).
1.3,4 Regulation of N C X
Calcium, as well as being one of the ions transported by NCX, also has an important 
role in the regulation of NCX function. In the presence of low internal [Ca], Ijqcx will 
inactivate, even when conditions otherwise favour ion transport (Miura & Kimura, 
1989). Thus, Ca appears to contribute to allosteric regulation of In c x -, and molecular 
studies have identified a site on the large cytoplasmic loop of the molecule where this 
may take place (Levitsky et a l, 1994; Matsuoka et a l,  1995). This site binds Ca 
cooperatively with a Hill coefficient of between 1.6 (Fang et a l,  1998) and -2  
(Levitsky et a l, 1994). Early studies suggested that the exchanger may be fully 
activated at relatively low [Ca]j (e.g. Miura & Kimura, 1989), however later 
experiments using giant excised patches have suggested that the K,n for Ca activation 
{KmCaAct) may lie within a physiologically-relevant range e.g. 300-600 nmol/L 
(Hilgemann et a l, 1992), -400 nmol/L (Matsuoka et a l,  1995). Reeves & Condrescu 
expressed NCXl in Chinese hamster ovary cells and obtained a K^coAct o f -300 nmol/L 
(Reeves & Condrescu, 2003). Interestingly, the activated state of the exchanger 
induced by Ca persisted for tens o f seconds after subsequent removal of Ca and it was 
proposed that this was due to a lasting conformational change and/or a persisting local 
elevation in Ca. It is likely that the local environment and regulation of NCX is 
substantially different in intact ventricular myocytes and this phenomenon has not been 
reported.
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Recently, Weber et al. demonstrated allosteric regulation of I n c x  in intact cardiac 
myocytes, by showing [Ca]i-dependent increases in outward I n c x  (Weber et a l, 2001). 
They used a simple voltage protocol to produce alternating inward and outward I n c x , 
whilst allowing control o f [Ca],. For each voltage step, mean I n c x  was plotted against 
mean [Ca]i and the resulting data-points were fitted using a model of NCX function to 
derive a value for KmCaAcu In ferret ventricular myocytes, they obtained a KmCaAci of 
125 ± 16 nmol/L. This implies that allosteric regulation of NCX by Ca could occur 
within the range of [Ca] seen on a beat-to-beat basis. In wild-type mouse ventricular 
myocytes, however, no appreciable allosteric regulation was observed. They were able 
to restore Ca activation by overexpressing canine NCX in mouse myocytes, and 
showed that if there was a mutation in the Ca regulatory domain (A680-685) then 
allosteric regulation was no longer conferred.
In a later paper, Weber et a l examined allosteric regulation in failing and non-failing 
human myocytes and found a similar KmCaAct for both (150 ± 31 nmol/L; Weber et a l,
2003). In this thesis, allosteric regulation of I n c x  was examined in ventricular 
myocytes from control rabbits and those exhibiting LV dysfunction. The voltage 
protocol employed was similar to that used by Weber et a l and further details are given 
in Chapter 3.
13,5 Uptake of Ca into the SR
13.5.1 SERCA structure, distribution & kinetics
SERCA proteins are members of the Mg-dependent P-type ATPase family, and are 
encoded by three different genes, displaying significant sequence homology 
(MacLennan et a l,  1997). Overall, SERCA has a widespread distribution in excitable
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and non-excitable cells, functioning to remove Ca actively from the cytoplasm against 
its concentration gradient. Particular SERCA isoforms are tissue specific, with 
SERCA la  found in adult fast-twitch skeletal muscle (replacing SERCAlb from 
foetal/neonatal tissues), SERCA2a found in the heail, and SERCA2b & 3 expressed 
more ubiquitously in non-muscle tissues (reviewed by Periasamy & Huke, 2001; 
MacLennan et a l,  1997).
SERCA2a is a 105 kDa protein consisting of a large cytoplasmic “head” (containing 
the nucleotide binding domain and phosphorylation site) connected by a “stalk” to the 
transmembrane and luminal domains. Hydrolysis of ATP appears to bring about a 
conformational change in the structure of SERCA, such that two Ca ions bound to the 
transmembrane domain ar e discharged into the SR lumen for each molecule of ATP 
consumed (MacLennan et a l,  1997). There is some variation in the reported of the 
SERCA pump for [Ca], which in part may be due to differences in the techniques used 
for its estimation. A reasonable estimate would be in the range of around 300 -  650 
nmol/L, with a Hill coefficient of 1.6 -  1.7 (see Movsesian & Schwinger, 1998; Bers, 
2001, Chapter 7). Thus, the K„i appears to be within the physiological range of 
cytoplasmic [Ca], and any shift in Km through regulation of the pump can have 
significant effects on Ca uptake. The turnover rate for each SERCA2a pump has been 
estimated to be around 10-15 Ca ions/s, and the SERCA pumps are present in the cell at 
a concentration of around 14 -  100 pmol/L cytosol (see Levitsky et a l, 1981; Bers, 
2001, Chapter 7). The expression level of SERCA appears to be critical for normal 
contractile function in the heart, since it contributes significantly to diastolic relaxation 
and replenishes the SR Ca stores for the next systole (Periasamy & Huke, 2001). The
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relationship between SERCA function and SR Ca content is discussed fuidher in 
Chapter 4, sections 4.4.2 & 4.4.3.
1.3.5.2 Regulation o f  SERCA2a
In the heart, SERCA2a is tightly regulated by the homopentameric phosphoprotein 
phospholamban (PLB), which has a total molecular weight of around 22 kDa (Frank et 
a l, 2003; Movsesian & Schwinger, 1998). PLB is present at a concentration of around 
2 -  2.5 PLB monomers per SERCA molecule (Colyer & Wang, 1991) and acts as an 
inhibitor of SERCA function, increasing the Kd for [Ca], with little change in the V^ax 
(reviewed by Frank ei a l ,  2003). The regulatory action of PLB can have important 
implications for contractile function. Sato et a l demonstrated that knockout of PLB 
could reverse some of the abnormalities of CICR and Ca handling which occur when 
calsequestrin is overexpressed in mice (Sato et a l, 2001).
Phospholamban itself can be phosphoiylated at three sites -  by PKA, Ca-activated 
phospholipid-dependent protein kinase C (PKC), and Ca / calmodulin-dependent 
protein kinase II (CaMKII). PKA phosphorylation blocks the interaction of PLB with 
SERCA, shifting the Kd for [Ca] to the left and restoring function (see Colyer & Wang, 
1991; Frank et a l,  2003; Rapundalo, 1998). CaMKII phosphorylation also lowers the 
Kd for [Ca] of SERCA, and may also increase the Vmox (see Frank et a l, 2003). 
CaMKII may also be able to directly phosphorylate SERCA and RyR, altering their 
activity (Wehrens et a l ,  2004; reviewed by Bers, 2001). The functional significance of 
PLB phosphorylation by PKC in vivo is unclear.
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13.6 Other mechanisms for removal of cytosolic Ca
NCX and SERCA are the main mechanisms by which Ca is removed from the 
cytoplasm during systole. A lesser role is played by the sarcolemmal Ca-ATPase 
(another P-type ATPase) and uptake o f Ca into other organelles, for example via the 
mitochondrial uniporter. These other removal mechanisms are often refen*ed to as the 
“slow systems”. The relative contribution of the different removal systems to the 
decline in Ca during a twitch or caffeine application has been extensively investigated 
by Bassani and co-workers (e.g. Bassani et a l, 1992; Puglisi et a l,  1996; Bassani et a l,
1994). They used selective block of each system and determined the change in the 
time-course of Ca decline or myocyte relaxation. From such experiments they 
concluded that the slow systems were responsible for 1-3% of Ca removal during a 
twitch, depending on the species studied (rabbit or rat) and the experimental conditions. 
Negretti et a l found a similar contribution from the slow systems in the rat, with 1.7% 
of removal attributed to mitochondrial uptake and 2.6% to the sarcolemmal Ca-ATPase 
(Negretti et a l, 1993). Choi & Eisner also examined the role of the sarcolemmal Ca- 
ATPase in rat cells (Choi & Eisner, 1999a; Choi & Eisner, 1999b). By comparing Ca 
entry via Ica and Ca efflux in diastole (which must balance at steady state), and using 
the blocker caihoxyeosin, they concluded that the sarcolemmal Ca-ATPase contributed 
around 24% of the total Ca efflux from the cell (Choi & Eisner, 1999a). This also 
equates to around 3% of total removal, if it is assumed that the SR removes 87% 
(Negretti et a l,  1993).
The relative contribution of different systems to Ca removal in the rabbit differs to 
values determined for the rat (see Bassani et a l, 1994). This is discussed further in
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Chapter 4, section 4.4.6, along with the findings in the model of HF studied in this 
thesis.
1.4 Calcium handling in heart failure
There is an extensive literature on the changes in Ca handling in heart failure, with 
many different animal models of the condition, and a full review is beyond the scope of 
this thesis. Some relevant points will be discussed here and, in addition, pertinent 
findings are included in each results chapter.
1.4.1 Contractile abnormalities in heart failure
At a basic mechanistic level, the reduced strength of myocyte contraction in heart 
failure could be due to smaller Ca transients or altered myofilament function (for 
example reduced sensitivity to [Ca]). Of course, a combination of both may be 
involved. Changes in myofilament function have been investigated by a number of 
workers and altered levels of contractile proteins, cross-bridge cycling and 
phosphorylation state have been reported. Intrinsic [Ca]-sensitivity of the 
myofilaments does not appear to be greatly altered in HF (reviewed by Mittmann et al., 
1998).
There has been much interest in documenting the abnormalities in Ca handling in 
failing or hypertrophied myocytes. In general, Ca transients are smaller in amplitude 
and have a slower upstroke and decline (reviewed by Balke & Shorofsky, 1998; 
Wickenden et a l, 1998; Houser & Margulies, 2003). Such findings in animal models 
of HF are discussed in section 4.4.1. In studies of human HF, a similar situation has 
been demonstrated (see Piacentino III et a l,  2003; Pieske et a l,  1999; Davies et a l.
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1995; Sipido & Callewaert, 1995; reviewed in Hasenfuss & Pieske, 2002; Balke & 
Shorofsky, 1998), and is particularly evident at higher stimulation rates. This negative 
force-frequency relationship (i.e. as stimulation frequency increases, force [or cell 
shortening] decreases) is a common finding in HF. Given the previous discussion on 
E-C coupling and Ca removal, it will be apparent that defects at many different levels 
could result in impaired Ca handling and hence contractile dysfunction.
1.4.1.1 L-type calcium current
Rather heterogeneous results have been obtained when Ica.i has been studied in animal 
models of hypertrophy and HF (reviewed by Richard et al., 1998; Hasenfuss, 1998). In 
general, in animals with HF it appears to be unchanged or downregulated (see Table 1 
in both review papers), and there may be differences depending on the stage of HF that 
is studied (Hasenfuss, 1998). Recently, He et al. studied Ica,L in dogs with pacing- 
induced HF and demonstrated that the overall current density and I~V characteristics 
were unchanged, but the number of channels (estimated from the intramembrane 
charge movement due to Ica gating) was reduced by >50% in HF (He et a l, 2001). 
This implies some upregulation of the function of individual channels. The findings 
were also associated with abnormalities of T-tubule structure (see section 3.4.4).
Studies in human myocytes also suggest little change in Ica under baseline conditions 
(see Piacentino III et a l, 2003; Hasenfuss & Pieske, 2002; Hasenfuss, 1998; Richard et 
a l,  1998), although one study showed a significant decrease in Ica current density and 
Ca entry (Tenacciano et a l ,  2003). Regulation of Ica may be altered in failing 
myocytes and Piot et a l reported that the response to increased frequency of
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stimulation was different, with failure of the cunent to augment in cells from patients 
with an ejection fraction (EF) <40% (Piot et al., 1996).
1.4.1.2 SRC a content
Given the almost exponential relationship between SR Ca content and SR Ca release 
(see section 1.2.4.1), there has been much interest in determining whether this is the 
primary defect in HF. In 1998, Lindner et al. demonstrated that caffeine-induced Ca 
transients were reduced by around one half in ischaemic and dilated caidiomyopathy in 
humans (Lindner et a l, 1998). They also showed that there was a significant positive 
correlation between the size of the caffeine-induced Ca transient and the EF for each 
patient (r=0.76). They suggested that the altered SR content was sufficient to explain 
the defective Ca transients in HF. In a later study, Pieske et al. used rapid cooling 
contractures (RCCs) to estimate SR Ca content in 26 failing and 4 non-failing human 
hearts (Pieske et a l ,  1999). Although they do not report absolute values for developed 
tension during RCCs under baseline conditions, they showed that SR content fell 
during long rest intervals and augmented little as stimulation frequency increased in 
failing muscle strips, compared to non-failing muscle. In a recent paper, Piacentino III 
et a l showed that SR content was reduced by around 42% in failing cells, mainly as a 
result of diminished uptake by SERCA, and contended that this abnoimal SR function 
accounted for the smaller Ca transients and slower [Ca] decline in HF (Piacentino III et 
a l, 2003). However, not all studies demonstrate reduced SR Ca content in human HF 
(Terracciano et a l, 2003).
Reduced SR Ca content has been found in canine (Hobai & O'Rourke, 2001; Pu et a l, 
2000), rabbit (Pogwizd et a l,  2001; Baartscheer et a l,  2003) and ferret (Diaz et a l.
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2004) models of HF or hypertrophy. Some studies of HF in the rat have revealed 
unchanged SR Ca content (McCall et a l,  1998; Gomez et a l,  2001), although Zhang et 
a l did find smaller caffeine-induced contractures after MI (Zhang et a l ,  1999). Studies 
in this thesis included an estimation of the Ca content of rabbit ventricular cells 8 
weeks after MI (see Chapter 4).
Given the general finding of reduced SR Ca content in HF, the documentation of 
triggered arrhytlimias which rely on SR Ca overload seems paradoxical. Pogwizd et al 
attempted to explain this paradox in their combined pressure and volume overload 
model of HF in the rabbit (Pogwizd et a l, 2001). They showed that although the SR 
content was reduced in HF, the cells retained p-adrenergic responsiveness and in the 
presence of isoproterenol the SR content would rise (tlrrough stimulation of SERCA) to 
the point where spontaneous release would occur. The tlireshold level of SR [Ca] for 
spontaneous release was no different to control cells (around 100 pmoI/L cytosol) but 
they postulated that the increased NCX and lower inward rectifier current (Jki) in HF 
meant that a given SR release was more likely to trigger an AP.
1.4.1.3 SERCA function and regulation by PLB
One critical determinant of SR Ca content is the level of activity of SERCA. 
Numerous studies have examined SERCA2a expression and function in heart failure. 
Hasenfuss & Pieske summarise the results of 11 studies of SERCA protein levels in 
HF, and the majority showed a significant reduction (Hasenfuss & Pieske, 2002). This 
also appears to be the case for mRNA levels and functional studies (summarised by 
Bers, 2001, Table 26; Houser et a l, 2000). Similar findings have been reported for 
animal models of HF (e.g. O'Rourke et a l,  1999; Yao et a l, 1998; reviewed by Phillips
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et a l ,  1998; Hasenfuss & Pieske, 2002). Studies on the rabbit infarct model of HF are 
discussed in Chapter 4, section 4.4.2.3.
Several groups have also studied the expression of PLB in HF, and most report that it is 
unchanged or reduced. However, given that in general there is a greater reduction in 
SERCA expression in HF, the ratio of PLB to SERCA may rise, indicating higher basal 
levels of inhibition (reviewed by Hasenfuss & Pieske, 2002). There may also be 
changes in the phosphorylation state of PLB (Currie & Smith, 1999; reviewed by 
Sjaastad et a l, 2003; Bers, 2001, Chapter 10).
L4.1.4 RyR function & SR Ca leak
A  number o f groups have reported reduced RyR expression in animal models of HF 
(e.g. reduced [^H] lyanodine binding in a rabbit pressure-overload model; Milnes & 
MacLeod, 2001), although the situation in humans appears to be more heterogeneous 
(reviewed by Hasenfuss & Pieske, 2002; Bers, 2001, Table 26). One recent theory is 
that the abnormalities seen in HF may be due to defective regulation of RyR. As 
outlined in section 1.2.3.2, Marks’ group have suggested that alterations in RyR- 
FKBP12.6 interactions could have profound effects on channel function, with 
phosphorylation of RyR leading to dissociation of FKBP12.6, causing abnormal gating, 
“leaky” channels and reduced SR Ca content. There has been considerable debate as to 
the importance of this mechanism in HF (Eisner & Trafford, 2002; Bers et a l, 2003). 
Marx et a l  reported that PKA phosphorylation of RyR was around four times higher in 
tissue fi'om failing human hearts and from dogs with pacing-induced HF (Marx et a l ,
2000). They proposed that this could account for the contractile abnormalities that 
were observed. However, Jiang et a l also examined RyR levels, function and
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phosphorylation state in human tissue and canine pacing-induced HF (Jiang et a l, 
2002). They found no difference in RyR protein density, [^H] ryanodine binding, 
channel open probability or presence of subconductance states in failing tissue. 
Similarly, phosphorylation levels of RyR were no different, and when PKA was 
incubated with RyRs there was no evidence of dissociation of FKBP12.6. There are 
also theoretical reasons why alterations in RyR function alone may not alter steady- 
state Ca transients, even in the face of reduced SR Ca content (discussed in detail in 
section 5.1.1.1). Thus, the debate regarding RyR function in HF has yet to be resolved.
1.4.1.5 Gain o f  E~C coupling
Given that Ica flux may be changed little in HF (see section 1.4.1.1), if  Ca transients are 
smaller then the amount of Ca released from the SR must be reduced, and the overall 
“gain” of E-C coupling will be lower. As discussed previously, E-C coupling gain is 
dependent on SR Ca content and in many cases this may be the underlying defect 
which causes the reduced gain in HF (e.g. Hobai & O'Rouike, 2001; Pogwizd et a l,
2001). However, some groups have reported reduced gain even in the presence of 
maintained SR content. Gomez et a l studied Ca handling in rat cells following MI, 
and showed that under conditions where caffeine-induced Ca transients were similar, 
A[Ca]i//ca was reduced compared to control cells (Gomez et a l,  2001). They suggested 
that this could be due to altered organisation of DHPR and RyR in HF, with 
“mismatch” of proteins, increased size o f the dyadic cleft or “orphan” RyRs due to T- 
tubule remodelling (see He et a l,  2001). Some other means by which SR Ca release 
could be smaller for a given Ica flux can be postulated by considering the reverse of the 
mechanisms outlined in Figure 1.2.
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Milnes & MacLeod found that the ratio of RyR to DHPR was reduced in a pressure- 
overload model of left ventricular hypertrophy (LVH) in the rabbit, and suggested that 
this could account for slowed contraction in this model (Milnes & MacLeod, 2001). 
Litwin et al. suggested that a similar situation could exist in the rabbit infarct model of 
HF (Litwin et a l,  2000). They documented that Ca sparks in this model were 
dyssynchronous, and correlated this with the slowed upstroke of Ca transients.
Again, there are theoretical grounds to suggest that cells may compensate for some of 
the above abnormalities, with changes in SR content. This is discussed in more detail 
in sections 5.1.1.1 and 5.4.I.2.
1.4.1.6 NCX
There has been considerable interest in the expression, activity and regulation of NCX 
in heart failure, given its central role in Ca removal (section 1.3.2.1) and 
arrhythmogenesis (section 1.3.3). In addition, the balance between NCX and SERCA 
in the removal of cytoplasmic Ca may influence SR Ca content and therefore could 
affect systolic Ca release. The findings in a large number of studies of animal and 
human HF / hypertrophy were recently reviewed by Sipido et a l (2002). They show 
that there is considerable heterogeneity in the results reported in the literature -  for 
example in 29 animal studies, 14 reported an increase in NCX expression and/or 
function, whilst 10 showed a decrease, and 5 no change. Variables such as the means 
of producing HF / hypertrophy, the time when cells or tissues were studied and the 
investigative techniques used (biochemical / functional) can all have a bearing on the 
results achieved. Chapter 3 addresses NCX function in the rabbit infarct model of HF,
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and the relevant literature regarding NCX in human and animal HF is reviewed in 
detail in that chapter (sections 3.4.2 & 3.4.5).
1.5 Regional differences in ion channels and Ca handling
Given the functional, structural and electrical specialisation of different regions of the 
heart, it is not suiprising that ion channels and Ca handling proteins vary at a cellular 
level. Differences can be considered in a number of planes, for example: atrium- 
ventricle, apex-base, LV-RV and transmurally (endocardium-epicardium). In some 
models of heart failure, other considerations can be made -  for example cells differ in 
the peri-infarct zone from those at more remote sites -  variation in the expression of 
NCX and SERCA between these areas have been reported (Yoshiyama et a l, 1997; 
Wasserstrom et a l,  2000).
Schram et a l recently reviewed the expression of ion channels in different regions of 
the heart and documented the marked differences in action potential shape and 
underlying cellular currents (Schram et a l, 2002). Previously, Antzelevitch had 
reviewed such differences in the ventricle (Antzelevitch et a l, 1991). Cells from the 
epicardium demonstrate a prominent “spike and dome” in the AP shape, compared to 
endocardial cells, which have a flatter plateau and longer action potential duration 
(APD), features which are important in producing the T-wave on the surface 
electrocardiogram. Epicardial cells have a larger transient outward current {Ito) which 
may be a consequence of differing expression of certain K-channel isoforms (see 
Schram et a l, 2002). The longer APD in endocardial cells has been shown previously 
for the animals used in this thesis (McIntosh et a l , 1998; McIntosh et a l , 2000). These 
AP differences and variation in properties of Lo have also been demonstrated for human
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cells, and changes have been shown in failing hearts, with a selective fall in Lo in 
epicardial cells (Nabauer et a l,  1996).
In addition to mediating repolarisation of the cardiac AP, potassium currents have 
important membrane-stabilising effects, and downregulation of some such currents has 
been linked to an increased likelihood of arrhythmias (Pogwizd et a l, 2001). 
Endocardial-epicardial gradients in the inward rectifier K-current {In) and delayed 
rectifier current {In  & h s )  may exist in some species (reviewed by Schram et a l,
2002), although no significant difference in I n  was found in the rabbit (McIntosh et a l , 
1998).
The distribution of other ion channels and transporters has also been investigated, 
although few studies have examined NCX. Bryant et a l reported no significant 
difference between endocardial and epicardial cells in Ca-activated tail currents 
induced by interrupted AP clamp protocols (Bryant et a l, 1997). However the 
amplitude of this current will also depend on the cytoplasmic [Ca] at the point where 
the AP is interrupted, and this was not measured in the study. Zygmunt et a l used two 
methods to estimate Incx in cells from different transmural regions in the dog (Zygmunt 
et a l,  2000). The most valid measure was made by rapidly removing external Na and 
examining the resulting current, and this showed no significant difference between 
endocardial and epicardial cells. However, this only measures In c x  in one direction 
(outward) and at a fixed membrane potential. Experiments in this thesis examined 
transmui’al differences in In c x  va  more detail (Chapter 3).
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Transmural Ca handling characteristics have also been reported in the literatuie. 
McIntosh et al. showed longer Ca transients in endocardial cells compared to epicardial 
cells in the rabbit, without significant differences in diastolic or peak systolic [Ca] 
(McIntosh et al., 2000). Similar results for the Ca transient amplitude have been found 
in the rat (Chamunorwa & O'Neill, 1995), although diastolic and systolic [Ca] appear to 
be higher in endocai’dial cells (Figuerdo et a l,  1993). The decay of Ca transients has 
been shown to be longer in endocaidial sites (Laurita et a l , 2003). The expression of 
certain Ca handling proteins has also been examined and the findings for SERCA and 
RyR are discussed in sections 4.4.2.1 and 5.4.1.1, respectively.
This thesis examines in detail several aspects of Ca handling in endocardial and 
epicardial cells from rabbits under control conditions and 8 weeks following 
myocardial infarction.
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CHAPTER 2
GENERAL METHODS AND CHARACTERISTICS OF ANIMAL 
MODEL
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2.1 Animal models of heart failure
As discussed in the previous chapter, heart failure due to left ventricular dysfunction is 
an increasing problem in the Western world, causing significant morbidity, mortality 
and cost to the healthcare system. Significant advances have been made in the 
management of condition, but there is still much to be learned about the underlying 
cellular processes involved. Animal models of LVD have played an important role in 
advancing the understanding of the pathophysiology of heart failure.
There are many animal models of heart failure in the literature, using a number of 
different species. Methods of induction of LVD include myocardial infarction (Litwin 
& Bridge, 1997; Zhang et a l,  1996), pressure overload (Wang et a l, 2001b), combined 
pressure and volume overload (Pogwizd et a l, 1999), rapid pacing (Yao et a l, 1998; 
Hobai & O'Rourke, 2000), complete atrioventricular block (Sipido et a l, 2000), and 
infusion of catecholamines (Muders et a l, 1999) or cardiotoxic substances (Amolda et 
a l,  1985; Shah et a l, 1997). There will always be concern over extrapolating results 
from animal models to the situation in humans. In order to minimise these concerns it 
is desirable to choose a model which mimics human pathophysiology as closely as 
possible. This study used a rabbit model of LVD, eight weeks after myocardial 
infarction, a model which has several advantages.
Firstly, coronary artery disease, and in particulai' myocai’dial infarction, is the 
commonest cause of heart failure in humans (reviewed by McMurray & Stewart, 2000) 
so it is an advantage to use a model where similai' haemodynamic alterations may 
occur. The coronary structure of the rabbit is similar to that of the human, with little 
collateral circulation, unlike that of other animals such as the guinea pig (Maxwell et
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a l,  1987). After infarction there is a similar process of thinning / scaning of the 
infarcted zone and hypertrophy of the remaining LV tissue (Pye et a l,  1996; Burton & 
Cobbe, 2000).
Secondly, this model has been well characterised in terms of haemodynamic function 
and arrhythmias. Pye et a l found a good correlation between echocardiographic 
measurements of ejection fraction and invasive measures of cardiac output (r=0.78 for 
in vivo cardiac index, r=0.84 for in vitro cardiac index; Pye et a l,  1996). They 
obsei-ved a 35% reduction in EF and significant reductions in cardiac output following 
infarction. The animals often exhibited signs of congestive cardiac failure, with pleural 
effusions, ascites or scrotal oedema (Pye & Cobbe, 1996). Using an extrastimulus 
protocol, it was found that ventricular arrhythmias were more easily induced in failing 
hearts (Pye & Cobbe, 1996). Indeed, in animals which survive the initial postoperative 
period, there is an increased mortality rate amongst those which have undergone 
coronary ligation. Kaplan-Meier survival curves for sham-operated (Sham) and LVD 
animals are shown in Figme 2.1 (Dr M. Hicks, unpublished observations). Although 
unconfirmed, it is likely that these deaths ai’e due to ventricular arrhythmias. Similarly, 
in human heart failure ventricular arrhythmias are the commonest cause of sudden 
death following myoeai'dial infaiction (Undeiwood et a l,  1997).
Thirdly, the size of the rabbit heait allows reliable isolation of cells from different 
regions, both along the apex-base axis and transmurally. As discussed in Chapter 1, 
regional differences in single cell electrophysiology have been demonstrated in a 
number of species. Reproducible isolation of cells hom different regions allows further
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Figure 2.1 Kaplan-Meier survival curves for sham-operated and LVD 
animals.
study of this phenomenon and also ensures that cells from like regions are used when 
compai'ing control animals to those with LVD.
Fourthly, as discussed in Chapter 1, aspects of cellulai* calcium handling differ between 
species. The rabbit, like non-failing human tissue, exhibits increased twitch force as 
the stimulation frequency increases (positive force-frequency relationship; Maier et al., 
2000; Pieske et al., 1999). In contrast, in the rat there is a negative force-frequency 
relationship (Maier et al., 2000). The relative contribution of different calcium removal 
systems (NCX, SERCA, “slow” systems) to the decay in [Ca]i during diastole appears 
to be similar in rabbit and non-failing human cells (Bers, 2000). The situation in failing 
human tissue is more complex and the adaptive (and maladaptive) responses may differ 
according to the pathophysiology of the ventricular dysfunction and the time-course of 
remodelling.
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2.2 Coronary artery ligation procedure
All procedures were carried out in accordance with the United Kingdom Animals 
(Scientific Procedures) Act 1986. The coronary artery ligation technique was 
performed as previously described (Pye & Cobbe, 1996; Pye et a l, 1996; Ng et a l, 
1998; McIntosh et a l, 2000). The operative procedures and echocardiographic 
characterisation of the animals was performed by technical staff in a separate 
laboratory.
Male New Zealand White rabbits (12 weeks old, 2 . 5 - 3  kg) were pre-medicated with 
0.4 mL/kg intramusculai' Hypnorm (0.315 mg/mL fentanyl citrate; 10 mg/mL 
fluanisone; Janssen Pharmaceutica, Beerse, Belgium) and given antibiotic prophylaxis 
with 100 mg intramuscular Amfipen (Mycofaim UK Ltd, Cambridge, UK). The 
marginal ear vein was cannulated and anaesthesia was induced with 0.25-0.5 mg/kg 
midazolam (Hypnovel; Roche, Basel, Switzerland). The animal was intubated and 
anaesthesia was maintained with 1% halothane in a 1:1 mixture of oxygen and nitrous 
oxide, delivered by a Harvard small animal ventilator (Harvard Apparatus Ltd, 
Edenbridge, Kent, UK). Access to the heart was obtained by a left thoracotomy 
tlnough the fourth intercostal space. The marginal branch of the circumflex coronary 
artery, which supplies most of the left ventricular free wall, was identified and ligated 
mid-way between the atrioventricular groove and the apex. This produces a 
homogeneous infarcted area comprising 30-40% of the left ventricle. 10 mg/kg 
quinidine hydrochloride (Sigma-Aldrich Company Ltd, Poole, Dorset, UK) was 
administered prophylactically as an antiarrhythmic agent, but in approximately 30% of 
cases ventricular fibrillation occurred, requiring a 5-10 J epicardial direct current shock 
to restore sinus rhythm. After ensuring the animal was stable, the thoracotomy was
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closed and animals were given 20 mL intravenous saline to replace operative losses. 
Analgesia was administered (0.04 mg/kg intramuscular buprenorphine hydrochloride; 
Reckitt Benckiser Pharmaceuticals Inc., Richmond, VA, USA) immediately after 
operation and again the next morning. During recovery animals were monitored for 
signs of distress. Sham-operated animals underwent the same surgical procedure, with 
the exception of the coronary tie.
2*2.1 Characterisation o f  model
One week before animals were sacrificed they were assessed by echocardiography 
(Sonolayer 100, Toshiba Medical Systems Europe Ltd, Zoetermeer, Netherlands) using 
a 5 MHz paediatric probe, under sedation with 0.3 mg/kg Hypnorm. Measurements of 
left ventricular end-diastolic dimension (LVEDD) and left atrial dimension (LAD) 
were taken from a parasternal long-axis view. Ejection fraction was assessed from the 
parasternal short axis view.
The haemodynamic changes induced by cardiac failure (e.g. increased pre-load) can 
lead to altered hydrostatic pressures in the tissues, causing venous distension and tissue 
oedema. Once animals had been sacrificed and their hearts removed for myocyte 
isolation, the liver and lungs were dissected out and weighed (wet, after blotting) to 
look for signs of congestion.
A summaiy of echocardiographic and pathological findings is presented in Table 2.1. 
It is apparent that the animals in the LVD group had a much-reduced EF (47.1 ± 0.9 % 
vs 71.7 ± 0.8 %; p<0.0001) and this was accompanied by cardiac enlargement and 
greater liver and lung weights (see table).
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Sham (n) LVD (n) p-value
Animal weight (kg) 3.6 ±0.05  (39)
3.5 ±0.04  
(49) 0.11
Liver weight (% 
bodyweight)
2.52 ± 0.06 
(32)
2.73 ± 0.07 
(41) 0.04
Lung weight (% 
bodyweight)
0.29 ± 0.03
(3)
0.44 ± 0.02 
(33) 0.04
LV ejection fraction 71.7 ± 0 .8  (38)
47.1 ±0 .9  
(47) <0.0001
LV end-diastolic 
dimension (mm)
17.7 ±0 .2  
(37)
20.9 ± 0.2 
(47) <0.0001
LA dimension (mm) 12.8 ±0.2  (38)
15.6 ±0.2  
(47) <0.0001
Table 2.1 Baseline characteristics of rabbit infar ct model of LVD.
2.3 Cardiac mvocvte isolation
Eight weeks after the coronary ligation procedure, animals were killed with 0.5 mL/kg 
of intravenous Euthatal (200 mg/mL sodium pentobarbitone, Rhone Mérieux Inc, 
Athens, GA, USA), mixed with 500 lU of heparin (CP Pharmaceutical Ltd, Wrexham, 
UK). The heart; was rapidly excised, including ~1 cm of the ascending aorta, and 
placed in ice-cold BK solution (all solution compositions described in section 2.5.1). It 
was then perfused retrogradely via a cannula in the aorta (Langendorff technique) with 
150 mL nominally Ca-free BK solution at 37 °C at a rate of 25 mL/min. Next, the heart 
was perfused with enzyme solution, which was re-circulated, and after 2-3 minutes, 100 
mmol/L CaCl2 solution was added to give a concentration of 0.05 mmol/L. Digestion 
was continued for 6-9 min, until the heart began to soften to the touch. At this point the
48
heart was perfused with 100 mL of bovine serum albumin (BSA) solution containing 
0.075 mmol/L Ca. Towards the end of the perfusion, the atria and right ventricle were 
removed and discarded. The apical area of infarction, with a 3-5 mm rim of non- 
infarcted tissue, was removed. Histological studies have shown that this will remove 
myocytes from the peri-infarct border zone (Burton & Cobbe, 2000). In the case of 
sham-operated animals, an equivalent-sized area was removed from the apex. The 
remaining basal LV tissue was cut down and placed into a Petri dish containing 0.075 
mmol/L Ca BSA solution. Using fine forceps and scissors, small pieces of tissue 
around 1 mm deep were dissected from the subendocardial (Endo) and subepicardial 
(Epi) surfaces in turn, and placed into 10 mL of BSA solution in 25 cm^ tissue culture 
flasks (Bibby Sterilin Ltd, Stone, Staffordshire, UK). The remaining mid-myocardial 
layer o f tissue was also cut into small pieces and placed into a flask. The three flasks 
were placed in a shaking water bath at 37 °C for 1 hr (first digest) or 2 hr (second 
digest), whereupon the cell suspension from each flask was removed into 15 mL 
centrifuge tubes (Elkay Laboratory Products Ltd, Basingstoke, Hampshire, UK) and 
gently spun down. The supernatant was removed and replaced with 0.125 mmol/L Ca 
BSA solution, the cells were then spun down again and the supernatant replaced with 
0.25 mmol/L Ca BSA solution. The cells were then allowed to settle under gravity and 
the [Ca] was increased in stages to 0.5 mmol/L and then 1 mmol/L.
The cell yield did not differ significantly between Sham and LVD animals. Cells were 
stored in 1 mmol/L Ca BSA solution at room temperature for up to 8 hr until used. 
Experiments were only performed on rod-shaped cells with cleaiiy visible striations 
and no evidence of spontaneous activity.
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2.4 Virus transfection and cell culture
When cells were required for culture, myocytes from the septum were used and the 
above process was carried out using sterile techniques and sterile-filtered solutions. 
Once cells were in 1 mmol/L Ca BSA solution they were allowed to settle and then re­
suspended in 15 mL cell culture medium (see section 2.5.2) at a density of 1x10^ 
rods/mL. The resulting cell suspension was added to a 75 crn^ culture flask (Iwaki 
brand, Bibby Sterilin Ltd, Stone, Staffordshire, UK) and the appropriate virus was 
added at a multiplicity-of-infection (MOI) of 100. Adenoviruses were kindly supplied 
by Dr J. Trestle (University of Gottingen, Germany). Cells were transfected with NCX 
adenovirns, and compared with two control groups. For a non-transfected control 
group, cells were treated as above, with the exception of the addition of the virus 
solution. A transfected control group was achieved by incubating with an adenovirus 
encoding p-galactosidase (Lac-Z gene). Cells were cultured for up to 2 days at 37 °C 
in a 5% CO2 incubator (Napco, Winchester, VA, USA).
2.5 Solutions
The following solutions were used (concentrations in mmol/L, except where stated 
otherwise). In each case, solutions were brought to the correct pH at the appropriate 
temperature. Chemicals were purchased from Sigma (Sigma-Aldrich Company Ltd, 
Poole, Dorset, UK) or BDH (marked with asterices; BDH Laboratory Supplies, Poole, 
Dorset, UK) unless otherwise indicated.
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2.5.1 Solutions for cell isolation procedure
2.5.1.1 Base Krebs ’ (BK) solution
NaCl (120), KCl* (5.4), N-(2-hydroxyethyl)piperazine-N’-(2"ethanesulphonic acid) 
(HEPES, 20), NaH2? 0 4 * (0.56), MgCli (3.5), 2-aminoethanesulfonic acid (taurine, 20), 
N-ainidinosarcosine(a-methylguanido)acetic acid (creatine, 10), glucose (11.1); pH 
adjusted to 7.4 with NaOH. Nominally Ca-free, and 0.075 mmol/L Ca solutions were 
made up.
2.5.1.2 Enzyme solution
0.67 mg/mL collagenase (Worthington Biochemical Corporation, Lakewood, NJ, USA) 
and 0.04 mg/mL protease were added to the BK solution,
2.5.1.3 BSA solution
1 mg/mL BSA (fraction V) solution was made up using BK solution, with the 
following Ca concentrations: 0.075, 0.125, 0.25, 0.5, and 1.
2.5.2 Cell culture medium
The following compounds were added to Medium 199 (M-199, HEPES modification): 
taurine (5), p-hydroxy~'y-(trimethylammonio)butyrate (DL-camitine, 5), creatine (5), 5 
mL lOOx penicillin-streptomycin solution (final concentration: 100 units/mL penicillin, 
0.1 mg/mL streptomycin). The solution was passed through a sterile filter (0.2 
pmol/L, Sartorius Ltd, Epsom, Surrey, UK).
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2.5.3 Normal Tyrode*s (NT) solution
NaCl (140), KCl* (4), HEPES (5), MgCE (1), CaClz* (1.8), glucose (11.1); pH 
adjusted to 7.4 with NaOH. Phosphate was omitted from this solution since it caused 
precipitation in nickel-containing solutions.
2.5.4 Solutions for NCX & SERCA activity studies (Chapters 3 ,4  & 5)
2.5.4.1 Superfusate
As for NT, with added 4-aminopyridine (5 mmol/L, to block K currents) and niflumic 
acid (0.1 mmol/L, to block Ca-activated Cl cuiTents); pH adjusted to 7.4 with HCl.
2.5.4.2 Pipette solution
KCl* (20), K aspartate (100), tetraethylammonium chloride (TEACl, 20), HEPES (10), 
MgCL (4.5, calculated free [Mg] » 0.9 mmol/L, using the computer program “React 
11”, G.L.Smith & L.S.Duncan, University of Glasgow), disodium ATP (4), disodium 
creatine phosphate (1), EGTA (0.01); pH adjusted to 7.25 with KOH.
2.5.5 Solutions for NCX current density studies (Chapter 3)
2.5.5.1 Superfusate
NaCl (140), CsCl (4), HEPES (5), MgCE (1), CaCL* (1.8), glucose (11.1), N- 
acetylstrophanthidin (0.01, to block Na-K pump) and nifedipine (0.01, to block Ica.ù'  ^
pH adjusted to 7.4 with NaOH.
52
2.5.5.2 Pipette solution
CsCl (45), EGTA/CaEGTA (Cs 100, EGTA 50, Ca 25, calculated free [Ca] = 258 
nmol/L), HEPES (20), MgCE (11, calculated free [Mg] « 1.2 mmol/L), disodium ATP 
(10); pH adjusted to 7.25 with CsOH.
2.5.6 Solutions for studies of Allosteric regulation of NCX (Chapter 3)
2.5.6.1 Superfusate
NaCl (140), CsCl (4), HEPES (5), MgCL (1), CaCL (1.8), glucose (11.1), N- 
acetylstrophanthidin (0.01), nifedipine (0.01) and niflumic acid (0.1) pH adjusted to 7.4 
with NaOH.
2.5.6.2 Pipette solution
CsCl (20), Cs aspartate (100), tetraethylammonium chloride (TEACl, 20), HEPES (10), 
MgCL (4.5, calculated free [Mg] % 0.9 mmol/L), disodium ATP (4), disodium creatine 
phosphate (1), EGTA (0.01); pH adjusted to 7.25 with CsOH.
2.6 Rapid solution switcher
A heated rapid solution switcher was custom-built as outlined in Figure 2.2. The 
solution heater consisted of a drilled aluminium block (35 mm x 18 mm x 3 mm), 
heated by two 15 mm x 15 mm Peltier devices (RS components Ltd, Corby, 
Northamptonshire, UK) controlled by a power supply with variable voltage (Farnell, 
Leeds, West Yorkshire, UK). Solution flow under gravity was regulated by solenoid 
valves (The Lee Company, Essex, CT, USA) controlled by a manual selector. After 
heating, the solutions passed to a manifold, with a perfusion tip made from a short
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Figure 2.2 Perfusion apparatus for delivery of heated solutions to the cell.
Flow from four reservoir syringes was controlled by solenoid valves with a 
manual switching device. The solutions were heated by passing them 
through a drilled aluminium block to which two Peltier devices were 
attached. These were controlled by a variable voltage supply, adjusted so 
that the temperature of flowing solution 1 mm from the perfusion tip was 
36.5 ± 0.5 °C. The four solutions came together at a manifold with a ~2 pL 
dead-space, the tip of which was placed ~1 mm from the cell.
piece of plastic tubing, 0.8 mm outside diameter, 0.5 mm inside diameter. The dead- 
space o f the manifold and perfusion tip was ~2 pL. The heating assembly and 
manifold inflow tubing were insulated with high-density foam to minimise heat loss.
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At the beginning of each experiment, it was ensured that the flow of each solution was 
equal (~2 mL/min) and the solution temperature was measured at the tip of the 
manifold and adjusted to give 36.5 ± 0.5 '^ C. The change in temperature when 
switching between solutions was <1 °C. During experiments, the tip of the manifold 
was placed ~1 mm from the cell, once voltage clamp had been achieved. This placed it 
opposite the outflow region of the chamber, and observations made using coloured 
solutions demonstrated that this would reliably place the cell in a jet of the heated 
solution, without interference from re-circulation of solution in the rest of the bath. 
Under voltage clamp, switching solutions was not found to disrupt the micropipette 
seal.
2.6.1 Speed of solution change
The low dead-space of the manifold allowed for rapid switching of solutions perfusing 
the cell, which was essential for several of the techniques outlined in this thesis. In a 
number of experiments, rapid application of caffeine was used to release SR Ca, and 
analysis of simultaneous membrane cunent recordings could be used to determine 
certain parameters for the perfusion device. Time-to-onset o f caffeine was measured 
from the artefact spike due to solution switching to the start of the inward current. 
Time-to-peak was measured from the same artefact spike to the peak of the inward 
current. An onset-to-peak time could then be determined, giving an estimate of the 
time taken from the arrival of caffeine at the cell / SR to its full effect at the SR (with 
the assumption that the time from SR Ca release to efflux on NCX producing the 
inward current is negligible). Time-to-onset, time-to-peak and onset-to-peak were 
measured at 293 ± 18  ms, 404 ± 21 ms and 111 ± 5 ms, respectively (n=22).
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A further assessment of the speed of solution change at the cell was made using 
solutions containing low or high Ca concentrations in the presence of the fluorescent 
Ca indicator Fluo-3. Fluorescence was measured, as outlined below, from an aiea of 
the image field masked off to the size of a typical cell, whilst the perfusing solution was 
repeatedly switched between a nominally Ca-free solution and one containing 10 
mmol/L Ca. The fluorescence signal was then analysed and the transition between the 
two solutions was fitted with a single exponential function using the graphical analysis 
program OriginPro 6.1 (OriginLab Corporation, Northampton, MA, USA; see Chapter 
4, Figure 4.4). The time constant for the switch was found to be 90 ± 8 ms (n=10).
2.7 Experimental apparatus
Cells were studied in a theimostatically-controlled heated chamber (Warner Instrument 
Corp., Flamden, CT, USA), with a circulai’ coverslip (uncoated) forming the base 
(thickness no. 0; BDH Laboratory Supplies, Poole, Dorset, UK). Generally, other cells 
in the bath which were not sealed on to the micropipette were washed away by the flow 
fr'om the solution switcher, so fi’esh cells were introduced after each experiment. The 
solution level was kept constant by suction from a roller pump (Watson-Marlow Ltd, 
Falmouth, Cornwall, UK) with outflow from the bath downstream from the perfusion 
apparatus.
The chamber was mounted on the stage of an inverted microscope (Nikon Diaphot, 
Nikon UK Limited, Kingston upon Thames, Surrey, UK), which supported a coarse 
micromanipulator for the solution manifold and both coarse and fine 
micromanipulators for the micropipette (Narishige International Ltd, London, UK).
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Cells were viewed at x40 magnification using an oil immersion lens with ultra-low 
autofluorescence immersion oil (Nikon UK Limited, Kingston upon Thames, Surrey, 
UK) under illumination fr om above. Duiing fluorescence experiments a 780 nm long- 
pass filter (Chroma Technology Corp., Brattleboro, VT, USA) was introduced into the 
light-path. Cells could be viewed throughout the experiment on a black-and-white 
monitor via a CCD camera (Watec Corp., Las Vegas, NY, USA, see Figure 2.3).
2.7.1 Electrophysiological recording
Micropipettes were pulled from borosilicate glass (GC120F-10; Harvard Apparatus 
Ltd, Edenbridge, Kent, UK; 1.2 mm outside diameter, 0.69 mm internal diameter, with 
internal filament) using multi-stage protocols on a Flaming/Brown micropipette puller 
(model P-97; Sutter Instinment Company, Novato, CA, USA). For current clamp 
(action potential) experiments, pipettes were fine-tipped, with a resistance of 15-25 
MQ, and filled with 2 mol/L KCl. For voltage clamp work, pipettes were lightly heat- 
polished (Narishige microforge model MF-9, Narishige International Ltd, London, UK) 
giving a final resistance of 2-5 MO (tip diameter «1 pm), except in the case of the 
NCX current density studies, where the resistance was 1-2.5 MQ (tip diameter -1.5 
pm) to enhance dialysis of pipette contents. Pipettes were back-filled with filtered 
pipette solution immediately before use.
The micropipette electrode was fashioned from a length of silver wire, electrolytically 
coated with silver chloride using a custom-built chloriding unit. Electrodes were 
fleshly coated at the start of each day’s experiments. The bath electrode consisted of 
an Ag/AgCL pellet, which was positioned near’ the bath outflow.
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The microscope and associated apparatus was positioned on a Micro-g air table 
(Technical Manufacturing Corporation, Peabody, MA, USA) to minimise vibration, 
and was contained within a Faraday cage. Electrophysiology recordings were made 
using Axon Instruments equipment (Axon Instruments Inc., Union City, CA, USA) on 
an Axoclamp 2B amplifier, with a headstage gain of 0.1 (model HS-2A). Signals were 
digitised using a 16-bit data acquisition system (Digidata 1320A) and P-Clamp 8.0.2 
software was used for recording of signals on an 866 MHz desktop computer (Dell 
Computer Corporation, Round Rock, TX, USA). Current, voltage and fluorescence 
signals were also displayed on a chart recorder (Gould Nicolet Technologies, Ilford, 
Essex, UK).
2.7.2 Electrophysiology protocols
Current- and voltage-clamp protocols were generated using P-Clamp 8.0.2 software 
(Axon Instruments Inc., Union City, CA, USA). Specific protocols are described in the 
relevant chapters, but some procedures were common to all experiments.
2.7.2.1 Whole-cell current- and voltage-clamp procedures
Micropipettes were introduced into the bath with positive pressuie applied to prevent 
superfiisate from contaminating the pipette solution. Voltage offset and pipette 
resistance were then balanced in “bridge” mode, and the pipette resistance could be 
read off a dial on the Axoclamp amplifier. For current-clamp work, cells were impaled 
using a short, but abrupt, downward movement of the pipette. It was occasionally 
necessary to apply a small amount of positive or negative pressure or a brief oscillating 
voltage (“buzz”) to gain adequate access to the cell interior. For voltage-clamp
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experiments the micropipette was brought down onto the cell membrane and a seal was 
formed using gentle negative pressure. The seal was monitored using small voltage 
steps (10 mV, 4 Hz) from a holding potential of 0 mV. Once a gigaohm seal was 
foimed, the holding potential was set to -80 mV and whole-cell access was obtained by 
brief, sharp suction to rupture the underlying membrane. Once stable access was 
obtained, the mode was switched to discontinuous single-electrode voltage clamp, 
which allows more accurate measurement of actual membrane voltages. To minimise 
potential difficulties in obtaining adequate voltage control of large cells (“space 
clamp”), the microelectrode was always placed towards the middle of the cell, and 
suspected double cells were excluded. The liquid junction potential was measured at 
<1 mV and was not coiTected.
For each cell, optimal settings for capacitance neutralisation and gain were set and the 
sampling rate of the clamp was adjusted to around 8 kHz. Cells where adequate levels 
of gain could not be achieved were rejected. Depending on the type of protocol used, 
the output bandwidth was set to between 0.3 kHz and 1 kHz, to give a good 
compromise between filtering of noise and resolution of rapid voltage or current 
changes. The output from the Axoclamp amplifier was sampled at >2 kHz to avoid 
aliasing. In general, further filtering of the signals was not employed, but, where
A
appropriate, traces were averaged. I
2.7.2.2 Cell capacitance measurement and cell volume calculation 
Cell capacitance was usually measur ed using the built-in protocol in P-Clamp 8, which 
uses the following method. Small depolarising and hyperpolarising voltage pulses (5 
mV) are applied around the holding potential to produce capacitance transients in the
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current trace. The small size of the voltage steps allows the ohmic properties of the cell 
membrane to be measured, without activation of significant ionic currents. The pulse 
rate is chosen to allow adequate time for each capacitance transient to decay (generally
1.3 Hz). The time constant (t) of the decay of the capacitance transients is obtained 
from a single exponential fit of a running average trace. The total charge ( g j  passed 
for a given change in voltage (AF) can be calculated from the area under the transient 
above the steady-state cuirent {Qi), plus a correction factor ( 1^ 2=^A7* r). Membrane 
capacitance (C^) is then calculated using the following formula;
C = Equation 2.1“ AF
In addition to using the built-in algorithm, for each cell a similar voltage-clamp 
protocol was applied and the resulting cunrents were recorded for later analysis. If 
there was any doubt over the accuracy of the automated analysis, then these currents 
were analysed manually by the same method.
Cell volume was calculated from the capacitance measurements using a conversion 
factor obtained by Satoh et a l (1996). They used confocal microscopy to measuie the 
cell volume of calcein-loaded myocytes and related the results to cell capacitance, 
assuming a “specific capacitance” for cell membranes of 1 pF/cm^. For adult rabbit 
ventricular myocytes, a value of 4.58 ± 0.45 F/L was obtained. This gives an estimate 
of the total cell volume, including organelles. In cases where accessible (non- 
mitochondrial) cell volume was required, a value of 6.44 ±0.63 F/L was used, which 
corrects for the proportion of the cell volume taken up by mitochondria (38.9% for 
rabbit cardiac myocytes; Barth et a l, 1992).
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2.7.3 Calcium measurement using fluorescent dyes
The development of new [Ca]-sensitive fluorescent dyes based on bis-(o- 
aniinophenoxy)-ethane-N,N,N\N'-tetra-acetic acid (BAPTA) in the 1980s greatly 
facilitated the measurement of intracellular Ca signals (Grynkiewicz et a l, 1985; 
Sipido & Callewaeit, 1995). When excited at appropriate wavelengths, the emission 
intensity of these indicators varies as a function of [Ca] and, with appropriate 
measurement and calibration, an accurate estimation of [Ca]i can be made, with 
excellent temporal resolution.
In this thesis, the indicator Fura-2 was used, in its acetoxymethyl ester (AM) foim. 
This dye alters its excitation spectrum when Ca binds, and this is detected by exciting 
the dye at two wavelengths (340 nm & 380 mn) and recording emitted light at a single 
wavelength (Grynkiewicz et a l,  1985). This ratiometric technique eliminates problems 
due to motion artefact experienced with previous indicators, and is also independent of 
the absolute dye concentration within the cell. The AM form of the dye is membrane- 
permeant, and once inside the cell is hydrolysed by intracellular’ esterases to release the 
[Ca]-sensitive indicator.
2.7.3.1 Dye-loading procedure
A stock solution of Fuia-2 AM (Molecular Probes Europe, Leiden, The Netherlands) 
was produced by dissolving 1 mg in 1 mL of anliydrous dimethylsulphoxide (DMSO), 
and this was stored in aliquots at -20 °C. When required, 5 pL of this stock solution 
was added to 1 mL of the cell suspension (see section 2.3), giving a final Fui’a-2 
concentration of -5  pmol/L. This was incubated for 10-15 min at room temperature to
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allow entry of the dye into the cells and de-esterification. A further 2 mL of NT 
solution was then added to dilute the Fura-2, slowing fuither loading, and the first 0.5 
mL aliquot of cell suspension was used immediately. Further aliquots of cells could be 
used for up to 45 min, before a fresh batch of cells was loaded. Removal of 
extracellulai’ Fura-2 was achieved by the perfusion of superfusate once the cells were 
added to the bath chamber. Preliminary experiments varying the loading conditions 
(Fura-2 concentration, temperatuie and loading time) showed that the above protocol 
would reliably produce a good signal-to-noise ratio on the Ca signal, without evidence 
of excessive Ca buffering by Fura (as determined by the rate of decline of the Ca 
transient).
2.7.3.2 Fluorescence measurement apparatus
Figure 2.3 outlines the optical setup to allow fluorescence measurements. Light from a 
150 W xenon arc lamp is focused by a reflector, then collimated by a lens and 
diffracted by a computer-controlled monochromator (Caim Research Ltd, Faversham, 
Kent, UK) to give the appropriate wavelengths for stimulation of Fura-2 (see below). 
The light is then conveyed to the microscope by a flexible liquid light guide, passes 
through a further focusing lens which is adjusted to give even illumination, and is 
reflected by a 45° 400 nm long-pass (LP) dichroic mirror. A x40 oil immersion lens 
focuses the excitation light onto the cell and collects the emission light. Appropriate 
emitted wavelengths pass through the dichroic mirror and are reflected out the sidepoit 
of the microscope. Here they pass through a rectangulai’ diaphiagm which is adjusted 
to match the outline of the cell under study, masking off light from any other cells or 
debris in the optical field. A further LP dichroic mirror reflects the light through a 510 
nm LP filter (Chroma Technology Corp., Brattleboro, VT, USA) for collection by a
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Figure 2.3 Optical apparatus for fluorescence measurement, a = xenon arc 
lamp; b  =  monochromator, controlled by Caim Optoscan device; c =  flexible 
liquid light guide; d = focusing lens; e = 400 nm LP dichroic mirror; f = x40 
oil immersion objective; g  = cell loaded with Fura-2; h = coverslip forming 
bottom of solution chamber; i = microscope sideport; j = rectangular 
diaphragm to limit collected light to cell dimensions; k = LP dichroic mirror;
1 = 510 nm LP emission filter; m = photomultiplier tube (PMT); n = from 
high-tension voltage supply; o = PMT output to Optoscan; p = microscope 
light-source; q = 780 nm LP filter; r = CCD camera; s = to monitor. Full 
details in text.
photomultiplier tube (PMT). The voltage output of the PMT is measured by an 
Optoscan device (Caim Research Ltd, Faversham, Kent, UK), which also controls the 
monochromator. The output from the Optoscan (raw wavelength signals and a 340/380 
ratio signal) was passed through the analogue-to-digital converter (Digidata 1320A,
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Axon Instruments Inc., Union City, CA, USA) for display on the chart recorder and 
recording by P-Clamp 8.0.2 software.
As outlined in section 2.7, cells could be observed during fluorescence experiments 
using a CCD camera and monitor.
2 .7.3.3 Optoscan parameters for fluorescence recording
Published data for Fura-2 suggest that the maximal changes in emission in response to 
[Ca] occur at around 340 nm and 380 nm, with an isosbestic point (wavelength where 
output is insensitive to changes in [Ca]) at 360 nm (Grynkiewicz et a l,  1985; Sipido & 
Callewaeit, 1995). The Optoscan equipment allows an assessment to be made of the 
wavelength profile of the intracellular dye, under the optical conditions used during an 
experiment. With a constant voltage setting for the PMT input, a cell loaded with Fura- 
2 was centred on the field, and the diaphragm was stopped down to the boundaries of 
the cell. A wavelength scan was then performed, with readings of the PMT output 
taken at 2 nm intervals from 300 nm to 500 nm. This was performed with a quiescent 
cell (low [Ca]i) and then with the cell punctured in 1.8 mmol/L NT solution (high 
[Ca]i), to observe the Ca-dependent wavelength shift (absolute values of [Ca], are 
unimportant for this, as long as there is a sufficient difference between them). An 
example is shown in Figure 2.4. For 4 cells, the mean isosbestic point (arrowed on 
figure) was 361.3 ±1 .5  nm, with peak differences between low and high [Ca], at 346.8 
± 1 .4  nm and 383.0 ± 0.9 nm. Thus the ratio of the 340 mn to 380 run signals gives an 
almost maximal dynamic range, and these wavelengths were used tlnoughout.
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Figure 2.4 Wavelength scans to deteimine intracellular properties of Fura-2.
Scans were perfoimed in 2  nm steps for a  quiescent cell (low [C a]i) and a  
mptured cell (high [C a]i). Absolute difference between scans is also plotted, 
and isosbestic point, where output is independent of [Ca] is arrowed. 340 
nm, 360 nm and 380 nm wavelengths are indicated.
The Optoscan also allows tight control over the wavelengths delivered and the time 
spent at each wavelength. Preliminary experiments showed that a bandwidth of 5 nm 
centred on each wavelength, with 8 ms at 340 nm and 4 ms at 380 ms, gave a good 
signal-to-noise ratio. Shorter times at each wavelength were possible, but since high 
temporal resolution on the Ca signal was not required (e.g. the upstroke of the Ca 
transient was not under study), the timings chosen were considered acceptable.
2.7. S. 4 Background subtraction
To optimise the quality of the signals at each wavelength, background fluorescence 
must be subtracted. Ideally this would be achieved by measuring the autofluorescence 
of the particular cell under study, prior to loading with Fura-2. However, given that
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loading was achieved with Fura-2 AM, this was not possible. Instead, non-cellular 
background fluorescence was subtracted from each wavelength signal. This was 
achieved by setting the diaphragm mask to the size of the cell and then moving it to an 
adjacent area of the field, free from cells or debris (and in the presence of perfusion to 
remove Fura-2 from the bath solution). In this position, the output of each wavelength 
signal was zeroed on the Optoscan. It was assumed that additional cellular 
autofluorescence would be minimal, especially since much of the autofluorescence is 
due to mitochondrial nicotinamide adenine dinucleotide (NADH), whose peak emission 
is at 447 nm (Eng et a l, 1989), which would be filtered out by the 510 LP emission 
filter.
2.7.3.5 Calibration o f  fluorescence signals and conversion to [Ca]
After background subtraction for each wavelength, ratio signals (7?) were converted to 
[Ca] by the method of Grynkiewicz et a l (1985), using the following formula:
[Ca] {R-Rmin) / {Rmax-R) Equation 2.2
where Kd is the dissociation constant of Fura-2; (3 is the ratio of the 380 nm signal with 
no Ca binding to that with saturating Ca binding; and R,nm and 7?,„ax are the ratio signals 
at minimum and maximum [Ca], respectively. The latter two terms were determined 
for each cell studied. Rmin was taken as the fluorescence ratio of the quiescent cell at 
the start of each experiment, prior to any stimulation. Separate experiments 
demonstrated that this ratio was indistinguishable from that obtained when cells were 
dialysed with a 10 mmol/L EGTA solution. R^ax was determined at the end of each 
experiment by impaling the cell in NT solution (1.8 mmol/L Ca) and measuring the
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Figure 2.5 Deteimmation of and Rmax- Left panel shows stimulated Ca 
transients from quiescent state, with ratio signal above and 340 nm & 380 nm 
signals below, as indicated. Rmm is taken as the minimum ratio at the start of 
the experiment (0.95 in this example). Right panel shows determination of 
Rmax (note different axes). Just after the beginning of the sweep, the cell is 
punctured and [Ca] rises (rapid oscillations of Ca can be seen). Rmax is taken 
at the ratio peak, prior to significant loss of dye from the cell. This is judged 
ft'om the 340 nm signal -  after the peak there is an initial small drop as the 
cell balls up in the field, then a short plateau before loss of dye from the cell.
Rmax is taken at the arrowed point (4.5 in this example).
peak ratio before significant loss of intracellular dye (judged from the individual 
wavelength signals). Figure 2.5 shows an example of the estimation of Rmm and Rmax, 
along with the ratio signal during stimulation of the cell at 0.5 Hz.
In order to determine and p, it is necessary to calibrate the Fura-2 340/380 ratio 
signal against known concentrations of Ca. In vitro calibration of the Fura-2 salt with 
solutions of known [Ca] is straightforward, however the intracellular properties of
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Figure 2.6 Intracellular calibration curve for Fui’a-2. Permeabllised cells 
weie exposed to 4 different concentrations of Ca. A logistic regression curve 
was fitted to the data, with resulting parameters as shown, n = 9 cells for the 
lowest point, n = 6 cells for all other points.
Fura-2 have been shown to differ (see Sipido & Callewaert, 1995), so an in vivo 
calibration is preferred. This was performed by permeabilising cells with 0.1 mg/mL 
escin (Sigma-Aldrich Company Ltd), then perfusing with a mock intracellulai' solution, 
with [Ca] buffered to different levels using EGTA. Four solutions were used, with 
each cell exposed to only one solution. The concentrations of Ca (pmol/L), estimated 
using the computer program “React” were: 8e^ (for R„,tn\ 0.14, 0.44 and 39 (for R„,ax). 
The results aie shown in Figure 2.6, with the fitting parameters for a logistic regression. 
This gave an estimate o f  ^  of 1.2 pmol/L, which was used throughout the thesis. 
itself is more difficult to determine since it must be measured in individual cells and is 
very sensitive to loss o f dye from the cell. From the experiment shown in Figure 2.6, /? 
was estimated at 3.03 ± 0.23 (n=6), giving a Æ^for Fuia-2 of around 400 nmol/L. This 
compares well with data provided by the manufacturer, where a of 371 nmol/L was 
obtained in astrocytoma cells (see www.probes.com/handbook/sections/2001 ).
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2.8 Statistical analysis
Data are presented in the text and on figures as mean ± standard error of the mean 
(SEM). Error bars are excluded on figures when they are smaller than symbols. 
Descriptive statistics were calculated within spreadsheets on Microsoft Excel 2000. 
Statistical comparisons were made using InStat software (v2.05, GraphPad software, 
AD Cunningham, University of Glasgow). Single comparisons were made using two- 
tailed Student’s t-tests, with paired or unpaired data, as appropriate, and statistical 
significance was taken at the p=0.05 level. For multiple comparisons, Fisher's 
protected Least Significant Differences (LSD) method was used. This was chosen over 
standard analysis of variance (ANOVA) methods (e.g. Tukey’s) since the number of 
planned comparisons to be made was less than the total possible number of 
comparisons. For example, for the four groups under study in the majority of 
experiments (Sham Endo, Sham Epi, LVD Endo, LVD Epi), there were four 
predetermined comparisons to be made: 1) between regions for each animal type (i.e. 
Sham Endo vj- Sham Epi and LVD Endo vs LVD Epi), and 2) between animal types for 
each region (Sham Endo V5 LVD Endo and Sham Epi vs LVD Epi). For Fisher’s 
protected LSD method, a one-way ANOVA is first performed and if the F-value does 
not reach significance then no significant difference between the groups is reported. If 
the F-value is significant then the predetermined comparisons can be made using 
Student’s t-tests. This method holds the chance of reporting a significant difference 
when there is none to 5%.
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CHAPTER 3
SODIUM-CALCIUM EXCHANGER FUNCTION UNDER 
CONDITIONS OF FIXED AND VARYING [Ca]i
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3.1 Introduction
3.1.1 Quantification of NCXfunction
A  variety of methods have been used to measure the function o f NCX, making use of 
the electrochemical properties of the exchanger. Changes in either the voltage or the 
ionic conditions will affect NCX function, and to quantify activity of the exchanger 
usually one of these factors is kept constant and the other is altered, while measuring a 
variable which is proportional to NCX function (e.g. current or [Ca]).
Early experiments commonly used radiolabelled ions (e.g. ^^Na and "^ ^Ca) to 
demonstrate flux across the membrane, and these experiments gave some limited 
information on the rate of exchanger function for a given weight of tissue (e.g. Balcer et 
a l, 1969; Glitsch et a l ,  1970).
The first detailed measurements of NCX function in single myocytes were performed 
by Kimura et a l (Kimui'a et a l, 1986; Kimura et a l, 1987). They carefully controlled 
the internal and external ionic conditions in whole-cell voltage-clamped guinea pig 
ventricular myocytes, in the presence of blockers of K and Ca cuiTents and the Na-K 
ATPase. Ijqcx was determined using triangular voltage ramps to +60 mV and back to 
-120 mV. More recently, Convery & Hancox analysed the effects of different ramp 
and step protocols, and different Ca buffers, on the characteristics of I^cx (Convery & 
Hancox, 1999). They demonstrated that the direction of the ramp (ascending compared 
to descending) had a significant impact on the reversal potential and the shape of the 
current. They provided evidence that subsarcolemmal [Ca] was perturbed more by a 
descending ramp than an ascending one, with local accumulation of Ca under the 
membrane. This altered the shape of the IncxAI curve and shifted the reversal potential
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further away from the predicted value. The Incx^  relationships obtained by ascending 
ramps were very similar to those obtained by voltage steps and the authors suggested 
that ascending ramps allowed better control of ionic conditions. Further experiments 
did not show any significant effect of using BAPTA rather than EGTA as the Ca 
buffer. For these reasons, ascending ramps were used in this study, and ionic 
conditions and control of [Ca], were verified as outlined in the methods section 
(3.2.1.1).
The voltage-clamp methods discussed above refer to measurement of Ixcx under 
conditions where the ionic composition on either side of the membrane is tightly 
controlled. NCX funetion can also be measured where voltage is kept constant and 
[Ca]i is allowed to vaiy. Since NCX is responsible for the majority of calcium 
extrusion from the cell, measuring the rate of extrusion can give information on NCX 
function. Commonly, a train o f stimuli is used to produce steady-state loading of the 
SR, followed by a prolonged caffeine application to produce a maximal release of Ca, 
at the same time preventing its re-accumulation into the SR. Some measure of the rate 
of Ca decay can then be used as a measure of NCX function (e.g. Varro et a l, 1993; 
Negretti et a l, 1995). This measure can be corrected for non-NCX removal 
mechanisms (e.g. sarcolemmal Ca-ATPase) by repeating the eaffeine application in the 
presence of nickel (Varro et a l, 1993; Negretti et a l, 1995) or in the absence of Ca and 
Na (Bassani et a l,  1992; Puglisi et a l, 1996).
One further method of quantifying NCX function is to keep the membrane potential 
constant and produce a sudden change in the external ionic conditions (e.g. to [Na]—0) 
using a rapid solution switcher. An inward or outward current will be produced, the
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amplitude of which will vaiy according to exchanger function. This approach has been 
widely used by Barry, Bridge and co-workers (e.g. Su et a l,  1999).
In this chapter, in addition to the voltage ramp protocols, NCX function was also 
estimated based on the rate of Ca decay during prolonged caffeine application, 
coirected for non-NCX removal using nickel.
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3.2 Methods
3.2.1 NCX current density
3.2.1.1 Solution compositions
The solutions used tightly controlled the intracellular and extracellular ionic conditions, 
and eliminated, as far as possible, currents other than Incx- Hence, the solutions were 
potassium-free to abolish K-currents (K replaced by Cs); V-acetylstrophanthidin was 
added to block the Na-K pump; and nifedipine was present to block Ica,L- It was also 
essential to constrain [Na] and [C a] tightly, such that a cun’ent-voltage relationship 
could be determined for a given set o f internal and external ionic conditions. The 
pipette solution was designed to buffer [C a], heavily, to ~258 nmol/L (calculated using 
the computer program “React II”, G.L.Smith & L.S.Duncan, University of Glasgow). 
To confiim the [C a] conditions, two approaches were used. Firstly, Fura-2 acid (10 pL 
o f 1 mg/mL Fui'a-2 per mL of solution) was added to the pipette solution. This gave an 
estimated [C a] of around 200 mnol/L. Secondly, experiments with Fura-2 AM loaded 
cells dialysed with the pipette solution suggested a [C a]i of 353 ± 52 nmol/L (n= ll). 
The calculated value was felt to reflect a reasonable estimate of the calcium 
concentration since it fell between these two values. In the absence of EGTA there was 
a  significant rise in [C a], during the ramp protocol, which was eliminated by 50 
mmol/L EGTA (see Figure 3.1). Preliminary experiments with 10 mmol/L EGTA in 
the pipette showed some escape of [C a]i during the ramp protocol, so the higher 
concentration of EGTA was used throughout.
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Figure 3.1 Effects of internal C a  buffering during ramp protocol. Bottom 
panel: voltage ramp protocol. Middle panel: resulting currents in the 
absence (black trace) and presence (red trace) o f 50 mmol/L EGTA in the 
pipette solution. Note the distortion of the current profile during the 
ascending ramp and the significant tail current on repolarisation (arrow). 
Upper panel: [C a]i during the ramp protocol. Note that in the presence of 
50 mmol/L EGTA the rise in C a  is almost completely abolished.
3.2.1.2 Voltage-clamp protocol
After achieving the whole-cell configuration, a period of 5-10 min was allowed for 
dialysis of the pipette solution into the cell. Currents were then measured in response to 
a ramp from -120 mV to +80 mV from a holding potential of -80 mV. The ramp 
protocol was performed at 0.1 Hz until steady-state currents were achieved, whereupon 
data from up to 12 ramps were averaged. The protocol was repeated in the presence of 
5 mmol/L NiClz to obtain the background (non-NCX) current. Initial experiments were 
performed varying the duration of the ramp from 1 s to 4 s. Voltage ramps of 1 and 2 s
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Figure 3.2 Voltage clamp protocol and initial data analysis. A: Voltage 
ramp protocol and resulting currents in the absence and presence of 5 
mmol/L Ni. B: Current in Ni subtracted from control current to give current 
due to NCX. C: 1-Vcurve, corrected for cell capacitance.
showed some activation of the sodium current, contaminating I^cx, and a 3 s ramp was 
found to give the best balance between speed of the protocol and adequate voltage 
control.
3.2.1.3 Data analysis
For each cell, continuous sweeps of current against time in the absence and presence of 
nickel were separately averaged and the data in the presence of nickel were then 
subtracted to give the current attributable to NCX. This was converted to current 
versus voltage (/-F) data, which was then corrected for cell capacitance (Figure 3.2).
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Equation 3.1 Mathematical model of I^cx- See text for details.
Data points were generated at 10 mV intervals between -120 mV and +80 mV. These 
data were averaged for each cell type (Sham Endo / Epi, LVD Endo / Epi) to allow for 
statistical comparison at given voltages (-110 mV and +70 mV).
The data points for each cell were also fitted using the model of NCX function of 
Weber et al. (Equation 3.1; Weber et a l,  2001), which is modified horn the work of 
Segel (1993), Mullins (1979) and Luo & Rudy (1994). Briefly, Ij^cx is expressed as the 
product of an electrochemical factor and an allosteric factor. The electrochemical factor 
is based on a Vmox (which is assumed to be equal for forward and reverse flux), the 
internal and external concentrations of Ca and Na, and dissociation constants (X„,) for 
each ion on either side of the membrane. The allosteric factor represents regulation of 
NCX as an instantaneous Hill equation for Ca binding to the regulatory site and the Hill 
coefficient {nnui) was taken as 2, based on previous studies (Levitsky et a l,  1994). For
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Term [Na]o [Ca]o [Cali EmNao E-mNai EmCao EmCai Esat EfnCaAct n
Units mmol/L mmol/L nmol/L mmol/L mmol/L mmol/L [Jmol/L nmol/L
Value 143 1.8 258 87.5 12.3 1.3 3.6 0.27 125 0.35 2
Ref. 1 2 3 2 3 4 3 3
Table 3.1 Values for terms in l^cx  model. References: 1 — Kimma et al., 
1987; 2 -  Hilgemann et a l,  1991; 5 -  Pogwizd et a l ,  1999; 4 -  Weber et a l, 
2001 .
[m i, ^
{Cal
Equation 3.2 Calculation of [Na];. F  = 96500 C m o f\ Ene  ^ = reversai 
potential, R = 8.3143 JmoF^K'^ and T - 310 K.
simplicity, when fitting the I^cx data it was assumed that no differences in allosteric 
regulation existed between cell types, and the K,n for calcium activation {K,nCaAct) was 
taken to be 125 nmol/L, based on data from the literature (fenet; Weber et a l, 2001). 
Later experiments designed to study in detail allosteric regulation in Sham and LVD 
cells are described below and the implications of the findings are examined in the 
discussion, section 3.4.3.2.
Values for the dissociation constants and other terms were derived fi'om the literature, 
and are summarised, with references, in Table 3.1. Since subsarcolemmal [Na] is 
difficult to buffer adequately, and small discrepancies in [Na]; have a large effect on the 
quality of the model fit, [Na]; was calculated for each cell. This was based on the 
reversal potential o f each If^cx E V  curve, using Equation 3.2. This equation is derived
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Figure 3.3 Example of Incx model fit to raw data from a Sham endocardial 
cell. Reversal potential {Er^v) and calculated [N a]i are indicated.
fi-om the Nemst equation for NCX, assuming a stoichiometry of 3Na: ICa. The 
calculated [Na]i was used in the fitting function for each cell, along with the values 
outlined in Table 3.1, to derive a Vmox for each cell. Fitting of the Incx  function was 
performed using the graphical program OriginPro 6.1 or 7.0 (OriginLab Coiporation, 
Northampton, MA, USA). An example of a typical curve fit is shown in Figure 3.3,
3.2.1.4 V ira l transfection o f cultured cells
In order to confirm the sensitivity of the above protocol for assessing NCX current 
density, the technique was also performed on cultured cells overexpressing NCX. As 
described in section 2.4, myocytes derived from the interventricular septum were 
cultured for 2 days in the presence of adenoviruses encoding NCX or Lac-Z, at an MOI 
o f 100. NCX current density in these cells was compared with that in non-transfected
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control cells. The data points for each cell were fitted using the model of NCX 
function, as outlined in the previous section.
3.2.2 NCX-mediated Ca efflux
3.2.2.1 Solution compositions
In these experiments, intracellular [Ca]i was allowed to vary, and the rate of Ca 
removal attributable to NCX could be estimated. The solutions were designed to block 
some ionic currents which could indirectly affect [Ca], or influence voltage control (see 
2.5.4). Thus, 4-aminopyridine was present in the superfusate, and tetraethylammonium 
chloride in the pipette solution, to block K-currents; and Ca-activated chloride currents 
were minimised using niflumic acid. The Na-K ATPase was not blocked, to allow for 
cellular regulation of [Na]i.
3.2.2.2 Experiment protocol
Myocytes were held at -80 mV and stimulated for 30 s by a 1 Hz depolarising train to 0 
mV for 150 ms, to achieve steady-state contractions. NCX activity was then estimated 
by rapidly switching to 10 mmol/L caffeine for a period of 10 s at a holding potential of 
-80 mV (see Figme 3.4). This produced a sudden rise in intracellular calcium due to 
SR release, followed by a decay phase as calcium was removed from the cell. The 
decay phase is accompanied by an inward cunent due to Ca extrusion by NCX. The 
protocol was repeated with 10 mmol/L NiClz applied just prior to, and duiing, the 
caffeine application to provide an estimate of non-NCX Ca removal mechanisms. 
Under these conditions NCX is inhibited, the rate of Ca decay is markedly slowed, and 
the inward current is virtually abolished.
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Figure 3.4 Protocol for estimating NCX activity. Panel A shows the final 
steady-state calcium transient at the end of a 1 Hz train of stimuli (•), 
followed by the rapid application of 10 mmol/L caffeine (Caff, black bar) in 
the absence (Ctrl) and presence (Ni) of 10 mmol/L NiCL. The 
corresponding current traces are illustrated below, vertically separated for 
clarity. Note that on caffeine application there is an inward current, which is 
virtually abolished in the presence of Ni. B: Expanded Ca decay phases, 
with superimposed single exponential fit functions, to estimate the rate 
constant of decay. In each panel, typical traces are illustrated for (1) Sham 
and (ii) LVD cells.
In most cases, the protocol could be applied more than once in a given cell, and for 
each cell the results were averaged. Since parts of the experiments described in 
Chapter 4 were carried out with the same solution compositions and identical voltage- 
dam p protocol, analysis of the Ca decays and characteristics of the inward current in
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the presence of caffeine from these experiments could be included in the analysis. 
These protocols did not include the application of caffeine in the presence of nickel, so 
the analysis of the rate o f Ca decay under these conditions relates only to the cells 
studied in this chapter.
3.2.2.3 Data analysis
Fura-2 fluorescence ratio data were converted to [Ca] as outlined in section 2.7.3.5 and 
the Ca decay phase after caffeine application was fitted with a single exponential decay 
function using OriginPro 6.1 (OriginLab Corporation, Northampton, MA, USA). The 
amplitude of the caffeine-induced inward current was measur ed and the decay phase of 
the current was also fitted with a single exponential function, to provide a further 
estimate of NCX activity.
3.2.3 Allosteric regulation o f NCX
3.2.3.1 Solution compositions
Solutions were designed to isolate In c x  from contaminating cuiTents and to prevent Ca 
uptake into the SR, to allow the relationship between Inc x  and [Ca]i to be studied. 
Thus, after voltage-clamp was achieved in NT solution, the cell was treated with 1 
pmol/L of the SERCA inhibitor thapsigargin (Calbiochem, La Jolla, CA, USA) for ~1 
min to disable the SR, then 10 mmol/L caffeine was applied to ensure that the SR had 
emptied of Ca. The superfusing solution was then changed to a K-free solution 
containing 10 pmol/L nifedipine (to block /cal), 10 pmol/L A-acetylstrophanthidin (to 
block Na-K ATPase), and 100 pmol/L niflumic acid (to block the Ca-activated Cl 
current). The pipette solution used throughout was K-ffee (K replaced with equimolar 
Cs) and contained 20 mmol/L TEA to block any remaining potassium cunents.
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Figure 3.5 Theory behind voltage protocol for investigating allosteric 
regulation of N C X . The cell is shown held at +100 mV, thus favouring 
outward (reverse-mode) N C X  current. In the case where no allosteric 
regulation exists (A), as [C a]i rises, the C a  gradient is reduced and the 
outward current will diminish. In the presence of allosteric regulation (B), in 
spite of the reduced C a  gradient, the exchanger is activated by the rise in 
[C a]i and the outward current increases.
i. 2.3.2 Voltage-clamp protocol
To determine whether allosteric regulation of N C X  was occurring in rabbit 
cardiomyocytes, a protocol was devised based on that of Weber et al. (2001) which 
entails examining the outward (reverse-mode) current as [C a]i rises. The theory behind 
the protocol is illustrated in Figure 3.5. Briefly, in the absence of allosteric regulation 
of N C X  by [C a]i, outward (reverse-mode) N C X  current will fall as [C a]j rises, since the 
gradient for C a  across the membrane will be reduced. However, if allosteric regulation 
is present then increasing [C a]i will at first increase the outward current.
Myocytes were initially held at -100 mV to initialise them to conditions of low [C a]j, 
whereupon they were stepped to +100 mV 20 times, with 100 ms intervals between
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Figure 3.6 A: Voltage clamp protocol used to investigate the allosteric 
regulation of NCX by intracellular Ca. Cardiomyocytes were alternately 
clamped at -100 mV and +100 mV as described in section 3.2.3.2 in the (i) 
absence and (ii) presence of 10 mmol/L Ni. Resulting Ca and cunent traces 
are illustrated in each panel. A(iii): Difference current generated by 
subtracting current in (ii) from that in (i). Outward current is indicated with 
arrowhead ('4 ). B; For each voltage step, mean cuirent was plotted against 
mean [Ca]i and the resulting data points were fitted using Equation 3.1 to 
generate a for calcium activation {K„,caAct)'
each step (see Figure 3.6). The duration of the voltage pulse (100 or 200 ms) was
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chosen for each cell to produce a rise in [C a]j within a  physiological range. The 
protocol was repeated in the presence of 10 mmol/L NiCL and the background current 
generated was subtracted.
3.2.3.3 Data analysis
The difference current (obtained by subtracting the cunent in the presence of Ni) and 
[C a]i were averaged for each voltage step to yield a  plot of current (conected for cell 
capacitance) against [C a]i (Figure 3.6 B). The data points were then fitted using 
Equation 3.1, with Vmox and K,nCaAct allowed to vary, and ion concentrations appropriate 
for the solutions used. The values for other terms in the equation are given in Table 
3.1. The fitting function was performed separately for inward (F=-100 mV) and 
outward (F=+100 mV) currents. The latter generally gave a better fit to the data, 
perhaps because of the more pronounced sigmoid shape of the curve, and in some cases 
it was not possible to find a satisfactory fit to the inward current. Cells were rejected if 
the range of [C a]i was too narrow to produce a reliable fit to the data.
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3.3 Results
3.3.1 I n c x  current density
3.3.1.1 Regional differences and altered NCX current density in L VD
I n c x  current density was estimated for each cell type using a voltage ramp protocol in 
the absence and presence of 5 mmol/L Ni. Mean I n c x  current-voltage relationships, 
corrected for cell capacitance, are illustrated in Figure 3.7 A, with results for Sham 
cells (Fig. 3.7 A(i)) and LVD cells (Fig. 3.7 A(ii)) plotted on the same scale. The 
number of cells in each group is stated on the figure; the cells were obtained Ifom 5 
sham-operated animals and 4 LVD animals. On average, results were obtained from 4- 
5 cells from each region in each animal.
Figure 3.7 A demonstrates that ///cvcurrent is larger in endocardial cells than epicardial 
cells in both Sham and LVD animals, with the differences apparent at both positive and 
negative voltages. However, the currents in LVD cells were significantly smaller than 
those in Sham cells. This is illustrated further in the summary data in the lower panel 
(Fig. 3.7 B) at two sample voltages (-110 mV and +70 mV). Statistical analysis 
confirms the endocardial-epicardial differences in both Sham and LVD animals, 
although the difference for LVD animals at —110 mV does not quite reach significance 
(p=0.07). Comparing like regions from Sham to LVD animals gives highly significant 
results (generally, p<0.001). For example, at +70 mV, the current in LVD is around 
68% of that in Sham animals (e.g. for endocardial cells, 3.15 A/F versus 4.62 A/F;
p<0.001).
The raw data for each cell were also fitted with the model of NCX function of Weber ei 
al. (2001). This generated a Vmox value for each cell, and also enabled a comparison
86
A(i) Sham
Sham Endo (n=25) 1 ^  -D - Sham Epi (n=23) ^
E. (mV)
-12@C^W# %  -40 -20 20 40 60 80
A(ii) LVD
LVD Endo (n=14) , -o-_Lyp_Epi__in=1  ^ ^u? 5Q .a  4
Ü
-12CPf65^6 -60 -40 -20
-1
^ r: -r/J -
E„ (mV)
20 40 60 80
B
I 5 i4-
2 
1 -  
0
-1 J
Sham Endo (n=25) 
Sham Epi (n—23) 
r 1 LVD Endo (n=14) 
C Z ] LVD Epi (n=15)
***
-110 mV +70 mV
Figure 3.7 Results — A: Current-voltage relationships for Sham and LVD 
cells. In both cases the current density is higher in Endo than Epi cells. B: 
Summary bar graphs showing current density at -110 mV and +70 mV for 
Sham and LVD cells. *p<0.05, ** p<0.01, ***p<0.001, + p=0.07.
between the shape of the I-V curves obtained in these experiments and the shape of an 
I-V curve from a published model. As shown in Figure 3.3, good fits to the raw data 
could be obtained, using dissociation constants derived from the literature, and ionic 
concentrations based on the solutions used or calculated using the reversal potential, as 
described in the methods section, 3.2.1.3. Summary data for the same set of cells
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Figure 3.8 Bar graph summarising mean Fa/ox data from In cx  curve fits, for 
each cell type. * p<0.05, ** p<0.01, *** p<0.001.
shown in Figure 3.7 are shown in Figure 3.8. These data again demonstrate the 
significant endocardial-epicardial differences, with the V^ ax in epicardial cells being 
around 74% of that in endocardial cells in both Sham and LVD animals (e.g. for Sham 
cells, 12.70 A/F vs 17.21 A/F; p<0.001). The Sham-LVD differences are also apparent 
-  the Vmox in LVD is around 64% of that in Sham animals (e.g. for endocardial cells,
11.04 A/F versus 17.21 A/F; p<0.001).
3.3.1.2 Viral transfection o f NCX
Figure 3.9 shows the results of analysing In cx  current density in day-2 cultured 
myocytes. No significant difference was found between non-transfected cells and the
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Figure 3.9 NCX current density in day-2 cultured cardiomyocytes. A: 
comparison of In cx  in non-transfected (wild-type) cells with those transfected 
with Lac-Z or NCX adenoviruses. B: Bar graph summarising mean Vmox 
data from In cx  curve fits, for each cell type. *** p<0.001.
transfected control cells expressing Lac-Z. However, adenoviral transfection of NCX 
resulted in a significantly higher NCX current density, with an increase in Vmox of 73%
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Cell type n Capacitance (pF)
/wcx reversal 
potential (mV)
[N a]i (mmol/L)
Sham Endo 25 176.8 ± 10.9 -62.5 ± 1.4 16.5 ±0 .3
Sham Epi 23 188.0 ± 10.2 -70.3 ± 2.2 ^ 18.2 ± 0 .5 *
LVD Endo 14 256.2 ± 14.4 *** -68.1 ± 2 .4 17.7 ±0 .5
LVD Epi 15 216.9 ± 16.4 -68.4 ± 2.2 17.7 ±0 .5
Table 3.2 Cell characteristics -  measured capacitance and Incx reversal 
potential, with calculated [N a]i. * p<0,05 versus Sham Endo, *** p<0.001 
versus Sham Endo, other statistical comparisons not significant.
compared to non-transfected cells, and 100% compared to Lac-Z transfected cells 
(p<0.001 in both cases).
3.3,2 Cell characteristics
3.3.2.1 Cell capacitance
Table 3,2 summarises the baseline characteristics of the cells studied. It is apparent 
that the capacitance of the LVD endocardial cells studied is significantly higher than 
the capacitance of the Sham endocardial cells, but other comparisons were not 
significant. Whilst this may reflect a true difference in cell size, the comparison is not 
valid since it is heavily biased by operator selection -  in an attempt to standardise 
voltage clamp conditions, cells of a roughly similar size are chosen irrespective of the 
cell group under study. However, previous studies of this animal model specifically 
aimed at determining cell size have indeed shown evidence of significant hypeitrophy 
in the LVD cells (McIntosh et a l,  2000; Quinn et a l,  2003).
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3.3.2.2 Reversal potential and [Na],
Analysis of the reversal potential {Ersv) data shows that Er v^ in Sham endocardial cells 
is significantly more positive than that in Sham epicai'dial cells (-62.5 ± 1 .4  mV vs -
70.3 ± 2.2 mV; p<0.05), but other comparisons aie non-significant. Since [Na], is 
calculated from the reversal potential, this similarly shows a small difference between 
Sham endocai'dial and epicai’dial cells (16.5 ± 0.3 minol/L 18.2 ± 0.5 mmol/L; 
p<0.05).
Close examination of the curves in Figure 3.7 shows that the portion of the curve 
crossing the abscissa is relatively flat, meaning that small vai'iations in the curve can 
have large effects on the estimated Er v^ It is also apparent that there is a small 
negative indentation in the curve around this point, which may be due to slight 
contamination of the current by I^a -  it is much more marked when a faster ramp 
depolarisation is used (e.g. 1 s, data not shown). Both these factors must be kept in 
mind before attributing the apparent difference in Ercv between Sham endocardial and 
epicardial cells to a property of the exchanger itself.
i. 3.2.3 Stoichiometry o f  NCX
Altered stoichiometry of the exchanger in LVD would result in a shift in the reversal 
potential of Incx and the cui’ve fitting function can be used to investigate this. If it is 
assumed that full equilibration of pipette contents with the cytoplasm takes place and 
that good control of [N a], is achieved, then [N a]i can be set to 20 mmol/L, rather than 
being allowed to vai’y, as in the analysis above. With these parameters set, the 
stoichiometry of the exchanger {ri) can be allowed to vary, to produce the best fît to the
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data, including Ersv. Using this approach, no significant difference is found in the 
stoichiometry between Sham cells («==3.21 + 0.05) and LVD cells («=3.16 ± 0.05).
3.3.3 NCX-mediated Ca efflux
These experiments were designed to estimate NCX activity in each cell type by 
measuring the rate of calcium removal from the cytoplasm under conditions where re­
sequestration into the SR is prevented. A train of stimuli was used to achieve steady- 
state SR loading whereupon 10 mmol/L caffeine was applied, resulting in Ca release 
from the SR and removal of Ca mainly via NCX. Both the calcium signal and the 
inward current on application of caffeine were analysed.
Figure 3.10 summaiises the results for each cell type. The “Caffeine” data were 
obtained from 14 animals for Sham Endo, Sham Epi and LVD Endo; and 13 animals 
for LVD Epi. The “Caffeine+Ni” data were obtained from 4 animals for each group. 
As shown in Figure 3.10 A, no significant differences were found in the rate of Ca 
removal with caffeine application in the presence of nickel. Under these conditions, SR 
re-sequestration and Ca removal on NCX aie both inhibited and the decay obseiwed is 
due to Ca removal by the sarcolemmal Ca-ATPase, and uptake into non-SR organelles 
(e.g. mitochondria; Bassani et a l, 1992). These results suggest that there are no 
differences across the cell types in the rate of Ca removal by these “slow” pathways.
In the presence of caffeine alone, calcium removal is achieved mainly by NCX, but 
there will also be a contribution from the “slow” pathways. Since the latter appear 
unchanged when the different cell types are compared, any differences in the rate 
constant of Ca decay with caffeine can be ascribed to differences in NCX activity. If it
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is assumed that the Ca removal mechanisms act independently, and thus additively, 
then the rate constant of decay attributable to NCX can be calculated by subtracting the 
rate constant for caffeine+Ni from the rate constant for caffeine alone. This analysis is 
pursued further in Chapter 4.
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Figure 3.10 NCX activity -  summary data. A: rate constant of Ca decay on 
application of 10 mmol/L caffeine, in the absence and presence of 10 
mmol/L Ni, for each cell type, as indicated. B: Characteristics of the 
resulting inward current due to NCX on caffeine application — (:): rate 
constant of decay; (ii): amplitude, corrected for cell capacitance. The figure 
legend in panel A refers to all three bar charts; number of cells is indicated 
on each column; statistically significant differences are indicated.
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Figui*e 3.10 A illustrates that Ca removal in the presence of caffeine is significantly 
slower in LVD when cells from like regions are compared (e.g. for endocardial cells, 
1.67 ± 0.11 s'^  vs 2.22 ± 0.12 s"’; p<0.01), indicating reduced NCX activity in LVD. 
The endocardial-epicardial differences, which were apparent with the voltage ramp 
protocols, do not reach statistical significance in these experiments.
Figure 3.10 B summarises the findings on analysis of the inwai’d current generated by 
NCX when caffeine is applied. Again, the rate constant of decay is significantly slower 
in LVD (e.g. for endocardial cells, 3.41 ± 0.29 s'* vs 5.72 ± 0.44 s"*; p<0.001). This is 
accompanied by a smaller amplitude current in LVD (e.g. for endocai'dial cells, 1.38 ± 
0.10 A/F vs 2.53 ± 0.19 A/F; p<0.001). These results support the data in panel A, 
confirming reduced NCX function in the LVD cells.
One unusual observation is that the rate constant of decay for the caffeine-induced 
inward current is around 2-2.5 times higher than the rate constant of C a  decay during 
the same caffeine application. This effect is consistently seen when the traces from 
individual cells aie examined. The reason for this is unclear, but two factors could 
contribute. Firstly, the relationship between [C a]i and Incx is non-linear, as is apparent 
from examining Equation 3.1, and simulating the ionic conditions shows that this is 
especially marked at lower levels of [N a]j (<-10 mmol/L). Figure 3.11 models the 
relationship, with a  typical exponential C a  decay being converted to a current decay 
using the N C X  model. The predicted In c x  decay is close to exponential, but the rate 
constant is around 25% higher. The second possible factor is that C a  may be released 
into a restricted subsarcolemmal space where it could be rapidly extruded on N C X  
before it has much effect on the bulk [C a] sensed by Fura-2. The discrepancies
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Figure 3.11 Conversion of a simulated exponential Ca decay (black line) to 
a current decay (grey line) using Equation 3.1. See text for discussion.
between subsarcolemmal [Ca] and bulk [Ca] are being increasingly recognised, 
paificularly at times when Ca is changing rapidly, for example at the peak of the Ca 
transient (Weber et a l, 2002), and this is likely to be the case on caffeine application. 
Other workers have noted that the measured tail current on repolarisation (due to NCX) 
decays faster than that predicted from the changes in bulk [Ca] (Trafford et a l ,  1995).
3,3.4 Allosteric regulation o f NCX
These experiments were designed to establish whether there was evidence of allosteric 
regulation of NCX in rabbit cardiomyocytes, and, if present, to characterise this 
regulation in terms of the calcium sensitivity of the exchanger. By examining the 
outward NCX cunent as [Ca], increases, it is possible to determine whether allosteric 
regulation is present, based on the theory outlined in Figure 3.5. Figure 3.6 illustrates 
the results from a typical cell. It is apparent from examining the difference current
96
(Fig. 3.6 A(iii)) that outward I^cx initially increases as [Ca], increases, implying that 
allosteric regulation does indeed occur -  the exchanger is being activated by calcium.
For each cell, the protocol generated a number of values of I^cx over a range of [Ca]i 
and these data were fitted with a mathematical model of N C X  function, to generate a 
Vmüx and K„, for calcium activation {K,nCaAct)‘ The function could also be applied 
without the “Allosteric” factor and under these circumstances the fit to the data was 
generally poor, again suggesting that allosteric regulation was occurring.
3.3.4.1 calcium activation in Sham and L VD animals
Data were obtained from 22 cells from 8 Sham animals and 18 cells from 8 LVD 
animals. For both Sham and LVD animals, no significant difference was found 
between the KmCaAct for the fit to the inward cuiTent data, compared to that for the 
outward cuiTent data (e.g. for Sham, 415.7 ± 98.8 nmol/L vj- 375.4 ± 62.4 nmol/L; 
p=0.73). Since the fit to the outwaid current data was generally more reliable, these 
values were used when comparing Sham to LVD. Similarly, in both Sham and LVD 
animals, no difference was found between the K„,caAct for endocardial and epicardial 
cells, so data from both regions were pooled. Analysing these data showed that the 
K-mCaAct was significantly lower in LVD myocytes (206.2 ± 42.4 nmol/L vs 375.4 ± 62.4 
nmol/L; p=0.03), indicating that the exchanger was significantly more sensitive to 
calcium. For both Sham and LVD cells, the KmCaAct falls within the physiological range 
of Ca for each cell type (see Chapter 4), suggesting that allosteric regulation by Ca 
could modulate the exchanger during the cardiac cycle. The values obtained are higher 
than those reported by Weber et al for ferret ventricular' myocytes (125 nmol/L; Weber
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et a l, 2001), but compare well with those of Reeves & Condrescu for NCXl expressed 
in Chinese hamster ovary cells (-300 mnol/L; Reeves & Condrescu, 2003).
33.4.2 VMax in Sham and LVD animals
As well as deriving a KmCaAct for each cell, applying the model of NCX function to the 
data in these experiments also gave a Vmqx value. As in the experiments examining 
NCX current density, the Vmox was significantly lower in LVD cells (24.8 ± 3 .2  A/F vj- 
40.8 ± 6.9 A/F; p=0.045).
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3.4 Discussion
The experiments in this chapter examined the activity and regulation of the sodium 
calcium exchanger in cells from the endocai'dial and epicardial regions of the left 
ventricular free wall of sham-operated rabbits and those with infarct-induced left 
ventricular dysfunction. The results show transmural differences in NCX current 
density and reduced NCX activity in animals with LVD. These findings will now be 
discussed in more detail.
3.4.1 Endocardial -  epicardial differences in NCXfunction
As discussed in Chapter 1, regional differences have been demonstrated in a number of 
ion channels in the heart and these differences have functional consequences in terms 
of action potential shape, contractile function and ai'rhythmogenesis (Antzelevitch et 
a l, 1991; Schi'am et a l,  2002). Few data are available on the transmuial distribution of 
NCX, and only limited functional assessments have been reported (Bryant et a l, 1997; 
Zygmunt et a l, 2000; see Chapter 1, section 1.5). The experiments in this chapter 
address this issue in detail, by examining NCX activity in endocardial and epicardial 
cells from the base of the LV free wall.
In the experiments examining I^cx current density, ionic conditions were tightly 
controlled and regional differences in Ixcx were observed. Higher current density was 
demonstrated in endocardial cells compared to epicardial cells, and this difference was 
preserved in LVD animals (Fig. 3.7 & 3.8). This parallels regional differences in NCX 
protein expression measured in membrane fractions of tissue homogenates from this 
model (Quinn et a l, 2003). When NCX-mediated Ca efflux was examined in separate 
experiments, the mean rate constant for Ca efflux was higher in endocardial cells than
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epicardial cells for both Sham and LVD animals (Fig. 3.10), but neither difference 
reached statistical significance, even with relatively high numbers of cells in the 
analysis. The internal conditions are controlled less rigidly in these experiments and 
this may contribute to the greater variability in the data. In particular, small differences 
in intracellular [Na] between cells could affect NCX activity, and regional differences 
in [N a]i have been observed in the rabbit (Cook et a l, 1997).
3.4,1.1 Functional significance o f  regional differences in NCX
Previous studies investigating regional electrophysiological properties in noiinal rabbits 
have demonstrated significant prolongation of the action potential duration in sub­
endocardial cells compared to sub-epicardial cells (McIntosh et a l,  1998; McIntosh et 
a l, 2000). In the later study by McIntosh et al, the APD was around 30% longer in 
sub-endocardial than sub-epicardial cells from Sham animals, and this was 
accompanied by a significantly longer Ca transient (by around 20%) but no difference 
in peak systolic [Ca]. The prolonged APD may allow a greater flux of Ca into 
endocardial cells during systole (via Ica.f) and increased NCX current density could 
facilitate the removal of a larger quantity of cytoplasmic Ca during diastole. The 
inward current generated by the removal of this Ca may even contribute to the 
prolongation of the APD in endocardial cells (see discussion in Chapter 1), since there 
do not appear to be significant regional differences in I n  or fo  in Sham cells (McIntosh 
et a l,  1998). Computer modelling of increased for example using the program 
LabHEART (D. Bers & J. Puglisi, Dept of Physiology, Loyola University, Chicago), 
does indeed generate slightly longer APDs.
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Higher NCX cun eut density in endocardial cells could also make this region more 
prone to arrhythmogenic afterdepolarisations, since for a given Ca release from the SR, 
one would expect a larger inward current to be generated. Observations in a non- 
ischaemic model of heart failure in the rabbit have demonstrated that premature 
ventricular complexes arise in the sub-endocardial region (Pogwizd, 1995) and this 
could be the focus for triggered airhythmias. Similarly, in a dog model of ischaemic 
cardiomyopathy, ventricular arrhythmias tended to arise from focal sub-endocardial 
sites (Pogwizd, 1994). There is also some evidence from human studies that the sub­
endocardial region may be important in anftythmogenesis. Using 3-dimensional 
intraoperative cardiac mapping, Chung et a l showed that of 36 beats of non-sustained 
VT, 42% initiated in the sub-endocardium by focal mechanisms, whilst the remainder 
were the result o f macroreentry (Chung et a l, 1997). Pogwizd et a l showed that 9 of 
11 beats of spontaneous ventricular arrhythmias arose focally in the sub-endocardium 
(Pogwizd et a l, 1998). Furlher work is required in the rabbit infarct model of LVD to 
establish whether anhythmias also tend to arise in this region.
3.4,2 N C X  function in LVD
As mentioned in Chapter 1, a large number of studies have investigated changes in the 
sodium-calcium exchanger in various models of heart failure. Variables examined 
have included mRNA levels, protein expression and functional assessments such as 
current density and Ca removal (reviewed by Sipido et a l, 2002; Pogwizd, 2000; 
Hasenfuss & Pieske, 2002). The results in this chapter have demonstrated that NCX 
activity is significantly lower (by around 30%) in this model of LVD, whether assessed 
by current density (Fig. 3.7 & 3.8) or by examining NCX-mediated Ca decay or current 
decay during caffeine application (Fig. 3.10). These results apply to both endocardial
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and epicardial regions and both forward and reverse modes of the exchanger (Fig. 3.7). 
There is no evidence that the stoichiometry of the exchanger is significantly altered in 
LVD (Section 3.3.2.3). It is also unlikely that altered intracellular conditions in LVD 
(e.g. raised [N a]i or lowered pHJ play a major role in this animal model since 
comparable results were obtained in myocytes with minimal intracellular dialysis (Fig. 
3.10) and those dialysed with EGTA and 20 mmol/L N a  (Fig. 3.7 & 3.8).
3.4.3 Potential mechanisms fo r  reduced NCX activity
Modelling I^cx can give insights into possible mechanisms to explain the reduced NCX 
activity in LVD. Examination of Equation 1 reveals three principal factors which could 
be involved:
(i) reduced Vmox-, representing a reduced number of exchangers available in the
sarcolemma and/or reduced turnover of individual units;
(ii) reduced affinity of the exchanger for Ca and/or Na;
(iii) reduced sensitivity of the exchanger to allosteric regulation by Ca.
Simulating changes in any one of these factors, whilst keeping the other two constant 
can result in an equally good fit to the data in LVD, as illustrated in Figure 3.12, 
demonstrating that the I -V curve alone cannot distinguish between them.
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uT 5I■ Sham Endo (n=25) o LVD Endo (n=14) 4 -
3-
Q,-120 40-40
Parameter Units Sham LVD(i) LVD(ii) LVD(iii)
^Max A/F 42.1 27.3 42.1 42.1
I^ NCX mmol/L 47.2 47.2 78.6 47.2
KmCaAct nmol/L 375.4 375.4 375.4 502.6
Figure 3.12 Modelling of NCX function. Parameters allowed to vary are 
shown in bold. First, data points for Sham endocardial cells were fit using 
Equation 1, with k^cx derived from the literature (see Table 3.1), KmCaAct 
experimentally-derived for Sham cells and Vmox allowed to vary. The 
resulting parameters were then used in the equation to fit the LVD 
endocardial data, with one of the three parameters allowed to vary, as 
indicated in the table. The resulting curve-fits are superimposable (dashed 
line).
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3.4.3.1 Affinity o f  NCXfor Ca & Na
The term Equation 1 incorporates the affinity constants for Ca and Na on each
side of the sarcolemma. Experiments to determine these affinity constants in this
model are beyond the scope of this thesis. Modelling the K^cx term shows that it is
most sensitive to changes in the K,n for Ca, particularly to changes in KmCar Even so, 
the K m C a i would need to increase by around 180% to account for the reduced I n c x  in 
LVD.
Previous studies have shown that cardiac NCX (NCXl) activity can be modulated by 
protein kinase-A (Perchenet et a l, 2000; Ruknudin et a l, 2000) and -C (Iwamoto et a l, 
1996). Phosphorylation of NCXl results in up-regulation of exchanger activity with 
increased currents (Perchenet et a l, 2000; Ruknudin et a l, 2000) or uptake of '^^Ca 
(Iwamoto et a l, 1996). Therefore, decreased phosphorylation of NCX in LVD could 
result in reduced exchanger activity. The phosphorylation status of the exchanger has 
not been measured in this model, however evidence to date suggests increased 
phosphorylation of proteins in heart failure (Rapundalo, 1998) and activation of protein 
kinase A can result in a phenotype of dilated cardiomyopathy with reduced contractility 
and increased mortality (Antos et a l, 2001 ; Carr et a l, 2002).
3.4J.2 Allosteric regulation o f  NCX in LVD
Experiments in this chapter have addressed the third possibility above: that changes in 
allosteric regulation of NCX by Ca could account for the differences seen in LVD. If 
this were the sole factor to account for the obseiwed differences in l^cx then 
examination of Figure 3.12 shows that the KmCaAct in LVD would need to increase by
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around 34% (from 375.4 nmol/L to 502.6 nmol/L). In fact, the measured KmCaAct in 
LVD is around 45% lower than that in Sham animals (206.2 ± 42.4 nmol/L 375.4 ±
62.4 nmol/L; p=0.03), showing that the exchanger is significantly more sensitive to 
regulation by Ca. If the measured values for KmCaAct in Sham and LVD animals are 
used in Equation 1 to fit the data, then even larger differences in Vmqx result (43.4 ±2.1 
V5' 14.7 ± 1.4 A/F for Sham Endo & LVD Endo, respectively, p<0.001; 32.0 ± 2.3 
10.7 ± 1.0 A/F for Sham Epi & LVD Epi, respectively, p<0.001). This analysis 
suggests that the Vmox in LVD is around one third of that in Sham animals. Considering 
this from another viewpoint, the reduced K„,caAct in LVD could be seen as an adaptive 
mechanism, upregulating NCX function for a given [Ca]i in an attempt to compensate 
for reduced exchanger numbers.
3.4.33 NCX protein expression & mRNA levels
Perhaps the simplest explanation for regional differences in NCX function and the 
changes seen in LVD would be altered expression of NCX protein in the cell, resulting 
in changes in Vmqx- Other workers in the group have studied NCX protein levels in 
tissue homogenates and membrane fractions from Sham and LVD animals (Quinn et 
a l,  2003). These experiments have demonstrated higher expression of NCX protein in 
membrane fractions from endocardial regions compared to epicardial regions in both 
Sham and LVD animals, in keeping with the results in this chapter. However, NCX 
protein levels in LVD were found to be significantly higher than those in Sham 
animals, by around 20-40%. NCX mRNA levels were similarly raised. This 
discrepancy between protein / mRNA levels and function merits some consideration, 
and highlights the potential danger of drawing conclusions from biochemical data 
alone, without confinnatory functional studies.
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3.4,4 Relationship between N C X  protein levels and N C X function
Several possibilities could explain increased protein expression but reduced NCX 
function in this model:
(i) presence of defective NCX protein,
(ii) presence of isoforms of NCX with reduced function,
(iii) downiegulation o f functional NCX units (discussed above),
(iv) NCX units present in the cell with no access to the extracellular space
(therefore non-functional).
The presence of defective NCX protein is difficult to assess. The primary antibody 
used to measure NCX protein levels in this model detected both a 120 kDa band, which 
reflects the matuie NCX protein, and a 70 kDa band which is thought to be a 
proteolytic subfragment of the full length exchanger. Densitometry was performed on 
both bands and the results summed to give a total NCX level for each region. There 
was no evidence that greater relative amounts of the proteolytic fragment were present 
in LVD -  the ratio of 70:120 kDa bands was the same (Quinn et al., 2003).
The presence of different NCX isofonns in LVD would also require further study. 
There is evidence of isoforms shifts in a number of channels and transporters in heart 
failure, including the Na-channel (Muller-Ehmsen et al., 2002; Schwinger et a l, 1999), 
Na-K ATPase (Paganelli et a l,  2001), and Na-H exchanger (Yokoyama et a l, 2000). 
A number of splice-variants of cardiac NCX have been identified (Quednau et a l,  
1997; Kim et a l, 1998) and their relative proportions do not appear to change during
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development in the rat (Koban et a l, 1998) or mouse (Kim et a l, 1998). To date, no 
study of the relative expression of different isoforms of NCX in heart failure has been 
published.
Another mechanism whereby increased protein expression could be accompanied by 
reduced function would be for NCX units to be present in the myocyte with no access 
to the extracellular space — either not inserted into the plasma membrane or present in 
membrane which is not continuous with the sarcolemma. As discussed in Chapter 1, 
there is ongoing debate in the literature about the distribution of NCX in the cell, in 
particular the proportion which is present in T-tubules compared to surface portions of 
the membrane. Dismption of the T-tubule system could result in blind ending, 
“nipped-ofP’ tubules within the cell, where NCX could not contribute significantly to 
Ca removal or produce a measurable current, but would still be detected on Western 
blotting.
There is recent evidence that the T-tubule system may indeed be disrupted in heart 
failure. He et a l assessed T-tubule density in canine tachycardia-induced heart failure 
using the membrane dye di-8-ANNEPS and quantified Ica using voltage clamp 
protocols (He et a l,  2001). They report that T-tubule density was reduced by around 
24% in failing cells and this was accompanied by a reduction in charge movement on 
Ica of around one half. Interestingly, overall Ica density appeared unchanged and they 
postulate that this is due to functional upregulation of a smaller number of Ca channels. 
Using confocal and electron microscopy, Kostin et a l showed altered T-tubule 
structure in human myocytes from patients with caidiomyopathy (Kostin et a l, 1998).
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Studies of the T-tubule stmcture in our model of LVD have been performed by other 
workers in the laboratory, also using di-8-ANNEPS and image processing to quantify 
T-tubule density (Quinn et a l, 2003). These experiments have shown that T-tubule 
staining within the cell is reduced by 41%, and this is accompanied by a reduction in 
the surface area:volume ratio. Further studies are underway to detennine whether 
“nipped-off ’ tubules are present within LVD myocytes. Such ultrastructural changes 
could help explain the apparent disparity between NCX protein / mRNA levels and 
NCX function in this model.
3,4.5 Comparison with other models o f LVD
Sipido et a l have recently reviewed the literature on NCX in heart failure and 
hypertrophy and it is apparent that a full range of responses can be seen -  from 
upregulation to downregulation or no change in exchanger activity (Sipido et a l , 2002). 
In part, these differences may depend on the type of animal studied (for example fewer 
rat models showed upregulation) and also the means by which hypertrophy / failure 
was achieved.
Some other studies have also found discrepant results between NCX abundance and 
function. Boateng et a l studied rats with cardiac hypertrophy induced by aortic 
constriction (Boateng et a l,  2001). They showed that in tissue horn hypertrophied 
hearts, NCX mRNA levels more than doubled and protein levels increased by more 
than foiu'-fold. In spite of these marked changes, decline of Ca in the presence of 
caffeine following rapid cooling contractures (which is mainly dependent on NCX) was 
no different.
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3.4.5.1 Comparison with other infarct models o f L VD
A number of groups have used ligation of the left coronary artery in the rat as a model 
of infarct-induced LVD. Dixon et al. (1992), Sethi et al. (1999) and Makino et al. 
(1996) found slowed Na-dependent Ca uptake into sarcolemmal vesicles in this model, 
implying reduced NCX function. This effect could be diminished or abolished by in 
vivo treatment with propionyl L-camitine (Sethi et a l, 1999) or Angiotensin Type 1 
receptor blockade (Makino et a l,  1996). Contractile abnormalities post-MI in the rat 
could also be reversed by transgenic overexpression of NCX, including an increase in 
SR Ca content (Min et a l , 2002).
Zhang et al. also demonstrated reduced NCX function, with diminished NCX currents 
(Zhang et a l, 1996) and slower Ca decay in the presence of caffeine (Zhang et a l,
1999) and these changes were associated with reduced SR Ca content and contractile 
abnormalities. Interestingly, immunoblotting showed no difference in NCX protein 
levels between post-MI and sham-operated animals (Zhang et a l, 1998). In contrast, 
Wasserstrom et a l  found increased NCX protein levels, mRNA, and NCX current in a 
similar' animal model (Wasserstrom et a l, 2000). Similarly, Yoshiyama et a l found 
significantly increased NCX mRNA levels in hypertrophied post-MI rat cells remote 
from the infarct site, although no functional assessment was performed (Yoshiyama et 
a l, 1997). The reasons for the differences between the latter two studies and the 
remaining rat MI studies are unclear, but Yoshiyama et a l demonstrated two possible 
factors - both the timing post-MI and the site from which myocytes were harvested 
influenced the level of NCX mRNA seen (Yoshiyama et a l, 1997). For example, at 1 
week and 3 weeks, NCX levels were higher in post-MI animals, but by 3 months the 
levels were lower.
109
NCX has also been studied following myocardial infarction in the dog. Pu et al.
examined NCX activity in the epicardial border zone 5 days after infarction to
deteimine whether early changes were present which could provide an arrhythmic 
substrate (Pu et a l, 2000). They found altered Ca handling in these cells, but no
significant difference in NCX current or Ni-sensitive Ca efflux.
3.4.5.2 Comparison with other rabbit models o f  L VD
As discussed in section 2.1, there are theoretical advantages to using the rabbit heart to 
model the situation in human heart failure, and this has been done by a  number of 
groups. Pogwizd et a l have recently characterised a rabbit model with combined 
pressure and volume overload due to aortic constriction and aortic valvular 
regurgitation (Pogwizd et a l,  1999; Pogwizd et a l, 2001). These miimals exhibit 
severely depressed LV function, with reduced cardiomyocyte twitch amplitude, and 
spontaneous ventricular aiThythmias. Analysis showed that N C X  protein levels were 
approximately doubled and there was a 2.7-fold increase in N C X  mRNA levels. These 
changes were accompanied by a 2-fold increase in N C X  current and a faster decline of 
[C a]i during caffeine application. In the initial paper, no significant difference was 
found between the SR C a  content in control and heart failure (assessed by the 
amplitude of caffeine-induced contractuies; Pogwizd et a l,  1999), however in the later 
paper, a  40% reduction in SR C a  content was reported (assessed by the amplitude of 
caffeine-induced C a  transients; Pogwizd et a l, 2001).
In a pressure-overload model of LVD in the rabbit, due to aortic constriction alone, 
Naqvi et a l found no change in NCX protein levels (nor the levels of SERCA2 or
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phospholamban), SR Ca content (derived from the integral of the caffeine-induced 
inward cunent) or NCX-mediated relaxation in the presence of caffeine (Naqvi et a l, 
2001). This animal model differed from that of Pogwizd et a l in that volume overload 
was not present (the aortic valve was not made incompetent) and the studies were 
cairied out much earlier in the development of heart failure (at 6 weeks compared to a 
mean of 9.5 months post-operatively).
In a pure volume-overload model of heart failure induced by arteriovenous shunting, 
Takahashi et a l show a reduction in NCX mRNA levels at 4 and 12 weeks, but no data 
on NCX function are reported (Takahashi et a l, 2000).
Yao et a l produced LVD in the rabbit by rapid pacing and studied cells 3-5 weeks 
later, when clinical heart failure was apparent (Yao et a l,  1998). At this stage the Ca 
transients were markedly reduced in amplitude (to <30% of those in control animals). 
NCX mRNA levels were strikingly reduced and the outward NCX current elicited by 
abruptly switching to a 0 Na external solution was decreased by around 24%.
The model most closely resembling the one used in this thesis is that of Litwin et a l 
who induced MI in rabbits of the same age by tying off the same branch of the left 
circumflex artery (Litwin & Bridge, 1997; Litwin et a l,  2000). The animals were 
saerificed for study at the same stage post-MI (8 weeks) and showed evidence of 
myocyte hypertrophy. With field stimulation, tlie amplitude of contraction appeared 
larger in MI cells (Litwin & Bridge, 1997), however in the later paper, the peak [C a]i of 
voltage-clamped cells was significantly reduced (Litwin et a l , 2000). This discrepancy 
is not commented upon, but may partly be explained by prolongation of the action
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potential in the non-voltage-clamped MI cells (Litwin & Bridge, 1997), In neither 
paper was a significant difference in SR Ca content seen, although there was a trend 
towards increased SR content in the MI cells.
Litwin et a l assessed NCX current density using the amplitude of the outward current 
induced by rapid switching to a 0 Na external solution, corrected for cell capacitance. 
In contrast to the results in this chapter, they found a significantly increased NCX 
current density (by 32%) in the infarcted hearts (Litwin & Bridge, 1997). They also 
showed that there was augmented SR loading by reverse-mode NCX in the MI cells 
after loading pulses to positive potentials.
One major difference between the studies of Litwin et a l and those reported here is in 
the origin of the cells examined. Litwin et a l selectively took cells from the 2-3 mm 
border zone around the infarct scar, whereas the cells in this thesis were taken from the 
basal region of the LV, remote from the scar, and cells from different transmural areas 
were studied separately. This important difference may help explain the discrepant 
results we have obtained. Overall, the peri-infarct border zone represents a small 
proportion of the remaining viable myocardium and whilst it may be important as an 
area where arrhythmias can arise, cells remote from this site will dictate the majority of 
the contractile performance post-MI. In addition, the border zone is likely to be a 
heterogeneous region, with areas of fibrosis and possible residual ischaemia. One 
cannot assume that results from border zone cells can be extrapolated to cells elsewhere 
in the surviving myocardium -  indeed, Yoshiyama ei a l and Wasserstrom et al. have 
demonstrated that NCX mRNA levels differ when peri-infai'ct and remote sites are 
compared in the rat (Yoshiyama et a l, 1997; Wasserstrom et a l, 2000). Litwin et a l
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do mention in their earlier paper that in some animals, cells hom the remote area of 
myocardium were studied, but they do not present any data for these cells (Litwin & 
Bridge, 1997).
3.4.5.3 Comparison with human studies
Studies of NCX expression and function in human heart failure have also given varying 
results (reviewed by Sipido et a l, 2002; Hasenfuss & Pieske, 2002; Houser et a l,
2000). The majority of studies have compared tissue from failing hearts explanted at 
the time of transplantation with tissue from donor hearts which were not suitable for 
transplanting. Most studies have only made biochemical measui’ements of NCX -  i.e. 
mRNA or protein levels -  since it is difficult to isolate sufficient cells for 
electrophysiological study.
In an early study by Komuro et al, NCX mRNA levels were significantly lower in 
foetal hearts, but there was no significant difference in hearts from end-stage heart 
failure (Komuro et a l, 1992). Similai'ly, Schwinger et a l studied myocardial NCX 
protein levels in patients with dilated cardiomyopathy and NYHA functional class IV 
and found no significant difference compared to non-failing hearts (Schwinger et a l, 
1999). Kubo et a l examined NCX protein abundance in hearts from patients with 
dilated and ischaemic cardiomyopathies and again found no difference compared to 
control hearts (Kubo et a l, 2001).
The groups of Studer, Reinecke, Drexler et a l have reported results on patients with 
end-stage heart failure and detected an increase in NCX mRNA (Studer et a l, 1994) 
and protein (Reinecke et a l, 1996). They also made a functional assessment of NCX
113
by measuring Na-dependant uptake into inside-out sarcolemmal vesicles prepar ed 
from a crude membrane fr action. This showed an 87% increase in transport activity in 
preparations from failing hearts (Reinecke et a l, 1996). Schwinger et al (1999) have 
questioned the methodology of Studer et a l in assessing NCX protein abundance, since 
in the latter paper they included a 40 kDa band as well as the 120 and 70 kDa bands 
normally detected by anti-NCX antibodies. Schwinger et a l point out that the 40 kDa 
band is not detected by monoclonal antibodies to NCX, nor does it enrich when 
sarcolemmal membranes are purified. Flesch et al detected increased NCX mRNA 
and protein levels in failing human hearts (Flesch et a l, 1996), however in a later 
study, this group reported no difference in NCX protein levels (Schwinger et a l, 1999). 
The reason for this discrepancy is not commented upon in the later paper, but may 
indicate significant phenotypic vaiiability between patients -  a suggestion supported by 
considerable scatter when results from individual patients are plotted (e.g. see 
Hasenfuss et a l, 1999; Heerdt et a l, 2000). Heerdt et a l reported a discrepancy 
between NCX mRNA levels and NCX protein abundance in patients treated with a left 
ventricular assist device (LVAD; Heerdt et a l , 2000) -  whilst mRNA levels increased 
significantly with LVAD treatment, protein levels remained unchanged.
Hasenfuss et a l have attempted to clarify some of these inconsistencies by dividing 
patients into subgroups according to their contractile function. Specifically, they 
separated patients into groups based on the change in diastolic force with increasing 
stimulation rates (Hasenfuss et a l, 1999). They found that NCX protein levels were 
only significantly elevated in patients who exhibited no frequency-dependent rise in 
diastolic force (i.e. preserved diastolic function). In these patients there was no 
significant difference in SERCA levels compared to non-failing heai’ts. In contrast, in
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patients with no change in NCX levels, SERCA function was significantly depressed. 
Thus, irrespective of the group, the ratio of NCX; SERCA was increased in heart 
failure, compared to controls. An additional factor in determining NCX expression 
may by the degree of sympathetic activation that patients display. Schillinger et al. 
have reported that NCX levels in human HF show a significant positive correlation 
with plasma noradrenaline levels (Schillinger et a l,  2002). They also found an 
increased incidence of ventricular an'hytlimias in patients with higher noradrenaline 
and NCX levels.
In an interesting paper. Piper et al used quantitative PCR to examine NCX mRNA 
levels in endomyocardial biopsies from 40 patients with myocardial dysfunction of 
different aetiologies and severity, and these results were compared with samples from 
13 hearts explanted at the time of transplantation (Piper et a l, 2000). Samples from 7 
controls were also obtained. They found no significant difference in NCX mRNA 
levels between controls and endomyocardial biopsies from patients in any group -  
whether divided up by disease aetiology, NYHA functional class, ejection fraction or 
wall stress. The only samples showing increased NCX transcription levels were those 
obtained from explanted hearts, suggesting two main possibilities -  either it was a 
response to severe haemodynamic, biochemical and neuiohumoral changes pre­
transplantation, or it was due to peri- / intra-operative events. The fact that even 
patients with the most severely reduced ejection fraction, and worst functional class 
showed no significant change in NCX on biopsy tissue provides some evidence against 
the former possibility, since one might expect these patients to show some similarities 
with pre-transplant patients.
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3.5 Conclusions
The experiments in this chapter have demonstrated transmural differences in NCX 
cuirent density in cells from both Sham and LVD animals. In post-infarction 
myocytes, NCX cun*ent density and activity are reduced by around Vs. Altered 
allosteric regulation of NCX by [Ca] is also apparent in these cells. Since others in the 
group have found slightly increased NCX expression in LVD animals, it is clear that 
functional measurements are essential when interpreting biochemical data. There is 
evidence that altered myocyte structure, in particular the arrangement of T-tubules, may 
aceount for some of the experimental findings.
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CHAPTER 4
CALCIUM HANDLING IN SYSTOLE AND DIASTOLE -  SR 
FUNCTION, E C COUPLING AND RELATIVE CONTRIBUTIONS 
OF CALCIUM REMOVAL SYSTEMS
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4.1 Introduction
4.1.1 Measurement o f  SR Ca content
In the literature, a variety of methods have been employed to estimate the Ca content of 
the SR in intact single cells. To make this measure, all the available Ca in the SR must 
be released, which can be achieved by exposure to an adequate concentration of 
caffeine, or by rapidly cooling the cell. The magnitude of Ca release can then be 
determined. One non-quantitative method to accomplish this is to compare the extent 
of cell contraction when SR Ca is released, as in “rapid cooling contractures” (RCCs; 
e.g. Bers & Bridge, 1989) or caffeine contractures (e.g. Bassani et a l, 1992). A further 
commonly used method is to load the cells with a Ca-indicator and use the amplitude of 
the caffeine-induced Ca transient as an indication of the SR Ca content (e.g. Lindner et 
a l,  1998). At best this method is semi-quantitative, since the peak of the caffeine- 
induced transient will depend on a number of factors including cellular buffering 
characteristics and saicolemmal Ca-removal mechanisms.
A quantitative method for estimating the SR Ca content was developed by Varro et a l 
(Varro et a l, 1993). This method makes use of the electrogenic nature of NCX to 
calculate the amount of Ca removed from the cell during caffeine exposure, and from 
this the total amount released from the SR. If it is assumed that the stoichiometry of 
NCX is 3Na:lCa, then for each Ca ion removed from the cell there is a net gain 
(inward current) of one positive charge. Using Faraday’s constant, the total charge 
movement can be conveiled to give the number of moles of Ca removed on NCX. To 
estimate the total amount of Ca released from the SR, this figure must be corrected for 
non-NCX (electroneutral) Ca removal systems, such as the sarcolemmal Ca-ATPase 
and uptake into mitochondria and other organelles (“slow pathways”). It is also
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important that potential contaminating currents (e.g. Ca-activated Cl currents) are 
blocked.
In this chapter, the latter method was used to determine the SR content. Corrections for 
non-NCX removal mechanisms were made based on the results in Chapter 3 where 
caffeine was applied in the presence of nickel (see Figures 3.4 and 3.10). Comparing 
the rate constant of Ca decay in the presence of Ni with that for caffeine alone can 
indicate the proportion of Ca removed by NCX during caffeine exposure. In view of 
the fact that there were significant differences in Ca removal rates with caffeine 
between sham-operated animals and those with LVD, separate correction factors were 
calculated for each group. Using this approach, for Sham animals it is estimated that 
76 ± 1 % of the Ca is removed by NCX during caffeine exposuie, whereas for LVD 
animals the figure is 70 ± 2 % (p<0.001). These values are lower than those found in 
the rabbit by Bassani, Bers and co-workers (Bassani et a l, 1992; Bassani et a l,  1994), 
as discussed in section 4.4.6.2.
Since cells were loaded with the Ca indicator Fura-2, the amplitude of the caffeine- 
induced Ca transient could also be measured. Results based on this approach could be 
compared with those obtained using the above method.
Finally, recent advances in the chemistry of fluorescent dyes have lead to novel 
methods for the measurement of the SR Ca content. Shannon et a l successfully used 
an intra-SR Ca-sensitive dye to report free [Ca] within the SR (Shannon et a l, 2003a). 
They used a long loading period to allow entiy and de-esterification o f the low-affinity 
Ca indicator Fluo-5N into the SR of rabbit ventricular myocytes. In an elegant study
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they were able to measure the dynamic changes in [Ca]sR during voltage-stimulated Ca 
transients at different rates.
4.1.2 Measurement o f SERCA activity
Several techniques have been described for estimating Ca uptake via SERCA in cardiac 
cells. Both direct and indirect methods have been reported. One approach is to 
permeabilise the cell and control conditions to allow a measure of SR Ca uptake. 
Neary et a l (Neary et al., 2002) used p-Esein to permeabilise rabbit ventricular cells, 
and added ruthenium red to prevent SR Ca leak and dipotassium oxalate to precipitate 
Ca within the SR (thus preventing intra-SR [Ca] from rising and inhibiting fuither Ca 
uptake). Cells were suspended in cuvettes and Ca was measured in a mock intracellular 
solution with Fura-2. Wlien Ca is added to the cuvette, it is taken up by the SR and the 
decay of bulk solution [Ca] can be attributed to SERCA. A similar approach can be 
used for isolated SR vesicles (Cuirie & Smith, 1999).
Yao et al. used a rapid solution-switcher to estimate SERCA function relative to NCX 
function in intact rabbit cardiomyocytes (Yao et a l, 1998). They compared the rate of 
C a  decline for normal electrically-stimulated twitches (where all extrusion systems are 
operating) with twitches induced by rapid switching to a 140 mmol/L K solution in the 
absence of Na and C a  (i.e. NCX inhibited). Differences in the time-course of C a  
decline could be attributed to SERCA activity. Boateng et a l estimated SERCA 
function by releasing SR C a  by rapid cooling, then rewarming the cells in Na-free, C a- 
free solution (Boateng et a l, 2001). Under these conditions, the decline in [C a]i is 
mainly detennined by SERCA, although the slow pathways will also contribute.
1 2 0
Finally, Bassani, Bers and co-workers have examined Ca decay under conditions where 
removal systems are selectively inhibited, to determine the contribution of each to Ca 
removal (e.g. see Bassani et a l, 1994; Puglisi et a l, 1996; reviewed in Bers, 2000; 
Bers, 2001). SERCA activity was determined from the decay of Ca in the absence of 
external Na (i.e. NCX disabled), which was then corrected for flux via slow pathways 
(measured separately in the presence of caffeine and Na-free, Ca-free external 
solution). Alternatively, SERCA activity could be inferred from the decay of a normal 
twitch if the characteristics of Ca flux in relation to [Ca]i were known for the other two 
systems (McCall et a l,  1998).
In this chapter, a novel, reversible, method was used to estimate SERCA function, as 
described in Section 4.2.3.1.
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4.2 Methods
4.2.1 Solution compositions
To allow for assessment of SR Ca content using the techniques outlined below, the 
internal and external solutions were designed to allow accurate quantification of Ca 
flux on NCX. Thus, blockers were present to minimise major interfering currents as 
described in sections 2.5.4 and 3.2.2.1. Ca transients for each cell type were measured 
under the same conditions so that Ca flux during a train of stimuli could be determined 
in systole and diastole.
4.2.2 Ca transient characteristics & estimation o f SR Ca content
4.2.2,} Experiment protocol
Cells were stimulated for 30 s at 0.5 Hz from a resting potential of -80 mV, with a 150 
ms depolarisation to 0 mV, to achieve steady-state contractions. To allow estimation of 
the SR Ca content and cellular buffering characteristics, at the end of this train, the 
superfusing solution was rapidly switched to 10 mmol/L caffeine, which was perfused 
for 10 s (Figure 4.1). Cells were held at the resting potential of -80 mV during caffeine 
exposure. In some cells, Ca transients were also measured at 1 Hz and 2 Hz.
4.2.2.2 Data analysis
After conversion of Fura-2 ratio data to [C a], C a  transients were averaged from the 
point at which steady-state contractions were achieved to the end of the train. This 
allowed data for diastolic [C a]i, peak systolic [C a], and rate constant for C a  decay to be 
obtained. In most cells, the train of stimuli was repeated on a number of occasions and 
for each cell the diastolic and systolic [C a]i for each train was averaged to give mean 
data for that cell.
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Figure 4.1 Protocol for determining C a  transient characteristics, SR Ca 
content, and cellular buffering parameters. Bottom panel: voltage protocol; 
middle panel: membrane current — for clarity, the capacitance spikes have 
been subtracted and the scale was chosen to demonstrate the inward current 
on application of caffeine (peak inward current on depolarisation is off-scale 
at this range -  see Figure 4.6); top panel: [Ca]i. The cell was stimulated at 
0.5 Hz from a resting potential of -80 mV for 30 s, allowing steady-state 
transients to be achieved. 10 mmol/L caffeine was applied for 10 s at the end 
of the train.
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Int X SL factorSR Ca content (mol/L cytosol) -  -------------------
Equation 4.1 Estimation of SR Ca content. Int = cumulative integral at end 
of inward current during application of 10 mmol/L caffeine; SL factor = 
correction for non-NCX Ca removal (1.31 for Sham, 1.42 for LVD, see text 
for details); F  = 96500 C/mol; Vol = accessible cell volume -  cell 
capacitance / 6.44 (see section 2 .122).
SR Ca content was determined using the technique of Varro et al. (1993), as outlined in 
the chapter introduction (section 4.1.1) and illustrated in Figure 4.2. The analysis was 
performed on the raw cuirent trace obtained during caffeine exposure using a 
customized routine in the graphical analysis program OriginPro 6.1 or 7.0 (OriginLab 
Corporation, Northampton, MA, USA). Briefly, the current trace was integrated with 
respect to time between user-defined start- and end-points, and the amount of Ca 
released from the SR was back-calculated from the resulting cumulative integral 
(charge movement) using Equation 4.1. The integration was performed between the 
time at which caffeine was applied and the time when the current had fully returned to 
baseline, as shown in Figure 4.2. As discussed in section 4.1.1, a correction factor was 
applied to allow for Ca removed from the cell by non-NCX mechanisms. The 
coiTection factors for Sham and LVD cells were 1.31 and 1.42, respectively. The 
resulting SR Ca content was expressed relative to the accessible cell volume, as 
described in the Methods chapter, section 2.7.2.2.
124
g  0.8
0.7rQ 0 . 6  
0.5 - 
0.4 -
0.3 - 
0.2 -  
0.1 -  
0
<  0c
IZ3O
Caffeine 10 mM
-0.5^
0
£5
s-EI
Ca content 
"  1.91 fM
5 sec
Figure 4.2 Estimation of SR Ca content by integration of the inward cuiTent 
on application of 10 mmol/L caffeine. Top panel: [Ca]i during application 
of 10 mmol/L caffeine (black bar). Middle panel: resulting inward Incx 
current. Bottom panel: cumulative integral of NCX current, corrected for 
non-NCX removal mechanisms to allow determination of SR Ca content.
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Figure 4.3 Estimation of SERCA activity. In the continued presence of 10 
mmol/L NiCE (open bar) to inhibit NCX, 10 mmol/L caffeine is briefly 
applied (black bai) to release SR Ca. On abrupt withdrawal of caffeine, Ca is 
removed from the cytoplasm, mainly via SERCA. The Ca decay during this 
phase can be fitted using a single exponential function (grey line). A 
con-ection can be made for Ca removal by “slow” pathways by determining 
the rate constant for Ca decay in the presence of 10 mmol/L caffeine + 1 0  
mmol/L NiCE in the same cell (dashed grey line, superimposed on the above 
trace). See text for details.
4.2.3 Estimation o f  SERCA function
4.2.3.1 Experiment protocol
A novel technique was employed to give an estimate of SERCA function in intact cells, 
making use of the rapid solution switcher. Once again, cells were stimulated for 30 s to 
achieve steady-state contractions, as described in section 4.2.2.1. At the end of the 
conditioning train, the superfusing solution was switched to one containing 10 mmol/L
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M CE for 20 s, to eliminate Ca removal on NCX. Immediately after switching to this 
solution, and in the continued presence of Ni, 10 mmol/L caffeine was briefly perfused 
and abmptly withdrawn (see Figure 4.3). This resulted in release o f SR Ca, followed 
by its re-uptake via SERCA. “Slow” removal pathways will also be operating during 
this phase, and to estimate their contribution to the decay, the protocol was repeated for 
each cell with application of 10 mmol/L caffeine + 10 mmol/L MCE after the 
conditioning train of stimuli.
4.23.2 Limitations o f  technique
Since uptake on SERCA has a rapid time course, this technique relies on the prompt 
removal of caffeine when the solution is switched. Examination of the Ca trace duiing 
the protocol (Figure 4.3) shows that there is an abmpt change in the rate of Ca decay, 
suggesting that caffeine removal is rapid and complete. Testing of the perfusion 
system as outlined in section 2.6.1, suggests that the solution at the cell is changed with 
a time constant of around 90 ms. Some additional time must be allowed for the full 
removal of the effects o f caffeine on the RyR. This compares with the time constant 
for Ca decay when caffeine is withdrawn of aiound 300 ms or longer (see results 
section 4.3.3). A comparison of typical decays for the solution switcher and caffeine 
withdrawal is shown in Figure 4.4. In theory, the time course of the solution switch 
should remain constant, and any error it introduces to the estimation of SERCA 
function should be the same irrespective of the cell type being studied. Therefore, 
although there may be a small error in the absolute value for SERCA activity, 
comparisons across cell types will remain valid.
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\T  = 305 ms
Figure 4.4 Comparison of timecourse of solution switching (noisy trace) 
with that of Ca decay on abrupt withdrawal of 10 mmol/L caffeine (upper 
trace). The decay for each is fitted with a single exponential function (grey 
lines).
It should also be noted that this technique estimates SERCA activity under relatively 
non-physiological conditions -  i.e. taking up cytoplasmic Ca into an “empty” SR. 
Given the complex regulation of SERCA, including the effects of SR luminal [Ca], as 
the SR fills an interplay of factors will determine the rate of SERCA activity. For this 
reason, in analysing the data, the RC of Ca decay was mainly determined from the 
initial steep portion of the decay, after the abrupt change in the rate of Ca decline with 
removal of caffeine (see Fig. 4.3). Over this range, the cytoplasm-to-SR [Ca] gradient 
is high and luminal [Ca] is still relatively low, meaning that the measuie of SERCA 
activity may be made under conditions where the pump is maximally activated.
4.2.3.3 Data analysis
For each cell, the rapid Ca decay on withdrawal of caffeine was plotted on an expanded 
timescale and the early pait of the decay was fitted with a single exponential function to
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obtain a late constant, RCca/f off- Similarly, the decay in the presence of caffeine + Ni 
was analysed to obtain a rate constant for the “slow pathways” -  RCsio,v^  The rate 
constant attributable to SERCA could then be determined by subtracting RCsiow from 
RCcaff off- This approach assumes that the Ca removal mechanisms act independently, 
such that the rate constants for each system will be additive.
4,2.4 Estimation o f cellular buffering power
An estimation of intracellular buffering properties was made on a cell-by-ceil basis, 
using the cunent and calcium tiaces during caffeine exposure to determine the 
relationship between free and total [Ca];. This method was described by Trafford et al. 
(1999). As outlined in section 4.2.2.2, the inwai'd cuiTent on NCX during caffeine 
application can be integrated and corrected for non-NCX removal mechanisms and cell 
volume to give an indication o f total [Ca]; (expressed as mol/L cytosol). If these data 
ai-e plotted against the simultaneous free  [Ca]; reported by Fura-2, then the buffering 
curve can be established (Figure 4.5). For an estimation of the buffering 
characteristics, this curve is fitted with an equation of the form:
^^Total — ^  + {K, + [c a ^ f)  Equation 4.2
where a is an arbitrary offset, Bmox is the satmating capacity of the buffer and Kd is the 
dissociation constant. The offset a is necessary because of the method used to calculate 
CüTotai — the back-calculation of Caxotai ft'om the current integral means that Carotai is 
set to 0 at the end of the current decay, at a time when free [Ca]; is at the resting Ca 
level at the end of the caffeine application. Thus, the buffering curve will cross the 
abscissa at the value for resting free [Ca];, and the buffering relationship can only be
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Figure 4.5 Estimation of cellular buffering characteristics. [CaJjotai 
calculated from the integral of the inward current on NCX is plotted against 
[Cajpree measured by Fura-2, The resulting buffering curve is fitted (grey 
line) using Equation 4.1, to derive a dissociation constant {KJ), maximum 
buffering capacity (Bmox), and intersect (a).
determined for values of [C a]i above this point. The overall buffering curve includes 
the intrinsic buffering properties of the cell and the buffering properties of the Fura-2 
within the cell. Thus, since the buffering characteristics ai*e determined for each cell, 
small differences in Fura-2 loading amongst different cells will be taken into account in 
the analysis.
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4.2.5 Analysis o f Ca flux on Ica (ind tail currents
4.2.5.1 Experiment protocol
Under the internal and external conditions outlined above (section 4.2.1), cells were 
stimulated at 0.5 Hz for 30 s to achieve steady-state contractions, using a protocol 
allowing determination o f Ca fluxes across the sarcolemma during systole and diastole. 
The voltage protocol consisted of an initial 50 ms ramp from a resting potential of -80 
mV to a potential of -40 mV, which was then held for 25 ms, before stepping to 0 mV 
for 150 ms. The initial ramp-and-hold allowed for activation and inactivation o f the Na 
current, which would otherwise have contaminated the initial portion of Ica if a simple 
step to 0 mV had been used. Preliminary experiments showed that this voltage protocol 
was effective in minimising the effects of Inq and that the addition of the Na channel 
blocker tetrodotoxin gave little additional benefit (data not shown). The voltage 
protocol is outlined in Figure 4.6, along with typical current and Ca traces. For the 
majority of cells, the protocol was repeated a number of times and for each cell the 
mean values of Ica and Iran were used for fuilher analysis.
4.2.5.2 Data analysis
For each train of stimuli, the current and Ca signals were averaged from the point at 
which steady state was achieved, until the end of the train. Ca flux on Ica was 
determined by integrating the inward current from a point just after the capacitance 
spike until the end of the 150 ms depolarising step. The resulting charge movement 
was converted to give the total amount of Ca entering the cell during systole, by 
dividing by Faraday’s constant and halving the result (since two positive charges are 
carried by each Ca ion).
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Figure 4.6 Measurement of Ca flux on L-type Ca cuiTent (Ica) and NCX tail 
current (Irau). A: voltage ciamp protocol -  initial ramp to -40 mV activates 
sodium current (Cvg), step to 0 mV results in Ca entiy via Ica- B: intracellular 
[Ca]. C; resulting membrane current, with inserts showing expanded tail 
current (i) and Ica (ii). D: cumulative integral of Ica followed by Ifan 
(corrected for non-NCX Ca removal mechanisms).
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The tail current on repolaiisation represents Ca removal on NCX, and Ca flux during
this phase was calculated using a similar* approach to that outlined in section 4.2.2.2.
The tail current was integrated following the capacitance spike, until the end of the
diastolic period (which was also taken to be the zero cuixent level). This integral was
converted to give the total amount of Ca removed from the cell by dividing by
Faraday s constant and coiTecting for non-NCX removal mechanisms as previously 
described.
For both Ica and 7%/, the calculated Ca flux was coiTected for cell volume as outlined in 
section 2.7.2.2, and expressed as mol/L cytosol. An example of the cumulative integral 
for Ica and Itou is shown in Figure 4.6 D.
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4.3 Results
4,3.1 Ca transient characteristics
Ca transients were examined under the conditions described in section 4.2.1, during 
trains of stimuli and on application of 10 mmol/L caffeine. Figure 4.7 A shows the 
mean amplitude of Ca transients at 0.5 Hz for each of the cell types, along with the 
amplitude of corresponding caffeine-induced Ca transients. Data were obtained from 
14 sham-operated animals and 14 LVD animals, and the number of cells for each group 
is indicated in the figure. There were no significant differences between the diastolic 
levels of Ca at 0.5 Hz in each group (275 ± 26 mnol/L, 262 ± 25 nmol/L, 240 ± 20 
nmol/L and 223 ± 22 mnol/L, for Sham Endo, Sham Epi, LVD Endo and LVD Epi 
cells, respectively), nor were there significant differences between Ca levels before 
caffeine application (267 ± 25 nmol/L, 257 ± 28 nmol/L, 211 ±21  nmol/L, 211 ± 2 3  
nmol/L, for Sham Endo, Sham Epi, LVD Endo and LVD Epi cells, respectively).
For each animal type, at 0.5 Hz there was no significant difference between the 
amplitude of Ca transients in endocardial cells and the amplitude of Ca transients in 
epicardial cells. However, transients were of smaller amplitude in LVD cells compared 
to control cells (218 ±11 nmol/L, n=76, 261 ±13  mnol/L, n=74; p=0.01). Likewise,
caffeine-induced transients were also significantly smaller (by around 25%) in LVD 
cells (576 ± 28 nmol/L, n=71, vs 767 ± 32 nmol/L, n=68; p<0.0001).
The rate constant of Ca decay during 0.5 Hz trains of stimuli was also determined, with 
results shown in Figure 4.7 B. In general, the rate of decay was faster in endocardial 
cells than epicardial cells, although this only reached statistical significance in LVD 
animals (for Sham animals: 3.31 ± 0.24 vs 2.71 ± 0.23 s‘*; p=0.07; for LVD animals:
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Figure 4.7 Characteristics of steady-state Ca transients and caffeine-evoked 
transients. A: Amplitude of Ca transients evoked by voltage-clamp protocol 
(left panel; 0.5 Hz stimulation train) and application of 10 mmol/L caffeine 
(right panel), for each cell type. B: Rate constant of Ca decay for voltage- 
clamped cells stimulated at 0.5 Hz. For each panel, number of cells is shown 
on each bar. Key refers to all panels. Statistically significant comparisons 
are indicated: * p<0.05, ** p<0.01.
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Figure 4.8 Effect of stimulation rate on Ca transients. Lower data points in 
each panel indicate diastolic [Ca] and upper data points systolic [Ca]. A: 
Each cell type shown. B: Overall data (Endo Epi) for Sham & LVD cells. 
C: Table summarising statistical comparisons from panel B. Dias = diastolic 
value, Sys ~ systolic value, Ampl = amplitude of Ca transient. Statistically 
significant results in bold.
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2.42 ± 0.17 vj 1.89 ± 0.17 s"^ ; p=0.04). For each area of myocardium, the Ca decay 
was slower in LVD cells than Sham cells (for endocardial cells p=0.002; for epicardial 
cells p=0.008).
In a subset of cells, the effect of stimulation rate on Ca transient characteristics was 
determined. The results are summarised in Figure 4.8. With each increase in rate, 
irrespective of cell type, diastolic [Ca], systolic [Ca] and the amplitude of the Ca 
transient increased (all p-values by paired t-test <0.0001). Again, there was no 
significant difference between endocardial and epicardial cells for each animal type. 
For clarity, Figure 4.8 B compares overall data (endocardial and epicardial cells 
combined) for Sham and LVD animals, with statistical comparisons in the 
accompanying table. It is apparent that at each rate both diastolic and systolic [Ca] are 
lower in LVD animals (e.g. at 1 Hz, diastolic [Ca]: 223 ± 23 nmol/L vj 304 ± 22 
nmol/L; p=0.01; systolic [Ca]: 452 ± 28 nmol/L vs 581 ± 3 1  nmol/L; p=0.003). The 
amplitude of the Ca transients is also smaller at 1 and 2 Hz (1 Hz: 228 ± 17 nmol/L vj" 
277 ± 1 7  nmol/L; p=0.047; 2 Hz: 263 ± 20 mnol/L vs 326 ± 23 nmol/L; p=0.04). At 
0.5 Hz, the difference does not meet statistical significance (203 ± 1 7  nmol/L v.s 227 
±15 nmol/L; p=0.3).
4.3.2 SR  Ca content -  regional differences and changes in LVD
The SR Ca content for each cell was estimated from the integral of the inwai'd NCX 
current on application of caffeine, as outlined in section 4.2.2. Results are summarised 
in Figure 4.9. In sham-operated animals, the SR Ca content in epicardial cells is 
greater than that in endocaidial cells (77.9 ± 3.4 vj 66.6 ± 3.8 pmol/L cytosol; p=0.03), 
but in LVD animals this difference does not reach statistical significance. The figure
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Figure 4.9 SR Ca content for each cell type. SR content was calculated 
from the integral of the inward NCX current on application of 10 mmol/L 
caffeine, as outlined in Figure 4.2 and in the text. Number of cells is shown 
on each bar. Statistically significant comparisons are indicated: * p<0.05,
*** p<0.001.
also demonstrates that the SR Ca content in LVD animals is significantly smaller than 
that in sham-operated animals (for endocardial cells: 55.2 ±2.1 vs 66.6 ± 3.8 pmol/L 
cytosol; p=0.008; for epicardial cells; 59.0 ± 2.4 vs 77.9 ± 3 . 4  pmol/L cytosol; 
p<0.0001). Overall, the SR content in LVD is around 22% smaller than that in control 
animals. One must ensure that this difference is not simply a consequence of the 
method used to estimate SR Ca content, in particular the correction for cell volume. If 
the cell capacitance/volume ratio was altered in LVD then this could confound the 
result. However, a further estimation of the SR Ca content was made by examining the 
amplitude of the Ca transients on application of caffeine, as shown in Figure 4.7, and 
this is independent of cell volume. This confirms the difference in SR Ca content 
between LVD animals and control animals (for endocardial cells: 554 ± 39 nmol/L vs 
755 ± 47 nmol/L; p=0.003; for epicardial cells: 602 ± 40 nmol/L vs 778 ± 44 nmol/L;
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Figure 4.10 Measured SERCA activity for each cell type. SERCA activity 
was estimated by briefly applying 10 mmol/L caffeine in the continued 
presence of 10 mmol/L NICE and determining the rate constant of Ca decay 
on caffeine withdrawal, followed by correction for “slow” removal 
pathways, as shown in Figure 4.3. Number of cells is shown on each bar. 
Statistically significant comparisons are indicated; * p<0.05.
p=0.005). In this case, the difference between LVD and control animals is around 
25%. This value compares well with that obtained from the integral of the NCX 
current on application of caffeine, suggesting that the differences in LVD are genuine. 
The caffeine-induced transients do not show significant differences between 
endocardial and epicardial cells for either animal type.
4.J.S SERCA function
In this chapter a novel method was used to estimate SERCA function for each of the 
cell types. The technique measured the rate constant of Ca uptake on SERCA in the 
presence o f Ni to block efflux on NCX. For each cell the rate constant was corrected 
for Ca removal via the “slow” removal mechanisms. Figure 4.10 summarises the
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results. Cells were obtained from 4 sham-operated animals and 4 LVD animals. In 
general, SERCA activity was higher in epicardial cells than endocardial cells, although 
the difference was only statistically significant for Sham cells (3.84 ± 0,61 s'^  vs 2.32 ± 
0.36 s'^; p=0.03). SERCA activity was higher in Sham epicardial cells than LVD 
epicardial cells (3.84 ± 0.61 vs 2.33 ± 0.24 s'^; p=0.02), but the difference for 
endocardial cells was not significant (2.32 ± 0.36 s'^  vs 1.87 ± 0.23 s'^; p=^0.33).
One reason for some comparisons failing to reach significance is the degree of 
variability of the raw data, resulting in a relatively high variance and standard error. 
Technical aspects of the experimental protocol may contribute to this variability, in that 
it is difficult to reproduce exactly the conditions of solution flow at each cell. This may 
result in variability in the efficiency of solution-switching, affecting the time-course of 
Ca decay when caffeine is abruptly withdrawn.
4.3.3.1 SR Ca content in relation to SERCA function
The relationship between SERCA activity and SR Ca content is examined in Figure
4.11. Panel 4.11 A plots the mean SR content data from Figure 4.9 against the mean 
SERCA activity from Figure 4.10 for each cell type. The plot suggests that there may 
be a relationship between the two variables -  for example, cells with the liighest 
measured SERCA activity (Sham epicardial cells) also have the highest SR Ca content.
This relationship was examined further by producing a similar plot for individual cells 
from the experiment shown in Figure 4.3. For those cells where data were available on 
SR content (n=21 for Sham animals, n=21 for LVD cells), these values were plotted 
against SERCA activity. Separate scatter plots were produced for Sham and LVD cells
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Figure 4.11 Relationship between SERCA activity and SR Ca content. A: 
Overall mean data for each cell type, derived from data in Figures 4.9 and 
4.10. B: Example of relationship for individual cells. Sham cells from the 
experiment illustrated in Figure 4.3, where SR content data were available 
(n=22), were plotted as individual points. Linear regression was then 
performed, with a correlation coefficient, r, of 0.82 (p<0.0001).
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Cell type n Kd (pmol/L) Sftfax (pmol/L) a (pmol/L)
Sham Endo 28 0.80 ± 0.06 176 ± 15 -46.7 ± 9.3
Sham Epi 32 0.85 ± 0.07 246 + 18 -54.7 ± 7.5
LVD Endo 35 0.89 ±0.08 200 + 16 -36.6 ±4 .3
LVD Epi 30 0.82 ± 0.08 222 ± 18 -48.9 ± 7.4
Table 4.1 Buffering characteristics for each of the cell types. For each cell, 
a plot of total [C a]i against free [C a], was fitted using Equation 4.2 to 
generate the above values. Bj^ax and a are expressed relative to accessible 
cell volume. There were no statistical differences amongst the four cell 
types.
and linear regression analysis was performed. Figure 4.11 B illustrates the results for 
Sham cells. The results suggest a significant positive correlation, with a correlation 
coefficient of 0.82 (p<0.0001). The correlation was less strong, but still significant, for 
LVD cells (r=0.69; p-0.001).
4,3,4 Cellular buffering characteristics
The relationship between free and total [Ca], was determined as outlined in Figure 4.5, 
and fitted using Equation 4.2 to determine the buffering characteristics for each cell. 
Mean values are reported in Table 4.1 and show that there were no significant 
differences in the buffering properties amongst the four cell types. The overall values 
foi Kd and B^ax (0.84 ± 0.04 pmol/L and 212 ± 9 pmol/L cytosol, respectively) are 
comparable to those published in the literature - e.g. Trafford et al. using ferret 
ventricular myocytes and the indicator Fluo-3 reported a Kd of 0.6 pmol/L and a Bmox of 
175 pmol/L cytosol (Trafford et a l,  1999), and Berlin et a l found a Kd of 0.96 pmol/L 
and a B^ax of 123 pmol/L cytosol in rat ventricular myocytes (Berlin et a l,  1994).
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As mentioned in the methods section, because the final cytosolic concentration of Fura- 
2 is unknown (since loading is via the Fura-2 AM form of the dye, rather than from a 
known concentration of Fura-2 in the pipette solution), only the overall buffering 
characteristics of the cell can be determined. It is not possible to separate out the 
proportion of the buffering that is due to the dye from that due to the intrinsic buffers in 
the cell. However, this is unimportant for the purposes of converting values of free 
[Ca] to total [Ca], since this is determined by the overall buffering curve.
4.3,5 Analysis o f  Ca flu x
4.3.5.1 Relationship between Ica cind tail currents
In steady-state conditions, to maintain cellular’ Ca balance the amount of Ca entering 
the cell during systole must be matched by the amount leaving the cell in diastole. 
Therefore, in theory an accurate measure of steady-state ItoU-, appropriately corrected 
for non-NCX Ca removal mechanisms, must equate to the flux of Ca into the cell 
during systole. Conversely, if  the amount of Ca entering the cell via Ica (and other 
lesser pathways) can be determined, then this will equate to the Ca flux out of the cell 
in diastole.
The protocol outlined in section 4,2.5 was designed to determine whether this 
relationship could be demonstrated under the chosen experimental conditions. The 
voltage protocol allowed for accuiate measurement of Ca flux on Ica and IraH, with 
interfering currents blocked and contamination of Ica by I^a eliminated as far as 
possible (see Figure 4.6). Paired measurements were made in each cell and results are 
summarised in Table 4,2. Overall systolic Ica flux of around 10 pmol/L cytosol is in 
excellent agreement with previously reported values for rabbit ventricular myocytes
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Cell type n /caamplitude
(A/F)
h a  flux 
(pmol/L)
Diastolic Ca 
flux 
(pmol/L)
p-value
( h a  V S
diastolic
flux)
Sham Endo 12 15.7 ± 1.4 9.5 ±0 . 8 9.7 ±0 . 5 0.77
Sham Epi 15 18 . 3±  1.1 10.0 ±0 .8 10.7 ±0 . 6 0.38
LVD Endo 8 15.3 ±1 .4 12.1 ±1.1 1 1 . 8 ± 0 . 5 0.76
LVD Epi 12 17.0 ± 1.4 10.3 ±0 . 6 11.3 ±0 .4 0.14
Table 4.2 Ica amplitude and cumulative Ca flux on Ica and in diastole for 
each cell type. In each case flux is expressed relative to accessible cell 
volume. Diastolic Ca flux was calculated by coiTecting the integral of Ijati 
for non-NCX Ca removal mechanisms, as described in the text. The final 
column indicates the statistical comparison between Ica and diastolic Ca flux 
for each cell type, made by paired Mest on the raw data. Separate 
comparisons between cell types showed no significant differences for Ica 
amplitude, Ica flux, or diastolic Ca movement.
under similar conditions (Delbridge et al. report a value of 9.7 ± 0.5 pmol/L cytosol; 
Delbridge et a l, 1996). For each cell type, there was no significant difference between 
Ca flux on Ica and Ca flux in the diastolic period, and indeed when all cells were 
considered, the difference remained non-significant (p=0.19). Overall, when all the 
data were combined, Ica flux was 96 ± 3% of the measured diastolic flux (n=47, 
p=n.s.). It is likely that any minor discrepancy is partly due to some failure of voltage 
control of the cell due to the lar ge Na cuiTcnt, activating a little Ca entry on Ica which 
will not be included in the subsequent current integral. This is supported by the small 
initial Ca rise seen during the ramp phase of the protocol (see Figur e 4.6). In addition, 
the Ica integral may be contaminated by Ca movement on Incx during the voltage pulse. 
However, without modelling subsarcolemmal [Na], [Ca] and Em during the pulse, the
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direction of this effect (i.e. the proportion of forward mode and reverse mode NCX) 
will be hard to determine. In similar experiments to measure Ica in rabbit ventricular 
myocytes, Delbridge et a l judged that the Ica integral was underestimated by around 
10%. However, this estimate was not based on a full modelling of hex, taking no 
account of possible reverse-mode NCX early in the voltage pulse (Delbridge et a l, 
1996).
The above analysis shows that at steady state, the corrected IxaH integral is an excellent 
surrogate measure for Ca entry into the cell on Ica- This enabled an expanded dataset to 
be included in the analysis of cellular Ca flux outlined in section 4.3.6 -  a number of 
cells had been studied under the same conditions but with a voltage protocol not 
including a ramp-and-hold prepulse -  for these cells the corrected Iran integral was used 
as a measure of Ca entry during systole.
4.3.5.2 Comparison o/Ica and Ijaii between cell types
The protocol also allowed the total systolic and diastolic Ca flux to be compared 
between cell types. No significant differences were found, implying that total Ca entry 
during systole does not differ between endocardial and epicardial cells, nor does it 
differ in LVD. Peak îca was also examined (see Table 4.2), and again there were no 
significant differences amongst cell types.
43 ,6  Analysis o f systolic Ca flux  and E-C coupling
The preceding data on Ca transient parameters, cellular buffering properties, SR Ca 
content, and Ica flux can be used to deteimine overall movements of Ca during systole 
and characteristics of E-C coupling. Firstly, for each individual cell, steady-state
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diastolic and systolic free [Ca] was converted to total Ca using Equation 4.1 and the 
buffering properties determined for that cell. For a small number of cells where an 
adequate fit to the buffering curve was not possible, mean buffering data for either 
Sham cells or LVD cells were used. The change in cytosolic total Ca (A[Ca]Totai) 
during systole was then calculated. The amount of Ca released from the SR was 
determined by subtracting Ca flux on Ica ( Jfca ) from A[Ca]Total- This enabled the 
fractional release of SR Ca to be established, as well as the relative contribution of the 
SR to A[Ca]Totai- Finally, the gain of E-C coupling was determined. By convention, 
gain is calculated as the magnitude of the response divided by the magnitude of the 
stimulus. In this case, the “response” was taken to be the amount o f Ca released from 
the SR, and the “stimulus” was taken to be J/ca- Thus, E-C coupling gain was defined 
as (A[Ca]Total - Sha) / iica -  an approach also used by Bers and co-workers (see Bers, 
2001; Shannon et a l,  2000). The results of this analysis are summarised in Figuie
4.12.
4.3.6.1 Systolic Ca flux
Figure 4.12 A gives an overall summary of the approach described above, showing the 
mean SR Ca content for each cell type, along with the Ca flux on Ica and the amount of 
Ca released from the SR, sunimating to give A [Ca] Total- A  statistical comparison of 
A[Ca]Tota! amongst the cell types is shown. This shows A[Ca]Totai to be greater in Sham 
epicardial cells than Sham endocardial cells (32.0 ± 1.5 vj 27.8 ±1.1  pmol/L cytosol, 
respectively; p=0.03), in parallel with the difference in SR Ca content between the two 
regions (see section 4.3.2). In LVD animals, there was no difference in A[Ca]Totai 
between the two regions (25.2 ± 1.5 pmol/L cytosol for epicardial cells vs 24.3 ±1.1
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Figure 4.12 Systolic Ca flux. A; Summary of SR Ca content and systolic 
flux. For each cell type, the left column shows SR Ca content estimated 
from the integral of hex, and the right column shows A[Ca]Totai during 
systole, split to show the absolute contribution of ha and SR release, as 
indicated. Statistically-significant comparisons of A[Ca]Toiai are shown 
(comparisons of SR Ca content are made in Figure 4.9). B: Relative 
contribution of ha  and SR release to A[Ca]xotai- C: Fractional SR Ca release 
during systole. D: Gain of E-C coupling, defined as (A[Ca]Totai - \ h a )  / \h a -  
Key refers to all panels. Statistically significant comparisons are indicated: * 
p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001.
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pmol/L cytosol for endocardial cells; p~0.63). Comparing Sham to LVD animals, 
A[Ca]Totai was significantly lower in LVD animals for each region (p=0.03 for 
endocardial cells, p=0.002 for epicardial cells). Given that Ca flux on Ica was similar 
amongst the regions (see Table 4.2), the difference in A[Ca]Totai in LVD must be due to 
less Ca release from the SR, and this was indeed the case (for endocardial cells; 12.7 ± 
0.9 vs 18.2 ± 1.0 pmol/L cytosol; p=0.0001; for epicardial cells: 15.0 ± 1.3 v.y 21.4 ± 
1.3; p=0.001).
Figure 4.12 B shows the relative contribution of ha  and SR release to A [Ca] Total, 
illustrating that in LVD the SR makes a smaller contribution to the Ca transient than it 
does in Sham cells (for endocardial cells: 51.3 ± 2.1 % v.? 64.5 ± 1.8 %; p<0.0001; for 
epicardial cells: 57.4 ± 2.4 % vs 66.1 ±1 .5  %; p=0.001). For Sham cells, the overall 
percentage contribution of h a  to A[Ca]Totai of 34.7 ± 1.1 % is higher than a previous 
published estimate for rabbit ventricular myocytes (23 ± 2 %), although the flux on ha  
relative to SR Ca content, at 14.4 ±  0.5 %, is virtually identical (14 ± 2 %; Delbridge et 
a l,  1996).
4.3.6.2 Fractional SR Ca release and E-C coupling gain
Figure 4.12 C compares fractional Ca release from the SR across the cell types. 
Fractional release was calculated as (A[Ca]Totai - l h a )  / SR Ca content (derived from 
U ncx  on application of caffeine -  see section 4.2.2.2). Overall fractional release in 
Sham cells was around 0.28, and in LVD cells, 0.23. In neither animal type was there a 
significant difference between fractional release in endocardial and epicardial cells. 
Fractional release in LVD endocardial cells was less than that in Sham cells from the
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same region (0.22 ± 0.02 va 0.29 ± 0.02; p^O.Ol) but for epicardial cells the difference 
was not significant (0.24 ± 0.02 for LVD cells va 0.28 ± 0.02 for Sham cells; p=0.17).
The gain of E-C coupling was calculated as outlined above, and is summarised in 
Figure 4.12 D. In LVD, gain was found to be higher in epicardial cells than 
endocardial cells (1.53 ± 0.14 va  1.17 ± 0.09; p=0.03), although this was not the case in 
Sham animals. However, gain was significantly lower in LVD animals in both regions 
(for endocardial cells: 1.17 ± 0.09 va 2.01 ± 0.14; p<0.0001; for epicardial cells: 1.53 ± 
0.14 VA 2.14 ± 0.14; p=0.003). This suggests defective E-C coupling in LVD cells, and 
is discussed further in sections 4.4.4 & 4.4.5.
4,3.7 Relative contribution o f different systems to diastolic Ca decline 
Experiments in this chapter and the last enable an estimation to be made of the relative 
contribution of different removal systems to the diastolic decline of C a. The studies 
involving application of caffeine in the presence and absence of nickel, along with the 
studies described in section 4.2.3, allow a comparison to be made between the rate 
constants of C a  decline attributable to SERCA, NCX and the slow removal pathways. 
For each cell, these comparisons are made over similar ranges of [C a]i (see Figure 3.4), 
although peak [C a]j with caffeine application in the presence of Ni was generally 
slightly higher than that in the absence of Ni. This is because in the absence of Ni, 
NCX acts to lower the peak [C a]i by beginning to remove C a  from the cell during the 
upstroke of the caffeine-induced transient. It should also be noted that the peak [Ca]i 
on application of caffeine exceeds that of normal voltage-stimulated C a  transients at 0.5 
Hz (see Figures 4.1 and 4.7). However, at higher stimulation rates, the peak systolic
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Figure 4.13 Relative contribution of removal systems to Ca decay. A: Bar 
chart showing percentage contribution of SERCA, NCX and slow removal 
systems to Ca decay for each cell type. Numerical values are indicated on 
each bar, with number of cells noted above. B: Summary of statistical 
comparisons (p-values) between cell types, with significant results indicated 
in bold.
[Ca]i does approach these levels, therefore comparing Ca removal across this range of 
[Ca]i appears valid.
Results for each cell type are summarised in Figure 4.13, with data derived from 4 
sham-operated animals and 4 LVD animals. Examining endocardial-epicardial
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differences first, it is apparent that the relative contribution of SERCA to Ca removal is 
higher in epicardial cells, for both animal types (for Sham animals: 65.6 ± 3.1 % vs
54.5 ± 3.5 %; p=0.04; for LVD cells: 65.6 ± 1.4 % vs 61.0 ± 1.5 %; p=0.04). This 
appears to be in keeping with the previous results demonstrating lower NCX current 
density in epicardial cells (e.g. see Figure 3.7) and higher SERCA activity in this region 
(see Figure 4.10, difference only statistically significant for Sham cells). The 
proportion of Ca removed by NCX is not significantly different between endocardial 
and epicardial cells (although tending to be less in epicardial cells), so the greater 
removal via SERCA is mainly at the expense of less removal via slow pathways (for 
Sham animals: 9.1 ± 1 .5  % V5 14.7 ± 1 .6  %; p=0.03; for LVD cells: 13.1 ± 1.7 % vs
17.3 ± 1.6%; p=0.08).
Comparing Sham animals to LVD animals, one would anticipate that the relative 
contribution of each system to Ca removal would depend on the relative change in each 
system between Sham and LVD animals -  e.g. if all three removal pathways were 
reduced by around the same amount, then the overall contribution of each in LVD may 
not change compared to Sham. Figure 4.13 suggests that for endocardial cells, NCX 
function has been reduced by a greater amount than SERCA function in LVD, resulting 
in a smaller role for NCX in Ca removal in these animals (21.7 ± 2.0 % vs 30.8 ± 2.8 
%; p=0.02). For epicardial cells, the reduction in activity of these two systems appears 
more proportional, such that although the percentage o f Ca removed by NCX is a little 
lower in LVD, it is not significantly so (21.4 ± 1.4 % vs 25.3 ± 2.3 %; p=0.13). In 
LVD, with reduced NCX and SERCA function, there is a trend towards a greater role 
for the slow pathways in Ca removal (for endocardial cells: 17.3 ± 1.6 % vs" 14,7 ±
1.6 %; p=0.27; for epicardial cells: 13.1 ± 1.7 % vs 9.1 ± 1.5 %; p=0.11).
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4.4 Discussion
The experiments in this chapter have examined fundamental properties of Ca handling 
in sham-operated and LVD animals, with data from different regions of the 
myocardium being presented. The results have allowed a detailed analysis of systolic 
and diastolic Ca flux to be carried out, and a number of differences amongst the cell 
types have been shown.
4,4.1 Properties of Ca transients in the rabbit infarct model of LVD
As mentioned in Chapter 1, many changes in Ca handling have been described in 
human heart failure and animal models of the condition. The majority of studies 
presenting data on Ca transients have shown that these are significantly reduced in 
amplitude, often with an increased diastolic [Ca] and reduced systolic [Ca] (reviewed 
by Balke & Shorofsky, 1998; Wickenden et a l, 1998; Houser & Margulies, 2003). 
Commonly, these changes are accompanied by slower diastolic [Ca] decay (or twitch 
decay).
In this chapter, Ca transient characteristics were determined at different stimulation 
rates for endocardial and epicardial cells ftom Sham and LVD animals. The results are 
summarised in Figures 4.7 and 4.8. Systolic [Ca] was significantly lower in LVD 
animals at all stimulation rates and, in general, transients were of smaller amplitude, 
particularly at higher stimulation rates. In contrast to some previous studies, however, 
diastolic [Ca] was also significantly lower in LVD cells. These results are in keeping 
with studies by other workers in the laboratory, as outlined below.
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4.4.1.1 Comparison with other studies o f  the rabbit infarct model o f  LVD 
Neary et al. presented results on field-stimulated ventricular myocytes from a separate 
set of rabbits with infarct-induced LVD (Neary et a l, 2002). They found very similar 
levels for diastolic [Ca] to those reported here (see their Figure 1), although the 
difference between Sham and LVD cells was not statistically significant. They also 
found reduced systolic [Ca] and Ca transient amplitude at all stimulation rates. Their 
absolute values for systolic [Ca] were higher than those reported in this chapter -  e.g. at 
1 Hz, -0.95 pmol/L vs 0.58 pmol/L. It is likely that this is due to differences in the 
experimental technique -  in this chapter cells were voltage-clamped and dialysed with 
the same mock intracellular solution, compared with field-stimulated, intact cells in the 
study by Neary et a l
As shown in Figure 4.8 B, the rise in systolic [Ca] with increasing stimulation rate was 
less steep in LVD cells, a finding which was also apparent in the study by Neary et al. 
This may conelate with an impaired force-frequency relationship -  a common finding 
in animal models of LVD (e.g. Neary et a l , 2002), and in cells from humans with end- 
stage heart failure (e.g. Davies et a l, 1995; Pieske et a l,  1999). However, the force- 
ffequency relationship was not directly measured in this thesis.
Cells from the rabbit infarct model of LVD were studied under current-clamp 
conditions, with simultaneous measurement of [Ca]i, by McIntosh et a l (2000). For 
epicardial cells, they found very similar results to those presented in this chapter -  both 
systolic and (at higher stimulation frequencies) diastolic [Ca] were lower in LVD cells, 
particularly those from animals with more severe LVD (EF<44%). However, for 
endocardial cells from animals with EF<44%, peak systolic [Ca] was significantly
153
higher than that in Sham cells, and at a stimulation rate of 3 Hz, diastolic [Ca] was also 
higher. Again, there are differences in the experimental technique in this study 
compared to the approach used in this chapter, which may contribute to these 
discrepant findings. McIntosh et al. used high resistance microelectrodes filled with 2 
mol/L KCl, and action potential durations were allowed to vary, whereas in this chapter 
all cells were dialysed with the same solution and the duration of the voltage pulse was 
the same for all cells studied.
In studies by a separate group, using cells from the infarct border zone, cell shortening 
during field stimulation was greater in MI cells than control cells at 0.5 Hz, although 
this was not the case at higher stimulation frequencies (Litwin & Bridge, 1997). In a 
later paper where intracellular Ca was measured using Fluo-3, the amplitude of the Ca 
transient in field-stimulated and voltage-clamped cells was significantly smaller in cells 
from the infai’cted hearts (Litwin et a l,  2000). Since they used a pseudoratio method 
for calculating [Ca], absolute values for diastolic [Ca] could not be determined. In this 
paper, time-to-peak [Ca] and time-to-5 0%-decline were both prolonged and it was 
suggested that this was due to dyssynchronous Ca sparks. The addition of 0.1 pmol/L 
isoproterenol lead to improved spark synchronisation, higher peak [Ca] and a faster rise 
and decline in the Ca transient.
4.4.1.2 Comparison with other rabbit models o f  L VD
In the combined pressure- and volume-overload model o f Fogwizd et al, Ca transients 
were smaller, with no significant difference in diastolic [Ca] or in the time constant of 
Ca decay (Pogwizd et a l,  1999; Pogwizd et a l,  2001). Naqvi et a l studied a pressure- 
overload model of LVH in the rabbit and found slowed contraction and relaxation, but
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no significant change in diastolic or peak systolic [Ca] (Naqvi et ah, 2001). Yao et a l 
induced heart failure by 3-5 weeks of rapid ventricular pacing (Yao et a l,  1998). 
Myocytes from these animals showed markedly reduced Ca transient amplitudes (0.09 
pmol/L V5 0.33 pmol/L; p<0.001), with lower diastolic [Ca] and much reduced systolic 
[Ca]. The transients also showed slower decline of [Ca], mainly due to slowing of the 
late phase of decay.
4,4,2 SR Ca content and SERCA activity -  regional differences and changes in LVD
4.4.2.1 Regional SR Ca handling in control (sham-operated) rabbit hearts 
Experiments in this chapter have demonstrated increased SERCA activity and SR Ca 
content in epicardial myocytes compared to endocardial myocytes from sham-operated 
rabbit hearts (see Figures 4.9 & 4.10). These findings are accompanied by a higher 
A[Ca]Totai in epicardial cells (see Figure 4.12). To my knowledge, this is the first direct 
functional demonstration of endocardial-epicardial differences in SERCA function and 
SR Ca content in the heart.
These findings are in keeping with reports of SERCA expression across the myocardial 
wall. Igarashi-Saito et a l demonstrated greater SERCA mRNA levels in epicardial 
cells compared to endocardial cells in the dog, and this difference was maintained in 
dogs with pacing-induced heart failm*e (Igarashi-Saito et a l, 1999). Transmural 
SERCA2a protein levels were measured in the dog by Laurita et al. and they also 
showed higher levels in epicardial cells compared to endocardial or mid-myocardial 
cells (Laurita et a l, 2003). Ca transient characteristics were also measured, using 
optical mapping of transmural wedges, and it was found that decay of the Ca transient 
was significantly faster in epicardial cells. Trestle et a l measured both mRNA and
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protein levels for SERCA2a in non-failing and failing human hearts (Prestle et a l, 
1999). In failing hearts, both levels were significantly higher in epicardial cells than 
endocardial cells, but in non-failing hearts, although a similar trend was obseiwed, this 
did not reach statistical significance.
4.4.2.2 Regional SR Ca handling in LVD
In contrast to the results for sham-operated animals presented above, transmural 
differences in LVD were not as marked. SERCA activity and SR Ca content were a 
little higher in epicardial cells, but not significantly so (Figures 4.9 & 4.10). Mean 
A [C a]Total was viitually the same in both areas (Figure 4.12). Few studies have 
examined regional differences in SERCA in failing hearts. As mentioned above, 
Prestle et a l found higher SERCA2a mRNA and protein levels in epicardial cells 
compared to endocardial cells, from human hearts with LVD due to dilated or 
ischaemic caidiomyopathy (Prestle et a l, 1999). This was accompanied by 23% less 
PLB protein in endocardial tissue compared to epicardial tissue. Spragg et a l studied 
dogs with pacing-induced heart failure and also found higher levels of SERCA2a 
protein in mid-wall/epicardial cells compared to endocardial cells, but only in dogs 
with dyssynchronous (right ventricular rather than right atrial) pacing (Spragg et a l, 
2003).
4.4.2.3 Changes in SR Ca content and SERCA function in LVD
The value obtained for SR Ca content in Sham animals (estimate for endocardial and 
epicardial cells combined = 73.2 ± 2.7 pmol/L cytosol) was in keeping with previously 
published values for rabbit ventricular myocytes under similar conditions 
(e.g.Delbridge et a l  estimated SR content at 87 ± 13 pmol/L cytosol, and 66 ± 7
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pmol/L cytosol in a subset of cells; Delbridge et a l, 1996). Endocardial and epicardial 
cells from rabbits with infarct-induced LVD showed reduced SR Ca content when 
compared with similar areas in sham-operated animals (Figure 4.9). This has 
previously been demonstrated for non-voltage clamped cells in the same laboratory 
(Neary et a l, 2002), although in this study cells were taken from across the whole 
ventricular wall. The result is also in keeping with the majority of published data from 
animal models of heart failure (reviewed by Sjaastad et a l,  2003; Houser & Margulies, 
2003). It is also a common finding in studies of human heart failure (see Piacentino III 
et a l, 2003; Hasenfiiss & Pieske, 2002; Lindner et a l, 1998; Sjaastad et a l,  2003) 
although not universal (Terracciano et a l,  2003).
Taken together with the findings of Litwin et a l on the same animal model, the results 
in this chapter suggest that cells are phenotypically distinct in the area adjacent to the 
infarcted tissue. Cells taken from this border zone tended to have higher SR Ca 
contents (Litwin & Bridge, 1997; Litwin et a l,  2000, online supplement). With the 
addition of increased NCX function reported for these cells (Litwin & Bridge, 1997), 
one could hypothesise that this area would be particularly at risk of triggered 
arrhythmias secondary to spontaneous Ca release.
Further experiments in this chapter demonstrated reduced SERCA activity in LVD 
epicardial cells compared to Sham epicardial cells (Figure 4.10). For endocardial cells, 
SERCA function tended to be reduced in LVD, although not significantly so. Two 
other studies in this animal model have also shown slowed SR Ca uptake in LVD — in 
permeabilised cells (Neary et a l,  2002) and SR vesicles (Currie & Smith, 1999). In the 
latter study, SERCA2a protein levels were reduced in LVD, by 61% in tissue
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homogenates and by 47% in SR vesicle preparations. These findings were 
accompanied by increased phosphorylation of phospholamban in LVD.
As discussed in the Chapter 1, reduced SERCA expression and function is almost 
universal in animal models of LVD and in human heart failure (also reviewed by Bers, 
2001, pp 318 -  320; Llasenfuss & Pieske, 2002; Houser & Margulies, 2003). Altered 
regulation o f SERCA (e.g. PLB levels, phosphorylation status or CaMKII activity) may 
contribute to the decreased activity (for review, see Frank et a l, 2003). Reduced 
SERCA function and SR Ca content critically affects Ca handling and may play a 
central role in producing the contractile abnoimalities seen in LVD.
4.4.3 What determines SR Ca content?
In simple tenns, steady-state SR Ca content will be deteimined by the balance between 
Ca uptake on SERCA and Ca efflux via the ryanodine receptor. The latter includes Ca 
release during systole and Ca “leak” during the diastolic period. Non-RyR leak 
pathways (e.g. SERCA “backflux”) have also been described (see Bers, 2001, Chapter 
7). Activity of NCX must also be considered, since it will compete with SERCA 
dui'ing diastole for the available cytoplasmic Ca. If NCX only acted to remove Ca from 
the cell (i.e. forward mode only), one would expect an inverse relationship between 
NCX activity and SR Ca content. However, as preceding discussions have alluded to, 
the relationship is more complex, and in certain circumstances reverse mode NCX may 
play a significant role in bringing Ca into the cell. For example, Litwin et a l suggested 
that NCX significantly contributed to SR Ca loading in their model of LVD (Litwin & 
Bridge, 1997). These considerations have also been reviewed by Sjaastad et a l (2003).
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The analysis presented in this chapter allows some conclusions to be drawn regarding 
the impoilance of the above mechanisms in determining SR Ca content under the 
conditions studied. Figure 4.11 demonstrates a strong positive relationship between 
SERCA activity and SR Ca content with an r-value of 0.97 for the mean data (Figure 
4.11 A). When data from individual cells are considered (see example Figure 4.11 B), 
an r-value of 0.82 was obtained for Sham cells (n=21; p<0.0001) and a value of 0.69 
for LVD cells (n=21; p<0.001). A similar analysis was performed for SR content 
against NCX activity (as estimated from the Ca decay in the presence of 10 mmol/L 
caffeine) and is shown in Figure 4.14. In this case there was no significant relationship 
between the two variables for either the mean data or for individual cells (for Sham 
cells: r=0.08, n=62; p=0.54; for LVD cells: r=0.24, n=65; p=0.06). The weak positive 
trend for LVD cells implies that some reverse mode NCX could affect SR content.
The above considerations suggest that the main determinant of SR Ca content in this 
model is SERCA activity. The experiments in this chapter did not address the role of 
SR leak. Shannon et a l  have examined this factor in intact rabbit cells in a different 
model of LVD (Shannon et a l,  2003b). They used tetracaine to block RyR-dependent 
SR leak and eliminated sarcolemmal Ca flux via NCX with 0 Na, 0 Ca solution. Under 
these conditions they used the rate of fall of cytoplasmic [Ca], and increase of SR [Ca], 
to infer the leak rate prior to application of tetracaine. They found that SR Ca leak was 
significantly increased in LVD for any given SR [Ca]. Further experiments would be 
required to determine whether this is also the case for intact cells from the model of 
LVD used in this thesis.
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Figure 4.14 Relationship between NCX activity (estimated from the rate 
constant (RC) of Ca decay in 10 mmol/L caffeine) and SR Ca content. A: 
Overall mean data for each cell type. B: Example of relationship for 
individual Sham cells (endocaidial and epicardial cells combined). Linear 
regression was performed, with a correlation coefficient, r, of 0.08 (p=0.54).
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4.4.4 What determines steady-state A[Ca]rotai^
4.4.4.1 Considering individual cells
For each cell, A[Ca]Totai will depend on the amount of Ca entering the cell and the 
amount released from the SR. The relative importance of these two factors could vary. 
At one extreme, if flux on Ica was constant from cell to cell, then differences in 
A[Ca]Totai would have to be due to differences in SR Ca release. Conversely, constant 
SR Ca release would mean that differences in A [Ca] Total would have to be due to 
differences in Ca flux on Ica- lu both of these cases, E-C coupling gain would need to 
vary from cell to cell. Figure 4.15 examines some of these relationships. It is apparent 
that the principal factor determining A[Ca]Totai is the amount of Ca released from the 
SR (Figure 4.15 B), with r-values of 0.94 for Sham cells and 0.91 for LVD cells. 
Variation in flux on Ica plays a smaller role (Figure 4.15 A), implying that there is less 
disparity in Ca entry on Ica amongst individual cells.
Figure 4.15 C illustrates that there is a significant correlation between SR Ca content 
and A [C a]Total, with a correlation coefficient of 0.60 for Sham cells, and 0.52 for LVD 
cells. Following on from this, Figure 4.15 D shows that SR release is also dependent 
on SR Ca content. However, the coiTelation, although significant, is not especially 
strong (r-value of 0.44 for Sham and 0.50 for LVD). This implies that some other 
factor is also important in determining SR release. Differences in ryanodine receptor 
numbers or properties may account for the remaining variability in the amount of Ca 
released from the SR. If altered RyR function was the only change from cell to cell, 
then, in theory, compensatory changes in SR content would occur to normalise the 
amount of Ca released from the SR (discussed in detail by Eisner and co-workers;
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Figure 4.15 Determinants of A[Ca]xotai for individual cells. Data is from 
cells presented in Figure 4.12. For each animal type, data for endocardial 
and epicardial cells were combined. Linear regression was performed, with 
correlation coefficients as shown. In all cases the linear fit was highly 
significant, with p<0.001. Relationships are shown between A[Ca]Totai and: 
A; flux on Ica (either directly measured, or calculated from diastolic Ca flux), 
B: calculated SR Ca release and C: SR Ca content. Panel D relates SR Ca 
release to SR Ca content. Key refers to all panels.
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Eisner et a l, 2000; Trafford et a l, 1998). However, altered RyR activity, along with 
concomitant changes in other Ca handling proteins (for example SERCA) could 
increase or decrease Ca cycling between the cytoplasm and the SR. These aspects o f 
E-C coupling are discussed further in the next chapter.
4.4.4.2 Considering different cell types
Figure 4.12 illustrates that A[Ca]Totai is significantly reduced in LVD. In this study no 
significant difference was found between Ica flux in Sham and LVD cells, nor were 
endocardial-epicardial differences seen (see Table 4.2). Several other studies have also 
found similar levels of Ica flux in animals with heart failure compared to control 
animals, and this may also be the case in human heart failure (reviewed in Sjaastad et 
a l,  2003). With unchanged Ica, differences in A[Ca]Totai must be accounted for by 
reduced SR Ca release in LVD. Figure 4.12 indeed shows that the SR makes a smaller 
contribution (both absolute and relative) to the Ca transient. Figure 4.15 B suggests 
that for all cell types, the relationship between A[Ca]xotai and absolute SR Ca release 
can be described by a single linear fit. This line crosses the ordinate at the predicted 
point for mean Ca flux via Ica (around 10 pmol/L cytosol) -  i.e. when SR release is 0, 
A[Ca]xotai will be entirely due to /ca.
The importance of SR Ca content in determining characteristics of the Ca transient has 
been widely recognised (reviewed in Sjaastad et a l,  2003; Bers, 2001, Chapter 8). 
Considering mean data for each cell type, the relationship between SR Ca content and 
aspects of Ca handling is explored further in Figure 4.16. In the figure, A[Ca]xotai, SR 
Ca release, SR fractional release and E-C coupling gain are related to SR Ca content.
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Figure 4.16 Characteristics of E-C coupling in relation to SR Ca content. 
Data is from cells presented in Figure 4.12. A: A[Ca]Totai- B: Absolute SR 
Ca release, with linear fit. C: Fractional SR Ca release, with lineai* fit, 
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alternative fit (dotted line, based on Bers, 2001). See text and Figure 4.12 
legend for definition of terms. Key refers to all panels.
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For illustrative purposes, linear fits to the data were performed. In each case, it is 
appreciated that a linear relationship may be an oversimplification, but since there are 
only four data points, and in several cases the data is over a limited range, more 
complex relationships are hard to discern. It is apparent that there is an excellent 
correlation between SR Ca content and both A[Ca]Totai (Figure 4.16 A) and SR Ca 
release (Figure 4.16 B), with linem: relationships describing the data well. Again, the 
data points for LVD appear to follow a similar relationship to those for Sham cells. 
This perhaps implies that altered SR Ca release and A[Ca]Totai in LVD could be 
accounted for by the fall in SR Ca content.
Figure 4.16 C plots data for fractional SR release against SR Ca content. An arbitrary 
line was plotted through the data, crossing the abscissa at the same point as the linear fit 
in Figure 4.16 B (i.e. when SR release = 0, fractional release = 0). The data for Sham 
epicardial cells does not appear to follow the same relationship as the other three cell 
types -  although SR content is higher in Sham epicardial cells than Sham endocardial 
cells, fractional SR Ca release is similar. The reason for this is unclear, but it could 
indicate lower than expected (for a given SR Ca content) efficiency of trigger Ca in 
causing SR release (i.e. altered gain characteristics).
The relationship between E-C coupling gain (as defined in section 4.3.6) and SR Ca 
content is explored in Figure 4.16 D. A simple linear fit does not appear adequate to 
describe all the data. One could speculate an alternative curve, based on data from 
Shannon et al. (2000), who found a non-linear relationship between gain and SR 
content, with an increasingly steep relationship at high SR contents. It should be noted, 
however, that their relationship was determined for individual cells under conditions of
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progressive SR loading from “empty”. Using this approach, again Sham epicardial 
cells appear not to follow the trend of the other data, with a lower gain than one would 
anticipate for a given SR Ca content.
Overall, the measured values for E-C coupling gain are somewhat lower than those 
previously reported for rabbit ventricular myocytes. Shannon et al. found a gain of 
around 3-8 in their experiments (Shannon et a l,  2000). Compared to the studies in this 
chapter, their conditions would tend to produce higher SR loads (longer voltage pulses, 
with Na~free solutions, higher resting membrane potential and slightly higher [Ca]o). 
The lower gains in this chapter could be accounted for by the lower SR content, and a 
different stimulation protocol and/or solutions may result in more comparable values.
4.4.5 E-C coupling in LVD
The discussion above suggests that the fundamental difference in this model of LVD is 
the lower SR Ca content. This may be brought about by reduced SERCA activity, and 
leads to reduced E-C coupling gain, with less SR Ca release for a given Ica trigger. 
Figures 4.15 and 4.16 suggest that in LVD, A[Ca]Totah SR Ca release , SR fractional 
release and E-C coupling gain follow a similar relationship to SR Ca content that they 
do in Sham cells. This implies that the overall “effectiveness” of E-C coupling (gain 
for a given SR content) may be relatively unchanged in LVD.
Similar results were reported by Hobai & O’Rourke for camne tachycardia-induced 
heart failure (Hobai & O'Rourke, 2001). They found unchanged Ica amplitude, with 
reduced Ca transients that could be entirely explained by the fall in SR Ca content. E-C 
coupling gain was reduced in failing myocytes, but this was in proportion to the
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lowered SR content, and defective E-C coupling could be reversed by restoring SR Ca 
to the level found in control cells. Similarly, in a combined pressure and volume 
overload model of heart failure in the rabbit, Pogwizd et a l demonstrated that Ca 
transients were ~40% lower, with unchanged Ica and a -40%  reduction in SR Ca 
content (Pogwizd et a l,  2001). As discussed in Chapetr 1, other workers have shown 
reduced E-C coupling gain in the presence of maintained SR content (e.g. Gomez et a l, 
2001; reviewed by Sjaastad et a l,  2003) and some have proposed that this could be due 
to altered T-tubule structure (He et a l, 2001).
4.4.6 Diastolic Ca flux  -  regional differences and changes in LVD
4.4.6.1 Regional differences in diastolic Ca flux
This study is the first to demonstrate that regional differences exist in the relative 
proportion of Ca removed by NCX, SERCA and slow removal pathways (Figure 4.13). 
In control epicardial cells, with increased SERCA activity and reduced NCX function, 
SERCA plays a greater relative role in the removal of cytoplasmic Ca during the 
diastolic period. Slow pathways play a proportionally lesser role. These differences 
are reflected in the greater SR Ca content in epicardial cells (Figure 4.9). For LVD 
cells, these endocardial-epicardial differences are less marked, although there is a 
similar' pattern in terms of increased relative removal via SERCA for epicardial cells 
(p=0.04), with less removal via slow pathways (p=0.08), and a slightly higher SR 
content (p=n.s.).
4.4.6.2 Diastolic Ca flux  in Sham cells
Bassani, Bers and co-workers have extensively investigated relative Ca removal via 
different systems in cardiomyocytes (e.g. Bassani et a l,  1994; Puglisi et a l, 1996;
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reviewed in Bers, 2000; Bers, 2001, Chapter 9). For non-failing rabbit ventricular 
myocytes, they found values for relative removal via SERCA, NCX and slow pathways 
o f 70%, 28% and 2%, respectively. The principal difference in these figures compared 
to those obtained in this chapter is that their contribution of slow pathways is much 
smaller (2% vs 12.6 ±1 .3  %, for combined Sham cells, n=24). This may be because 
when estimating removal via the slow pathways it is difficult to achieve complete 
inhibition of NCX and SERCA function using 10 mmol/L Ni and 10 mmol/L caffeine. 
If either system is still operating, even at a much-reduced level, then the amount of Ca 
removed by the slow pathways will be overestimated. In the studies quoted above, 
slow pathway activity was measured with caffeine in the absence of external Na and 
Ca, or with twitches in the presence of thapsigargin and no external Na. The 
irreversible nature of thapsigargin meant that it could not be used for the experiments in 
this chapter. Some preliminary experiments were conducted with caffeine and 0 Na-0 
Ca solutions, but it was found that the cells were sensitive to the re-introduction of 
normal external solution and often did not smwive to the end of the protocol.
Nonetheless, from the experiments in this chapter and Chapter 3, there was some 
evidence that inhibition of NCX by 10 mmol/L Ni may have been adequate. Firstly, 
examination of the raw current traces when caffeine + Ni was applied generally showed 
little inward (NCX) current (e.g. see Figure 3.4). Secondly (although more indirectly), 
the measured systolic and diastolic Ca flux at steady state can be used to test the 
assumptions regarding the relative contribution of electrogenic and non-electrogenic 
removal pathways. The role of these pathways was determined from the relative rates 
of Ca removal with caffeine in the absence and presence of Ni, as discussed in section
4.1.1. The calculated correction factor for non-electrogenic (i.e. slow) pathways was
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then applied to the integrated tail current to determine total diastolic Ca flux. The fact 
that this calculated flux matched closely the measured systolic flux on Ica (see Table 
4.2) implies that the correction factor is valid. Thirdly, one would expect that the 
percentage contribution of NCX + slow pathways to Ca removal should match the 
percentage contribution of Ica to the systolic Ca transient (since relative flux across the 
sarcolemma in systole should match that in diastole). Mean data for Sham cells suggest 
that the former is around 41% and the latter around 35%, showing reasonable 
agreement.
4.4.63 Diastolic Ca flux in LVD
In both endocardial and epicardial cells there is a reduction in NCX function in LVD 
(see Chapter 3). SERCA activity is reduced in LVD epicardial cells (see Figure 4.10), 
and is a little lower (although not significantly so) in LVD endocardial cells. Overall, 
the relative contribution of NCX to Ca removal is reduced in LVD (21.5 ± 1.2 % vs 
28.8 ± 2.0 %; p=0.003) and changes in the other two systems are not significant (for 
SERCA, 63.5 ± 1.1 % vi- 58.6 ± 2.7 %; p=0.10; for slow pathways, 15,0 ± 1.2 % V5
12.6 ±1 . 3%;  p=0.17).
Bers (2000) has reported values for cells from rabbits with combined pressure and 
volume overload, based on data from Pogwizd et al. (1999). As discussed previously, 
NCX is upregulated in this model, and extrusion by this route becomes more important 
— indeed it matches the amount removed by the SR (both 49%). This model would 
appear to be phenotypically different from that described in this thesis, perhaps because 
of the different mechanism of inducing heait failure.
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4.5 Conclusions
The experiments in this chapter have examined Ca handling throughout the cardiac 
cycle in cells from sham-operated and post-infarction animals. In general, LVD cells 
display smaller Ca transients, with slower Ca decay in diastole. SR Ca content is 
significantly lower in LVD cells, and this may be related to reduced SERCA activity, 
particularly for epicardial cells. Ca entry via Ica.i appears unchanged in the post­
infarction myocytes, however, the gain of E-C coupling is significantly reduced. Small 
endocardial-epicardial differences in SERCA activity are present (significant for Sham 
cells) and, coupled with the transmural differences in NCX demonstrated in Chapter 3, 
SR uptake accounts for proportionally more Ca removal in epicardial cells for both 
animal types.
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CHAPTER 5
MANIPULATION OF CALCIUM HANDLING
171
5.1 Introduction
A large number of methods can be used to alter cellular Ca handling from baseline 
levels. Simple methods such as changing the stimulation frequency or voltage pulse 
duration can alter the size of Ca transients and SR Ca content (e.g. Maier et a l,  2000; 
Janczewski et a l,  1995). Similarly, changing [Ca] in the superfusate can have dramatic 
effects on intracellular' [Ca] and contraction (e.g. Trafford et a l,  2001). Many studies 
have used blocking agents or inhibitors in an attempt to alter one particular aspect of Ca 
handling and examine the effect. However, it can prove difficult to restrict the effects 
of such agents to the one area of interest -  often even fairly specific blockers will affect 
other cellular processes (reviewed by Taylor & Broad, 1998). For example, 
preliminary experiments for this chapter using the NCX inhibitor 2',4'- 
dichlorobenzamil showed that, at a concentration of 0.1 mmol/L, it successfully 
inhibited NCX current, but also reduced peak Ica cunent by around 40% and shifted the 
peak of the Ica V curve a few millivolts more positive.
In this chapter, two methods were used to alter E-C coupling and overall Ca handling. 
Firstly, low concentrations of caffeine were used to alter the sensitivity of the 
ryanodine receptor to Ca, transiently enhancing SR Ca release. Secondly, Ca handling 
was examined with an altered holding potential, inhibiting Ca efflux via NCX, and 
resulting in changes in SR Ca content.
5.1.1 Effects o f caffeine on Ca handling
The methylxanthine caffeine has been shown to have several effects on different 
aspects of cardiac myocyte physiology. It has been known for over 20 years that 
caffeine is a potent enhancer of myofilament Ca sensitivity. It also acts as a
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phosphodiesterase (PDE) inhibitor, increasing intracellular cyclic AMP (cAMP), 
leading to a cascade of effects through increased phosphorylation of a variety of Ca- 
handling proteins (for reviews, see Bers, 2001, Chapters 2 & 10). The property of 
caffeine exploited in this chapter is its action at the sarcoplasmic reticulum, aspects of 
which will now be discussed.
In previous chapters 10 mmol/L caffeine has been used to cause release of Ca from the 
SR, enabling its quantification. It exerts this effect by increasing the Ca-sensitivity of 
the RyR, such that the open probability of the receptor is markedly increased (both 
frequency and duration of opening) for a given [Ca]i (Rousseau & Meissner, 1989). At 
lower concentrations of caffeine, this modulatory effect on CICR can be used to give 
insights into the complex relationship between trigger [Ca], SR Ca release, Ca transient 
properties and the balance of Ca influx and efflux. Such studies have been perfbimed 
in detail by Eisner and colleagues (e.g. O'Neill & Eisner, 1990; Trafford et a l, 1998; 
Trafford et a l, 2000; reviewed in Eisner et a l, 1998).
5.1.1.1 ''Autoregulation ” o f  SR Ca release
One consistent finding of Eisner and colleagues has been that maintained alterations in 
SR Ca release (e.g. by low concentrations of caffeine) have only short-lived effects on 
the Ca transient. This has been termed “autoregulation”, and results from 
compensatory changes in the SR Ca content, which normalise SR Ca release. For 
example, when cells are stimulated in the presence of low concentrations of caffeine, 
initial transients will be increased in size due to enhanced release of Ca from the SR. 
However, in the absence of changes in SERCA function, this will progressively unload 
the SR, with net loss of Ca from the cell via NCX and other extrusion processes. A
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new steady state will be achieved where the combination of a sustained increase in SR 
fractional release and reduced SR Ca content will return overall SR Ca release to pre- 
caffeine levels. With no change in sarcolemmal Ca influx and efflux this steady state 
should be reached at the point where the Ca transients have returned to control levels. 
Trafford et a l measured the Ca fluxes involved in this process and showed that for rat 
ventricular myocytes in the presence of 0.1 mmol/L caffeine, the SR Ca content had 
fallen by around 20% at steady state (Trafford et a l,  1998).
For this chapter, preliminary experiments were performed with 0.1 mmol/L, 0.25 
mmol/L, 0.5 mmol/L and 1 mmol/L caffeine. The two higher concentrations were 
chosen for further study since they lead to reproducible increases in the initial Ca 
transients and reductions in the steady-state SR Ca content.
5.1.2 Reversible inhibition o f Ca efflux via NCX
Given the findings in Chapter 3 of reduced NCX activity in LVD, one aim of the 
studies in the current chapter was to examine the effects of acute inhibition of NCX 
function on cellular Ca handling. As discussed above, some available NCX inhibitors 
have additional actions on the cell, which would complicate analysis of their effects. 
Instead of pharmacological inhibition, it was decided to make use of the fact that the 
cells were voltage-clamped to alter Ca extmsion during the diastolic period. Since 
NCX is electrogenic, the driving force for forward-mode Ca efflux can be reduced by 
elevating the membrane potential. Thus, a voltage protocol was designed which 
included a period of stimulation with the holding potential raised by 20 mV. The 
effects of this intervention could then be elucidated.
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5.2 Methods
5.2.1 Solution compositions
Internal and external solutions were once again chosen to allow accurate quantification 
of Ca fluxes, as outlined in sections 2.5.4 and 3.2.2.1.
5.2.2 Manipulation o f SR Ca handling with caffeine
5.2.2.1 Experiment protocol
Cells were loaded with Fura-2, as previously described, and were voltage-clamped with 
a holding potential of -80 mV. All experiments were performed at 37 °C. The 
experimental protocol is outlined in Figure 5.1. First, steady-state Ca transients were 
achieved by stimulating at 0.5 Hz, with a 150 ms step to 0 mV. 10 mmol/L caffeine 
was then rapidly applied and the baseline SR Ca content deteimined, as described in 
section 4.2.2.2. Cells were then stimulated again to re-load the SR, and once this was 
achieved the superfusate was switched to one containing 0.5 mmol/L caffeine. Cells 
were stimulated for a further 30 s, and then the SR Ca content was again estimated 
using 10 mmol/L caffeine. The protocol was repeated using 1 mmol/L caffeine in the 
superfusate.
5.2.2.2 Data analysis
After conversion of Fura-2 ratio signals to [C a]i, systolic and diastolic values for C a  
transients were determined at several points in the protocol. Steady-state C a  transients 
were measuied before and after the switch to the low concentration of caffeine by 
averaging the last few transients of each train (at points a, c and e on Figure 5.1). 
Transients at a and c are obtained under identical conditions and were combined to 
determine the mean “pre-caffeine” C a  transient. The first transient after the switch to
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Figure 5.1 Protocol for altering SR Ca release with low concentrations of 
caffeine. Cells were stimulated at 0.5 Hz to achieve steady-state Ca 
transients (a), then 10 mmol/L caffeine (Caff, b) was applied to give an 
estimate of SR Ca content under baseline conditions. SR content was 
determined from the integral of the NCX inward current, as outlined in 
Figures 4.1 & 4.2, Steady-state Ca transients were once more established (c), 
then the perfusion solution was rapidly switched to one containing 0.5 or 1 
mmol/L caffeine (open bar). Characteristics of the initial (d) and steady-state
(e) transients were determined. 10 mmol/L caffeine was once more applied
(f) and the new SR Ca content was measured.
0.5 mmol/L or 1 mmol/L caffeine was also measured (point d on Figure 5.1). Thus, 
data for “initial” (d) and “steady-state” (e) transients were obtained after the switch to 
caffeine.
SR Ca content was estimated from the integral of the inward NCX cun'ent, as outlined 
in Figures 4.1 & 4.2. This measure was made before (b) and after (f) the switch to 0.5
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Figure 5.2 NCX inhibition protocol. Cells were initially stimulated at 0.5 
Hz from a holding potential (F/,) of -80 mV until steady state was achieved 
(a). 10 imnol/L caffeine (Caff) was then applied (b) and SR Ca content
estimated as previously described. After a further period of stimulation (c), 
the holding potential was changed to -60 mV and stimulation continued. At 
steady state (d), caffeine was again applied (e). The rate constant of Ca 
decay in the presence of caffeine at -60 mV (e) was compared with that at 
-80 mV (b) to give an estimate of the degree o f inhibition of NCX function, 
as described in the text. Finally, cells were stimulated again to load the SR at 
Vh = -60 mV and the SR Ca content was estimated by applying caffeine at F/,
= -80 mV (f).
mmol/L or 1 mmol/L caffeine. For each cell, Ca transients and SR content before and 
after the switch to 0.5 mmol/L or 1 mmol/L caffeine were compared using paired t- 
tests. Comparisons between separate cell groups were first made by ANOVA, and 
where a significant F-value was achieved, subsequent post hoc two-tailed t-tests were 
performed (see section 2.8).
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5.2.3 Inhibition o f  NCX
5.2.3.1 Experiment protocol
The protocol for altering NCX function is outlined in Figure 5.2. Baseline 
characteristics of Ca transients and SR Ca content were determined with a 0.5 Hz train 
o f stimuli (a), followed by application of 10 mmol/L caffeine (b), as described above. 
Steady-state Ca transients were once more achieved (c), then the holding potential 
between voltage steps was increased to -60 mV (d). This reduces the driving force for 
Ca extrusion on NCX, as discussed in section 5.1.2. The degree of inhibition of NCX 
was estimated by examining the Ca decay on application of 10 mmol/L caffeine at a 
holding potential of -60 mV (e), as described below. A further stimulation train was 
used to load the SR again with Ca (at the higher holding potential), then the SR content 
was determined by applying caffeine at a holding potential of -80 mV (f). The latter 
caffeine application was performed at -80 mV rather than -60 mV to standardise 
conditions under which SR Ca content was determined, allowing a direct comparison 
with the baseline value (since the altered holding potential affects the resting current 
level and timecourse of Ca extrusion).
5.2 3.2 Data analysis
Characteristics of steady-state Ca transients were deteimined before (a and c combined) 
and after (d) the switch in holding potential to -60 mV. Corresponding SR Ca contents 
were measured (b and f), as previously described. An estimate of NCX activity was 
made by examining the Ca decay on application of 10 mmol/L caffeine. The rate 
constant o f Ca decay was determined by fitting a single exponential function to the 
converted Ca data (see Figure 3.4). The contribution of NCX to this decay was 
estimated by subtracting the mean rate constant for non-NCX removal mechanisms
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previously determined for each cell type (see Figure 3.10). The degree of inhibition of 
forward-mode NCX activity using the voltage protocol described above was estimated 
by comparing the corrected rate constant obtained at a holding potential of -60 mV (e) 
with that obtained at -80 mV (b).
As with the previous protocol, for each cell paired t-tests were used for statistical 
analysis of Ca transients and SR Ca content before and after the switch in holding 
potential to -60 mV. ANOVA and subsequent unpaired two-tailed t-tests were used to 
compare cells from different groups, as outlined in section 2 .8 .
5.2.4 Analysis o f Ca handling
For each of the protocols outlined above, a similar analysis of C a  handling to that 
described in section 4.3.6 was performed. As before, buffering characteristics were 
determined for each individual cell (see section 4.3.4) and these were used to convert 
free [C a]i to total C a. This allowed A [Ca] Total to be calculated for transients at different 
stages of the protocols. Systolic C a  entry was either measured directly ftom the 
integral of Ica or calculated from the integral of the tail eurrent, as described in section
4.3.5.1. Using this value, SR C a  release, SR fractional release and E-C coupling gain 
could be calculated (see section 4.3.6).
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5.3 Results
The experiments in this chapter were designed to alter aspects of myocyte Ca handling 
to gain insights into E-C coupling amongst the cell types. Low concentrations of 
caffeine were used to increase the open probability of the ryanodine receptor, causing 
changes in the SR Ca content and altered SR Ca release in systole and diastole. In 
separate experiments, the membrane potential in diastole was manipulated to alter Ca 
extrusion, with resulting changes in SR Ca handling.
For the caffeine experiments, data were obtained from 8  Sham animals and 10 LVD 
animals, and for the NCX inhibition experiments, 4 animals of each type were used.
5.3.1 Effects o f low concentrations o f caffeine on steady-state SR Ca content 
By altering the relationship between [Ca]i and SR Ca release, low concentrations of 
caffeine have the effect of unloading the SR. Figure 5.3 shows the absolute and 
relative effect of 0.5 mmol/L and 1 mmol/L caffeine on steady-state SR Ca content (all 
figures and tables for experiments with low concentrations of caffeine are grouped at 
the end of section 5.3.4). For each individual cell, paired t-tests show the incremental 
effects of 0.5 mmol/L and 1 mmol/L caffeine on the SR content, with significance 
levels generally p<0.001. Each caffeine concentration lowered the SR content by 
similar relative amounts, iiTcspective of the cell type (see Figure 5.3 B). In general, 0.5 
mmol/L and 1 mmol/L caffeine reduced the SR content to around 65% and 45% of 
baseline levels, respectively. The only statistical difference apparent between cell types 
was that 1 mmol/L caffeine lowered the SR content in LVD endocardial cells by more 
than it did for Sham endocardial cells (to 37 ± 4 % of baseline SR content, 52 ± 3 %,
p=0.02).
180
Comparisons of the absolute levels of SR Ca content amongst the different cell types 
are made in Figure 5.3 A. Baseline Ca content (i.e. in the absence of caffeine in the 
superfusate) shows the same trend as the results in Chapter 4 (see Figme 4.9), although 
with fewer cells, the only comparison reaching statistical significance was that between 
Sham epicai’dial cells and LVD epicardial cells. On application of 0.5 mmol/L and 1 
mmol/L caffeine, smaller steady-state SR Ca contents were obtained for LVD 
endocardial cells than Sham endocardial cells. The application of caffeine also 
revealed small differences between LVD endocardial and epicardial cells, with higher 
SR contents in epicardial cells at each caffeine concentration.
5.3,2 Effects o f low concentrations o f caffeine on Ca transient characteristics
5.3.2.1 Diastolic & systolic [Ca/,
Table 5.1 summarises the changes in diastolic and systolic [C a]i with the switch to 0.5 
mmol/L and 1 mmol/L caffeine in the superfusate. For each cell type, values are given 
for the first C a  transient after the switch to caffeine (point d on Figure 5.1) and for the 
steady-state C a  transient (mean of transients at point e on Figure 5.1). In general, the 
data show that on initially applying caffeine there was a  small rise in diastolic [C a],, 
particularly with 1 mmol/L caffeine. This measure was made at the end of the first 
transient, i.e. just before the upstroke of the second transient. The elevated diastolic 
[C a]i at this point in the protocol may be due to the increased release of C a  from the 
SR, before extrusion processes have had a chance to cause net loss of C a  from the cell. 
Once steady state was achieved, diastolic [C a]i was no different to baseline values 
(except for Sham epicardial cells with 0.5 mmol/L caffeine, where it was a little lower).
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In all cases, except for LVD endocardial cells with 0.5 mmol/L caffeine, the first 
transient after the switch to caffeine had a significantly higher systolic [C a]i than the 
baseline level. However, overall steady-state values of systolic [C a]j were slightly 
lower in the presence of caffeine, reaching statistical significance for Sham epicardial 
cells at 0.5 mmol/L caffeine, and for Sham endocardial and LVD endocardial cells at 1 
mmol/L caffeine.
5.3.2.2 A[Ca]Total immediately after switch to caffeine
The above values for diastolic and systolic free [Ca] were converted to total [Ca] using 
the buffering properties of each cell, as described in section 4.3.6. This enabled 
calculation of A [Ca] Total at different stages of the protocol. The results are presented in 
Figures 5.4 and 5.5 for initial transients and steady-state transients, respectively.
As expected, A [C a] Total for the first transient after the switch to each concentration of 
caffeine was higher than baseline values for all cell types (see Figure 5.4, p-values by 
paired t-tests generally <0.01 or <0.001). In the majority of cases, 1 mmol/L caffeine 
produced an incremental increase over 0.5 mmol/L caffeine. Interestingly, there appear 
to be regional differences in the amount that caffeine enhances the size of the transient. 
As shown in Figuie 5.4 B, caffeine increased the relative size of the transient more in 
epicardial cells than endocardial cells. This reached statistical significance for both 
concentrations of caffeine in LVD cells (p=0.003 for 0.5 mmol/L caffeine, p~0.02 for 1 
mmol/L caffeine), and for 1 mmol/L caffeine in Sham cells (p=0.03).
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Caffeine was less effective at increasing A[Ca]Totai for LVD endocardial cells than 
Sham endocardial cells, but it seemed equally effective when epicardial cells were 
compared (Figui'e 5.4 B).
Differences in absolute A[Ca]Total amongst the cell types are outlined in Figure 5.4 A. 
For each cell region, at 0.5 mmol/L and 1 mmol/L caffeine, A[Ca]Totai was smaller in 
LVD cells than Sham cells. This was also trae for baseline A[Ca]Totai for epicardial 
cells (see Figure 4.12 for full comparison of baseline Ca handling).
5.3.2.3 Steady-state A[Ca] Total
Changes in A [Ca] Total at steady state after the switch to caffeine are presented in Figure 
5,5. Panels A and B show that for each cell type A[Ca]Total is lower in the presence of 
caffeine (statistically significant, except for Sham epicardial cells with 1 mmol/L 
caffeine). Steady-state transients with low concentrations of caffeine were around 85- 
95 % of the amplitude of baseline transients. For Sham endocardial cells the effect of 
caffeine was incremental, with a greater reduction in A[Ca]Totai with 1 mmol/L caffeine 
compared to 0.5 mmol/L caffeine. Reduced Ca transient amplitude in the presence of 
low concentrations of caffeine was also apparent when free [Ca] was analysed (data not 
shown).
These consistent findings are at odds with the theory that acute alterations in RyR 
function will only produce transient changes in Ca transient amplitude (Eisner et a/., 
1998; Trafford et a l,  2000; Eisner et a l,  2000). As discussed earlier (section 5.1.1.1), 
Eisner and colleagues showed that enhanced SR release (through caffeine application)
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initially causes larger transients (as seen in this chapter), but this leads to net loss of Ca 
from the cell, causing unloading of the SR and hence reduced SR Ca release. This 
autoregulation returns the transients to the same size as before caffeine was applied. 
The fact that the steady-state transients measured in this chapter are smaller than those 
at baseline implies one of two main possibilities: that less Ca is entering the cell in 
systole and/or that SR Ca cycling is altered. The first of these possibilities was 
examined in a subset of cells, where systolic Ca entiy was measured before and after 
the switch to caffeine (as described in section 4.2.5 and Figure 4.6). This showed no 
significant difference between systolic Ca entry before (13.7 ± 1.7 pmoles/L cytosol) 
and after (13.8 ± 1 .6  pmoles/L cytosol) the switch to caffeine (n=10 cells; p value by 
paired t-test = 0.58). This implies that the smaller transients are due to a persisting 
alteration in SR Ca cycling. This possibility is examined further in the Discussion, 
section 5.4.1.2.
When different cell types were compared, transients in LVD epicardial cells were 
smaller than those in Sham epicardial cells at all concentrations of caffeine (Figure 5.5
A). The differences between Sham and LVD endocardial cells did not reach statistical 
significance.
5.3.3 Effects o f low concentrations o f caffeine on SR fractional release
SR fractional release of Ca was deteimined before and after the switch to caffeine, as 
previously described (see section 4.3.6). Again, results are presented for the 
transient after the switch (Figure 5.6) and for transients at steady state (Figure 5.7).
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For the first transient after the rapid switch to caffeine, it was assumed that the SR Ca 
content had not altered from the baseline level (i.e. it was the same as that determined 
at point b on Figure 5.1). This assumption is likely to be reasonable since depletion of 
the SR through increased RyR Ca “leak” would be negligible in the short period (<1 s) 
prior to the subsequent transient. As expected, by enhancing RyR sensitivity to Ca, the 
rapid application of a low concentration of caffeine lead to increased fractional release 
for the first transient after the switch (Figure 5.6). This was true for all cell types and, 
in general, 1 mmol/L caffeine had an incremental effect over 0.5 mmol/L caffeine.
Figure 5.6 B shows that for endocardial or epicardial cells, the degree of enhancement 
of fractional release was similai' for Sham and LVD cells at each concentration of 
caffeine. There was a trend towards proportionally greater increases in fractional 
release for epicardial cells compared to endocardial cells (statistically-significant for 1 
mmol/L caffeine for Sham cells, and 0.5 mmol/L caffeine for LVD cells). This is in 
keeping with the results for A[Ca]Total described in section 5.3.2 .2 .
At steady state in the presence of low concentrations of caffeine, the SR is depleted of 
Ca through enhanced release and net loss of Ca from the cell (see Figure 5.3). A new 
balance of SR uptake and release relative to SR content will be achieved. At very low 
SR Ca contents other factors, in addition to enhanced RyR activity, may start to play a 
role in determining the overall Ca release. This could affect the final steady-state 
fractional release, may affect overall A[Ca]Totai, und is discussed in more detail in 
section 5.4.1.2.
185
Figure 5.7 shows the measuied effects of 0.5 mmol/L and 1 mmol/L caffeine on steady- 
state SR fractional release for each of the cell types. The figure shows that 1 mmol/L 
caffeine significantly enhanced fractional release for all cell types, more than doubling 
fractional release for Sham epicardial, LVD endocardial and LVD epicardial cells. The 
relative increase for Sham endocardial cells was less (see Figure 5.7 B), but was still 
significant (p=0.008). 0.5 mmol/L caffeine had a smaller effect on fractional release, 
but almost reached statistical significance for Sham endocardial cells (p=0.064) and 
LVD endocardial cells (p=0.054).
5.3.4 Effects o f low concentrations o f caffeine on E-C coupling gain
E -C  coupling gain was calculated as in the previous chapter ((A[Ca]Totai - Uca) /  fc o )-  
As expected, for the initial transient after the switch to caffeine, the effects on E -C  
coupling gain (Figure 5.8) match the effects on fractional release (Figure 5.6), with 
increased gain in the presence of caffeine. The percentage increase in gain (Figure 5.8 
B) at each concentration of caffeine is also similar to that for fractional release (Figure
5.6 B). At baseline and at each concentration of caffeine, gain was higher in Sham 
endocardial cells than LVD endocardial cells (Figure 5.8 A). This did not quite reach 
statistical significance for the comparison between Sham epicardial cells and LVD 
epicardial cells (p=0.09, 0.14 and 0.08, for baseline, 0,5 mmol/L caffeine and 1 mmol/L 
caffeine, respectively). As for fractional release, there were small differences in the 
percentage increase in gain achieved in epicardial cells, compared to endocardial cells.
Figure 5.9 shows the results for steady-state transients in the presence of caffeine. 
Given that there was no significant change in systolic Ca entry (see section 5.3.2.3), if 
there was full autoregulation of SR Ca release then one would expect E-C coupling
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gain to remain the same as it was at baseline (absolute SR Ca release would be 
maintained by increased fractional release in the face of a smaller SR Ca content). In 
fact, gain was significantly lower in the presence of caffeine (significantly so for all cell 
types except Sham epicardial cells at 1 mmol/L caffeine, where p=0.064). In broad 
terms, the relative changes in gain (Figure 5.9 B) match those for A[Ca]Totai (Figure 5.5
B). In a similar manner to the findings for the transient after the switch to caffeine, 
gain was lower for LVD endocardial cells than Sham endocardial cells (although 
statistical significance was not reached at 0.5 mmol/L caffeine, p=0.11). The analysis 
of Ca handling is taken further in section 5.3.9.
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Figure 5.3 Effect of different concentrations of caffeine on SR Ca content. 
A: Absolute values. B: Values relative to baseline (in the absence of 
caffeine in the superfusate). Key and number of cells, n, shown on each 
column in A apply to both panels. Comparisons by paired t-tests within cell 
types are shown across columns, unpaired t-tests, after determining 
significance by ANOVA, are shown above columns. * p<0.05, ** p<0.01,
***p<0.001.
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A Diastolic [Ca]i
Cell
type Baseline
0.5 mmol/L caffeine 1 mmol/L caffeine
1"t SS i s t SS
Sham
Endo 2 6 0  ±  3 7 3 0 3  ±  4 8  ** 2 7 3  ±  4 2 2 8 3  ±  4 2  * 2 6 7  ±  4 0
Sham
Epi 2 6 2  ± 3 7 2 7 3  ±  3 8 2 5 0 ± 3 6  * 2 7 9  ± 4 1  ** 2 5 3  ±  4 0
LVD
Endo 2 0 3  ±  3 4 2 1 4  ± 3 1 2 0 0  ±  2 8 2 2 3  ±  3 6  ** 2 0 1  ± 3 2
LVD
Epi 2 1 1  ± 2 5 2 4 2  ±  2 8  * 2 2 9  ±  2 8 232 ± 33 2 0 7  ±  2 5
3 Systolic [Ca]i
Cell
type Baseline
0.5 mmol/L caffeine 1 mmol/L caffeine
i s t SS i s t SS
Sham
Endo 5 5 8  ±  6 0 6 8 9  ±  9 4  ** 5 3 5  ±  59 7 0 1  ±  8 8  ** 5 0 3  ±  5 3  **
Sham
Epi 4 6 9  ±  4 9 5 2 6  ±  4 8  * 4 2 0  ±  4 3  ** 5 9 3  ±  6 7  *** 4 4 6  ±  5 9
LVD
Endo 4 7 6  ±  5 8 4 8 2  ±  5 8 4 1 5  ± 4 8 515 ± 6 5  *** t 4 1 1  ± 5 1  *
LVD
Epi 3 7 0  ± 4 1 4 4 6  ±  50*** 383 ±  43 447 ±  57 ** 3 5 1  ± 3 9
Table 5.1 Diastolic (A) and systolic (B) [Ca]j at baseline and with switching 
to 0.5 mmol/L and 1 mmol/L caffeine. Values for the first transient on 
switching to caffeine (L^) and steady-state transients (SS) are given, in 
nmol/L. Statistically-significant comparisons by paired t-test aie indicated: 
*p<0.05, =^*p<0.01, ***p<0.001, all vs baseline; ^p<0.05 V5- 0.5 mmol/L caff, 
transient. No comparisons amongst cell types were significant. Number 
of cells for each cell type matches those in Figures 5.4 & 5.5.
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U 15-
■ ■  Sham Endo 
Sham Epi 
C Z3  LVD Endo 
C Z2  LVD Epi
0 0.5 1 ! 0 0.5 1 0 0.5 1 0 0.5 1
Caffeine concentration (mM)
B A[Ca]Totai relative to baseline (%)
0 0.5 1 0 0.5 1 0 0.5 1 0 0.5 1
Caffeine concentration (mM)
Paired
Mests
n cells
to 130 -
o
<  100 -
Figure 5.4 A[Ca]Totai at baseline and immediately after switching to 0.5 
mmol/L and 1 mmol/L caffeine. Full figure legend as for Figure 5.3.
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Figure 5.5 A[Ca]Totai at baseline and in steady-state after switching to 0.5 
mmol/L and 1 mmol/L caffeine. Full figure legend as for Figure 5.3.
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A SR fractional release for 1® transient after switch to caffeine
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Figure 5.6 SR fractional release at baseline and immediately after switching 
to 0.5 mmol/L and 1 mmol/L caffeine. Full figure legend as for Figure 5.3.
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Figure 5.7 SR fractional release at baseline and in steady-state after 
switching to 0.5 mmol/L and 1 mmol/L caffeine. Full figure legend as for 
Figure 5.3.
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Figure 5.8 E-C coupling gain at baseline and immediately after switching to 
0.5 mmol/L and 1 mmol/L caffeine. Full figure legend as for Figure 5.3.
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Figure 5.9 E-C coupling gain at baseline and in steady-state after switching 
to 0.5 mmol/L and 1 mmol/L caffeine. Full figure legend as for Figure 5.3.
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5.3.5 Effects o f altered resting membrane potential on NCX function and Ica
An estimate of the effect on NCX activity of raising the resting membrane potential 
from -80 mV to -60 mV was made as described in section 5.2.3. In brief, the decay of 
Ca after application of 10 mmol/L caffeine was compared at each of the holding 
potentials, with corrections made for non-NCX removal mechanisms. Overall, this 
showed that NCX function was inhibited by 23.9 ± 1 .7  % (n=44 cells), with no 
significant difference amongst the cell types by ANOVA (p=0.25). Ca flux on Ica was 
also measured before and after the switch in holding potential. As for the previous 
chapter, there were no significant differences amongst the cell groups in Ica flux at 
baseline. However, changing the holding potential to -60 mV significantly reduced Ica 
flux, to 89.1 ± 1.8 % of the flux at -80 mV (n==43 cells, p<0.0001, by paired t-test). 
This is unlikely to be due to the smaller size of the voltage prepulse to -40 mV, since 
negligible Ica is activated below this level. Instead, the reduced Ica flux is likely to be 
caused by the elevation in diastolic [Ca], (see below). The effects of these alterations in 
systolic and diastolic Ca handling will now be described.
5.3.6 Effects o f altered resting membrane potential on steady-state SR Ca content
By inhibiting removal of Ca from the cell during the diastolic period, a new balance 
will be achieved between efflux of cytoplasmic Ca and its uptake into the SR. Figure 
5.10 shows the effect that this has on SR Ca content (all figures and tables for 
experiments with altered resting membrane potential are grouped at the end of section 
5.3.8). In all cases, SR content is significantly increased, and in each case this is by 
around the same relative amount (between 24 % and 32 %).
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5.3.7 Effects o f altered resting membrane potential on Ca transient characteristics
5.3.7.1 Diastolic & systolic [Ca/,
Table 5.2 summaiises the data for diastolic and systolic [C a]i for each of the cell types. 
In all cases, there was a significant elevation in diastolic and peak systolic [Ca], when 
the resting membrane potential was raised to -60 mV. The proportional increase in 
diastolic [Ca], was slightly greater than the proportional increase in systolic [Ca], 
(around 14 % v.y 10 %, respectively; p=0.002, n=44 cells).
5.3.7.2 Steady-state A[Ca]Total
Given the above findings, when [Ca], was converted to total [Ca], there was little 
change in A [Ca] Total, as shown in Figure 5.11. For Sham endocardial cells, and LVD 
endocardial cells, there was a small, but significant, fall in A[Ca]Totai at the -60 mV 
holding potential (to around 95% of baseline levels). For epicardial cells, any 
differences were not significant. As shown in Figure 5.11 B, in Sham animals, this 
regional disparity in effects on A [Ca] Total lead to a significant difference between the 
relative change in A [Ca] Total for endocardial and epicardial cells (94.5 ± 1 .8  % 101.4
± 1.2%; p=0.003).
5.3.8 Effects o f altered resting membrane potential on SR fractional release and E-C 
coupling gain
In all cases, SR fractional release was lower at a holding potential o f -60 mV, compared 
to -80 mV, as shown in Figure 5.12. For both Sham and LVD animals, the decrease in 
fractional release was more marked for endocardial cells than epicardial cells (Figure
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5.12 B). Overall, at baseline and at -60 mV, fractional release was lower for LVD 
endocardial cells than for Sham endocardial cells.
The findings for E-C coupling gain are outlined in Figure 5.13. With the reduced 
trigger Ca due to smaller Ica flux (see section 5.3.5), to maintain the observed levels of 
A[Ca]Totai, E-C coupling gain was a little higher for all cell types. This was statistically 
significant for Sham endocardial cells (p=0.02) and LVD epicardial cells (p-0.0005) 
and almost reached significance for Sham epicardial cells (p=0.056). The increase was 
smaller, and non-significant, for LVD endocaidial cells. As for SR fractional release, 
gain was lower at both holding potentials for LVD endocardial cells compaied to Sham 
endocardial cells.
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Figure 5.10 Effects of altering resting membrane potential from -80 mV to 
-60 mV on steady-state SR Ca content. A: Absolute values. B: Values 
relative to baseline (in the absence of caffeine in the superfusate). Key and 
number of cells, n, shown on each column in A apply to both panels. 
Comparisons by paired t-tests within cell types are shown across columns, 
unpaired t-tests, after determining significance by ANOVA, are shown above 
columns. * p<0.05, ** p<0.01, *** p<0.001.
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Cell type Diastolic [Ca], Systolic [C a ]i
-80 "60 "80 -60
Sham Endo 
(n=12) 3 4 0  ±  5 0 3 9 4  ±  5 4  *** 6 6 0  ±  6 3 730 ± 72 ***
Sham Epi 
(#7=13) 3 3 0  ±  4 6 372 ± 53 *** 6 5 7  ±  6 3 734 ± 75 ***
LVD Endo
(#7=8) 3 1 5  ± 4 4 3 4 5  ±  4 7  ** 5 9 6  ±  61 627 ± 64 *
LVD Epi 
(#7=11) 2 4 4  ±  4 4 280 ± 48 ** 5 3 1  ± 5 1 5 9 1  ±  5 9  ***
Table 5.2 Diastolic and systolic [Ca], at resting membrane potentials of -80 
and -60 mV. All values in nmol/L. Number of cells {n) indicated for each 
row. For each cell type, statistically-significant comparisons by paired t-test 
are indicated; "^p<0.05, **p<0.01, ***p<0.001, all v.s baseline values at -80 
mV. No comparisons amongst different cell types were significant by 
ANOVA.
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Figure 5.11 Effects of altering resting membrane potential from -80 mV to 
-60 mV on steady-state A[Ca]Totai- Full figure legend as for Figure 5.10.
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Figure 5.12 Effects of altering resting membrane potential from -80 mV to 
-60 mV on steady-state SR fractional release. Full figure legend as for 
Figure 5.10.
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Figure 5.13 Effects of altering resting membrane potential from -80 mV to 
-60 mV on steady-state E-C coupling gain. Full figure legend as for Figure 
5.10.
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5.3.9 Characteristics o f E-C coupling with manipulation o f Ca handling
The overall effects of the above interventions on various aspects of E-C coupling, in 
relation to the SR Ca content are summarised in Figure 5,14. The foui’ panels of the 
figure match those of the baseline findings, presented in Figure 4.16, with added 
datapoints for the steady-state findings in the presence of 0.5 mmol/L and 1 mmol/L 
caffeine, and with raised resting membrane potential. The number of cells for each 
datapoint matches those for the corresponding cell type and conditions in the previous 
figures. Panel A shows the findings for A[Ca]Toiai, and the general fall in Ca transient 
size in the presence of caffeine is illustrated. Were full autoregulation to take place, for 
each cell type the datapoints for A[Ca]Total would shift to the left as SR Ca content was 
reduced, but they would not fall. Panel B displays the results for absolute SR release 
relative to SR content. Examining the four datapoints at baseline, and those with each 
intervention, in general the relationship between the cell types is preserved -  Sham Epi 
> Sham Endo > LVD Epi > LVD Endo. Overall, it appears that as SR content falls, 
absolute SR release also falls. The opposite relationship appears to occur for fractional 
release, as shown in panel C. This appearance is mainly due to the enhanced fractional 
release caused by low concentrations of caffeine, in the presence of reduced SR 
content. In addition, with the increased SR Ca content when the resting membrane 
potential was elevated (see section 5.3.6), there was a slight fall in fractional release. 
This may partly be due to the reduced trigger Ca and is discussed further in section 
5.4.2. The pattern o f findings for E-C coupling gain (panel D), are similar to those for 
SR Ca release shown in panel B.
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Figure 5.14 Characteristics of E-C coupling in relation to SR Ca content, at 
baseline and with altered Ca handling. A: A[Ca]xotai- B: Absolute SR Ca 
release. C: Fractional SR Ca release. D: Gain of E-C coupling. Key refers 
to all panels -  left panel identifies cell types, right panel identifies conditions 
under which measurement was made -  baseline (filled symbols), steady-state 
0.5 mmol/L caffeine (crossed symbols), steady-state 1 mmol/L caffeine 
(half-filled symbols) and with elevated resting membrane potential (open 
symbols). Each datapoint represents a mean of 8-32 cells (“baseline” values 
are combined datasets from the previous figures).
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5.4 Discussion
Experiments in the previous chapter showed that cells isolated from rabbits with 
infai'ct-induced LVD had smaller Ca transients and reduced E-C coupling gain. These 
findings appeared to be mainly due to reduced SR Ca content (see sections 4.4.4.2 & 
4.4.5). The experiments in this chapter were designed to alter aspects of Ca handling, 
including SR Ca content, and to examine the effects on the Ca transient.
5.4.1 Effects o f caffeine on Ca handling
5.4.1.1 Effects on the initial Ca ti^ansient
The rapid application of caffeine causes an abrupt increase in RyR sensitivity to Ca, 
such that the first Ca transient after the switch will be increased in size for the same 
trigger Ca. This is apparent in Figure 5.4, and the concomitant increases in SR 
fractional release and E-C coupling gain are demonstrated in Figures 5.6 and 5.8, 
respectively. As presented in sections 5.3.2.2, 5.3.3 and 5.3.4, the results suggest that 
caffeine was more effective at increasing initial SR fractional release, E-C coupling 
gain and resulting A[Ca]xotai in epicardial cells than endocardial cells. Other workers in 
the laboratory have examined regional expression of RyR and found evidence that 
ryanodine receptor mRNA and protein levels were higher in epicardial cells than 
endocardial cells (Currie et a l,  2003). This was true in both Sham and LVD animals 
and was also apparent in binding studies using tritiated ryanodine. Although it must be 
accepted that complex regulation of the RyR occurs, one could speculate that higher 
RyR density in epicardial cells could make a given concentration of caffeine more 
effective in enhancing E-C coupling in this region.
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Figure 5.4 B also shows that caffeine was less effective at increasing A[Ca]xotai for 
LVD endocardial cells compared to Sham endocardial cells, but that the relative 
increase in A[Ca]Totai for epicardial cells was similar in both Sham and LVD. Again, 
this fits with findings for RyR expression and labelled ryanodine binding. Cunie et al 
reported that RyR mRNA and protein levels were reduced by —25% and -40% , 
respectively, in LVD endocardial cells compared to Sham endocardial cells, and this 
was supported by experiments with specific ryanodine binding (Currie et a l, 2003). In 
contrast, there were no significant changes in these parameters for epicardial cells.
As discussed in Chapter 1, there has been much recent debate regarding the importance 
of RyR density and regulation in the pathogenesis of heart failure (for reviews, see Bers 
et a l,  2003; Marks et a l,  2002; Hasenfuss & Pieske, 2002). Studies into the levels of 
RyR mRNA and protein in heart failure have given disparate results (reviewed in Bers, 
2001, Chapter 10). In a rabbit model of heart failure induced by pulmonary artery 
banding, Matsui et a l  reported reduced RyR mRNA (Matsui et aï., 1995). In our 
laboratory, Neary et al. measured RyR-mediated SR Ca flux in intact, permeabilised 
rabbit myocytes from the same model of heart failure as that studied in tliis chapter 
(Neary et a l, 2002). RyR-mediated Ca efflux was reduced by around 50%, and this 
was coupled with a similar decrease in SERCA-mediated uptake. The cells in this 
study were not separated into transmural regions, but the findings do suggest that 
overall there is a reduction in RyR activity in this model of LVD.
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5.4.1.2 Effects on steady-state Ca transients
In all but one case (Sham epicai'dial cells with 1 mmol/L caffeine), the maintained
application of low concentrations of caffeine caused reduced steady-state A[Ca]xotai
compared to levels before caffeine was applied (see Figures 5.5 & 5.14). It was 
demonstrated that this was not a consequence of reduced Ca entry on Ica (see section 
5.3.2.3). This implies some persisting alteration in SR Ca handling in the presence of 
caffeine which means that “autoregulation” does not fully occur. A number of 
possibilities must be considered:
(i) non-linearities in negative feedback system,
(ii) altered SR Ca uptake and/or NCX function,
(iii) marked SR Ca depletion,
(iv) altered diastolic SR leak,
(v) other effects of caffeine in the ceil.
To examine the effects of some of these possibilities it is instructive to model the 
situation which leads to autoregulation. Eisner et al. proposed a simple model which 
includes the main parameters of Ca flux and E-C coupling (Eisner et a l, 1998). At the 
stimulus, A[Ca]xotai will be determined by Ca entry on Ica and the fraction, of Ca 
released from the SR. Thus:
[^Ca]xotai = /*  SRn + Ica  Equation 5.1
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Eisner’s model included a scaling factor, a, but with the sum expressed as A [Ca] Total, 
and for simplicity, we can assume that a = 1. A proportion, r, of this Ca will be 
removed from the cell, with the rest taken up into the SR. Thus:
Caout A [Ca] Total  ^ f Equation 5.2
The resulting amount of Ca in the SR before the next systole will be:
SRn+i -  SR„ + ~ Caout Equation 5.3
From Equation 5.3 it can be seen that at steady state (i.e. SRn+i = SRn), Ica must equal 
Caout and the cell is in net Ca balance.
Figure 5.15 A simulates how this model will behave when fractional release, /  is 
doubled from 0.25 to 0.5 (e.g. in the presence of a low concentration of caffeine). With 
the equations above, the system will autoregulate and steady-state A[Ca]xotai at the 
higher fractional release (point b on the figui'e) is the same as that at baseline (point a). 
This autoregulation will only occur if the amount of Ca removed from the cell relative 
to that taken up into the SR (r) remains constant (e.g. it is set at 0.33 in Figure 5.15). If 
this relationship alters then a new steady state will be achieved, with a different 
resulting A[Ca]Totai- This is illustrated in Figure 5.15 B, where r  was changed to 0.38 
during the period where the fractional release was increased. In this case the final 
A[Ca]xotai is around 8 6 % of the baseline level. Given the complex kinetics of Ca 
removal systems, including differing affinity for Ca and effects of cytoplasmic and SR
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Figure 5.15 Modelling of Ca handling with caffeine application. Full 
details of model are described in text. A: Simple model. Between stimuli 20 
and 100, fractional release,/ was increased from 0.25 to 0.5. B: Model, with 
altered ratio of Ca efflux to SR uptake during the period where fractional 
release was increased. C: Simulation of SR Ca leak exponentially related to 
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C. Key refers to panels A, B and D.
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luminal [Ca], it would not be surprising for non-linearities in r to occur. This may be 
particularly apparent for species, such as the rabbit, where sarcolemmal transport plays 
a proportionally greater role in Ca removal (see Chapter 4) than it does in species such 
as the rat, where around 92% of Ca removal is by SERCA (Bassani et a l, 1994).
One would also expect significant deviation from the model in situations where the SR 
is heavily depleted of Ca -  e.g. at higher concentrations of caffeine. With markedly 
increased fractional release, the SR content may fall to very low levels. The SR Ca 
content at this point may be insufficient to support the level of Ca release required to 
maintain A [Ca] Total, or, indeed, a threshold level may be passed where SR release fails 
altogether (see Shannon et a l, 2000). Both these circumstances will cause smaller 
steady-state Ca transients, however, it is unlikely that the SR content reached such 
levels in the experiments presented in this chapter.
Persisting leak of Ca from the SR during diastole will also complicate the analysis. 
Given the low stimulation rate (0.5 Hz) relative to the physiological heart rate of the 
animals (around 3 — 5 Hz), diastolic leak may be particularly important to consider in 
such experimental studies. If it is assumed that any Ca leaked into the cytoplasm 
during diastole is removed in the same way as Ca released dui’ing systole (i.e. the 
proportion removed from the cell remains r), then Equation 5.2 becomes;
Caout -  A[Ca]iotai *  ^+  SRieak * r Equation 5.4
In the simplest situation of a leak linearly proportional to the SR content (i.e. dependent 
only on the SR-cytoplasm [Ca] gradient):
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SRieak = «y * SRn Equation 5.5
where ai is a constant. In this situation, autoregulation will fail and A[Ca]Totai will 
increase slightly as SR content falls. However, if it is assumed that alterations in SR 
fractional release have the same effect on SR leak (i.e. if caffeine doubles fractional 
release, the SR leak also doubles) then:
SRieak = «2  SRn Equation 5.6
Under these circumstances, autoregulation will once more occur -  A [Ca] Total will be 
smaller than it was in the absence of SR leak, but will remain the same as fractional 
release is changed.
The relationship between SR Ca content and SR leak, however, is complex. Shannon 
et al. made a quantitative assessment of this relationship in isolated rabbit ventricular 
myocytes (Shannon et a l,  2002). They estimated that resting SR leak was around 12 
pmol/L/s, and that this depended heavily on the SR content. As SR Ca content 
increased, SR leak increased in a non-linear manner, with a much steeper relationship 
at higher SR loads. They postulated that SR Ca content, as well as providing the 
driving force (gradient) for leak, also affected the leak process itself tlirough effects on 
RyR gating. They fitted their data with a modified exponential function, but for the 
purposes of modelling in this chapter, a simple exponential function can be used for 
illustrative puiposes. Thus:
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SRieak = «3 * /*  V '  Equation 5.7
This again includes a dependence on fractional re lease ,/ Values of gj, xq and t were 
chosen to give an approximation of the relationship reported by Shannon et ah Figure 
5.15 illustrates this leak-load relationship in panel C, along with the resulting effects 
when fractional release is doubled, in panel D. In this case, steady-state A[Ca]Totai at 
the higher fractional release is slightly increased compared to baseline levels.
It should also be recognised that the removal of Ca which has leaked from the SR may 
differ from the removal of bulk cytoplasmic Ca released during systole. If  the SR leak 
is principally via RyRs, then it will mainly be into the dyadic cleft. One could 
postulate that the relative removal of Ca from this space by NCX and SERCA may be 
different from the situation where Ca is being removed from the bulk cytoplasm. If this 
is the case then a different value of r would be required for the SRieak in Equation 5.4.
The above analysis has illustrated that if  complexities are introduced into the simple 
model of E-C coupling then autoregulation may not occui'. One further consideration is 
that caffeine may have other effects on the cell, which could alter cellulai" Ca fluxes. 
As discussed in section 5.1.1, caffeine is a PDE inhibitor and can change intracellular 
levels of cAMP. This could alter the phosphorylation of a number of proteins involved 
in Ca handling, changing their activity. This could feasibly lead to changes in the 
proportion of Ca removed from the cell (r) compared to that taken back up into the SR, 
although the overall effects of PDE inhibition on the Ca transient are unpredictable and 
would need to be addressed by separate experiments.
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Finally, it should be remembered that the estimation of A[Ca]Totai used in this chapter, 
and in much of the literatuie, is based on the amplitude of the Ca transient ([Cajpeait - 
[Ca]trough), which makes some assumptions about Ca release. Since this is an 
“instantaneous” measure ([Ca]peak is one moment in time) it does not account for the 
profile of Ca release. One could envisage a situation where the same total amount of 
Ca could be released over a longer time (e.g. see Litwin et a l, 2000), giving removal 
mechanisms a chance to act during the upstroke of the transient. This would result in a 
lower [Ca]peak and hence a lower estimation of A[Ca]xotai- Even though the Ca removal 
mechanisms would not “see” as high a [Ca]peak, the same total Ca efflux could be 
achieved -  these efflux mechanisms operate throughout the cardiac cycle and the 
“average” [Ca] that they act on could be the same. Thus, Ca influx and efflux could 
balance as before, with a smaller Ca transient amplitude.
5.4,2 Effects o f raised resting membrane potential on Ca handling 
Figure 5.11 shows that elevating the resting membrane potential from -80 mV to -60 
mV had a less dramatic effect on A[Ca]Total than did the application of low 
concentrations of caffeine. For all cell types, SR Ca content was increased by around 
25-30% (Figure 5.10 B). Given the dependence of SR release on SR content 
demonstrated in Chapter 4, if this were the only change then one would expect that 
A[Ca]Totai would also be increased. Indeed, using the simple model of Ca handling 
(Equations 5.1 to 5.3), if r is altered to simulate a 25% reduction in Ca efflux (e.g. 
changed from 0.33 to 0.27), SR content increases by 33% and A[Ca]Totai rises by 22% 
(Figure 5.16 A), However, the results presented in Figure 5.11 show that this was not 
the case -  for epicardial cells from both Sham and LVD animals A[Ca]Totai did not alter,
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Figure 5.16 Modelling of Ca handling with altered efflux parameters. A: 
Between stimuli 20 and 100, the proportion of Ca removed from the cell, r, 
was reduced from 0.33 to 0.27. Other parameters were kept constant. B: In 
addition to reducing r, influx on Ica was reduced from 1 0  to 8 arbitrary units 
and fractional release was reduced from 0.25 to 0.21. See text for full 
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and for endocardial cells from both animal types it fell by a small, but significant, 
mnount.
For the model to begin to approximate the experimental findings, two other factors 
must be taken into account. Firstly, as shown in section 5.3.5, there was a significant 
fall in the trigger Ca, probably due to raised diastolic [Ca]. Secondly, for all cell types, 
fractional release was slightly reduced at the higher resting membrane potential (see 
Figure 5.12). At first, this latter point appears at odds with the relationship between 
fractional release and SR content described in the previous chapter (see Figure 4,16)
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and in the literature (Shannon et al^ 2000). However, these relationships were 
determined for a (relatively) constant Ica^  If Ica is reduced then fractional release for a 
given SR Ca content will fall, and overall, the relationship between the two will be 
flatter (see Bassani et a l,  1995). Thus, the situation could arise where the fall in Ica 
reduces the overall fr actional release in spite of an elevated SR Ca content.
The above considerations were included in the model for Figure 5.16 B. The 
proportion of Ca extruded fr om the cell, r, was altered as before, and in addition, Ica 
was reduced from 10 to 8  arbitrary units and /w as reduced from 0.25 to 0.21, based on 
the mean measured reduction in fractional release. Under these circumstances, steady- 
state A[Ca]xotai is slightly reduced, in keeping with the experimental findings. Similar 
results were obtained when the model included terms for SR Ca leak (not shown).
Further examination of Ca handling under these circumstances shows that the smaller 
trigger Ca is more effective at causing release of Ca from the SR (i.e. the gain is 
increased -  see Figure 5.13). This may be a consequence of the elevated SR Ca content 
increasing the sensitivity of the RyR to cytosolic Ca. As discussed in Chapter 1, such 
luminal regulation has been demonstrated in RyRs in lipid bilayers (Gyorke & Gyorke, 
1998) and in intact ventricular myocytes (Lukyanenko et a l,  1996; reviewed in 
Guatimosim et a l,  2002). The findings discussed above emphasize the complex 
relationship between trigger Ca, SR content, E-C coupling gain and A[Ca]Totai-
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5.5 Conclusions
In this chapter, experimental protocols were used to alter Ca handling in cells from 
each animal type. Low concentrations of caffeine were used to increase SR fractional 
release, reducing steady-state SR Ca content. In contrast, altering the resting 
membrane potential to reduce Ca efflux via NCX was used to increase SR Ca content. 
These techniques can give insights into the cellulai' processes involved in E-C coupling. 
Results were consistent with transmural differences in RyR function, in keeping with 
previous work by others in the group. The findings in the presence of low 
concentrations of caffeine did not fit with a simple model of cellular / SR Ca fluxes and 
imply that some persisting change in Ca cycling occurs under these conditions. When 
SR Ca content was increased using a voltage protocol, only small changes (if any) in 
A[Ca]Total were obsei'ved. This appears to be the consequence of reduced Ca entry via 
Ica with resulting changes in SR Ca release. The broader implications of the findings in 
this chapter are discussed in Chapter 6 .
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CHAPTER 6
GENERAL DISCUSSION
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6.1 Cellular phenotype in the rabbit infarct model of LVD
Experiments in this thesis have explored the chai'acteristics of Ca handling in cells from 
the left ventricle of rabbits with infarct-induced LV dysfunction. In general, the 
findings have shown reduced Ca transient size compared to sham-operated animals, 
and this was associated with lower SR Ca content, lower SERCA activity (statistically 
significant for epicardial cells), and reduced gain of E-C coupling, with maintained Ca 
flux via Ica (Chapter 4). There was also evidence of a reduction in NCX activity of 
around %, with differences in the allosteric regulation of the exchanger by [Ca] 
(Chapter 3). A discrepancy between NCX protein levels and activity was also noted, 
emphasizing the importance of making functional measurements before conclusions are 
drawn from biochemical results. The critical factor in determining the magnitude of 
the Ca transient appeared to be the SR Ca content, as discussed in Chapter 4. Although 
the gain of E-C coupling was reduced, this appeared to be in keeping with the fall in SR 
Ca content -  i.e. the “effectiveness” o f E-C coupling was relatively unchanged.
6.1.1 Relationship o f  cellular findings to arrhythmic risk
One might expect that the findings in LVD of reduced SR Ca content and lower 
diastolic [Ca] would lead to a reduction in the incidence of arrhythmo genic 
spontaneous Ca release. This was not directly studied in this thesis, but the increased 
incidence of sudden death in LVD (see Figure 2.1) suggests that arrhythmias may be 
more likely in the HF animals. Other factors may be important in increasing the 
arrhythmic risk. Ng et al. demonstrated that there were differences in the duration of 
Ca transients across the epicai’dial surface in HF (Ng et a l, 1998), and it is known that 
inhomogeneities in repolarisation and/or refractoriness can increase the likelihood of 
reentrant ventriculai' arrhythmias (Burton & Cobbe, 2000). The infarct border zone
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may also be a site where arrhythmias can arise, and the infarct scar tissue could provide 
a substrate for reentry. Other factors at a cellular level can be considered. Pogwizd et 
a l showed that in their combined pressure and volume overload rabbit model of HF, 
cells retained p-adrenergic responsiveness and stimulation by isoprenaline could 
elevate the SR Ca content and trigger spontaneous Ca release (Pogwizd et a l, 2001). 
Such factors could be important in vivo.
An additional consideration for the propensity to arrhythmias is the ease with which a 
given Ca release can depolarise the membrane. To some extent this depends on the 
ohmic properties of the membrane, including the “background” currents present at the 
resting potential. Pogwizd et a l found a steeper relationship between injected current 
and resulting change in membrane potential in HF, consistent with reduced background 
K currents (Pogwizd et a l,  2001). Preliminary experiments were performed in this 
thesis under current clamp conditions, with small positive and negative 50 ms square- 
wave current injections and measurement of Em at the end of each current step. The 
results are summarised in Figure 6.1, and show that there was no significant difference 
in resting membrane potential or ÙÆm for a given current injection. Similar findings 
were obtained when the current injections were made just before each AP in a 
stimulated train at 0.5 Hz, 1 Hz and 2 Hz (data not shown). Thus the ohmic properties 
of the membrane do not appear to differ between Sham and LVD cells and a similar 
A£',„ would be expected for a given arrhythmogenic cunent.
6.1.2 Relationship o f cellular findings to overall cardiac performance
The findings for Ca handling outlined above would be consistent with what has been 
found for this model of LVD at the whole-heart level. The reduced Ca transients would
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Figure 6.1 Ohmic properties of the cell membrane in Sham and LVD cells. 
Quiescent cells were studied under current clamp conditions and small 50 ms 
cuiTent injections were performed. A: Example of protocol, with family of 
current injections (lower panel) and resulting membrane voltage (upper 
panel). In this case the final current injection of 0.55 nA triggered an action 
potential (*). Resting membrane potential was no different between Sham 
and LVD eells (-85.4 ± 0.5 mV vs -85.7 ±1.1 mV; p=0.8). B: Mean data for 
each cell type, showing AE„, for each current step. Sham and LVD cells 
behaved similarly.
be reflected by impaired contractile performance, as demonstrated on echocardiography 
(Table 2.1). Reductions in NCX and SERCA function resulted in a significant slowing 
of the Ca transient decay (see Figure 4.7 B), and it is known that LV relaxation is 
prolonged in this model in whole-animal studies (Mahaffey et a l, 1995). This would 
contribute to the increased LV end-diastolic pressure that is observed (Pye et al., 1996; 
Mahaffey et a l,  1995). These factors could combine to produce the signs of tissue 
congestion reflected in the greater liver and lung weights in the LVD animals (see 
Table 2.1).
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6.2 Can manipulation of Ca handling in Sham cells mimic the phenotype of LVD 
cells?
The experiments in Chapter 5 were designed to examine the outcome of mimicking two 
of the findings in LVD -  reduced NCX function, and reduced SR Ca content. When 
NCX activity was acutely inhibited (by -24%  -  i.e. approaching the observed reduction 
in NCX seen in LVD animals) using a voltage protocol, this lead to an increase in the 
SR content, implying that there is an inverse relationship between forward-mode NCX 
activity and SR Ca content. This differs from the findings in LVD, where NCX 
function and SR Ca content are both reduced compared to Sham animals. This implies 
that some other factor in LVD is more important in determining the SR Ca content, and 
the experiments in Chapter 4 suggest that SERCA function may be the critical 
determinant (see Figure 4.11). Thus, reduced NCX function alone does not bring about 
changes in Ca handling to mimic those in LVD.
Further experiments in Chapter 5 were designed to alter SR Ca content by increasing 
the [Ca]-sensitivity o f the RyR, using low concentrations of caffeine. This causes 
unloading of the SR, and 0.5 mmol/L caffeine reduced the SR Ca content of Sham cells 
to around the same level as the baseline content in LVD cells (see Figure 5.3). This did 
indeed lead to small, but significant, reductions in steady-state A[Ca]Total (see Figure 
5.5). However, given the complex feedback mechanisms and “autoregulation” of SR 
content and Ca release (see section 5.1.1.1), it is unlikely that increased RyR [Ca]- 
sensitivity is the underlying defect in LVD, As discussed in section 5.4.1.1 , there is 
some evidence that RyR-mediated Ca flux is reduced in LVD for a given [Ca].
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Given the findings in this thesis and the literature, it is cleai' that alterations in several 
different cellular processes conspire to produce the phenotype observed in LVD. This 
includes changes in the expression of critical Ca handling proteins, and differences in 
their regulation. Structural changes in the cell, for example altered T-tubule structure, 
also play a role (see section 3.4.4). At a tissue level, fibrosis and remodelling will 
affect contractile performance, and the overall haemodynamic state will also be 
affected by altered neurohumoral regulation of the kidneys and vasculature.
6.2.1 Possible further experiments
To confirm some of the above assertions, it would be enlightening to carry out 
experiments where SERCA function was directly affected in cells from sham-operated 
animals -  for example through paitial inhibition by an appropriate concentration of 
thapsigargin or cyclopiazonic acid. This should reduce the SR Ca content and the 
resulting effects on Ca handling could be determined. It would also be possible to 
design experiments to look in more detail at SR Ca leak in intact myocytes, for 
example using the technique of Shannon et al, as outlined in section 4.4.3 (Shannon et 
a l,  2003b).
Given the complex changes observed in LVD, computer modelling could be used to 
suggest the outcome when multiple parameters are altered together. Programs such as 
LabHEART (D. Bers & J. Puglisi, Dept of Physiology, Loyola University, Chicago), 
model the properties of several ion channels and tiansporters along with cellulai' 
buffering processes and SR function. Simulations could give insight into the relative 
importance of different factors in determining the action potential shape and properties 
of the Ca transient.
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6.3 Can contractile function in LVD be “rescued”? Potential therapeutic targets
6.3.1 SERCA function and SR Ca content
One important aspect of investigating the cellular changes in LVD is to determine 
whether particular processes could be targeted in an attempt to restore function and 
prevent adverse complications. From the point of view of systolic contractile 
performance and diastolic relaxation, it would be beneficial to increase SR content and 
enhance removal of Ca from the cytoplasm. An increase in SERCA activity could 
achieve this dual objective, and this has been attempted by a number of groups. In 
general, this has been accomplished by either overexpressing SERCA protein or 
decreasing the inhibitory influence of phospholamban (reviewed by Prestle et a l, 2003; 
del Monte & Hajjar, 2003; Scoote et a l, 2003). Schmidt et a l used adenoviral 
transfection of SERCA2a to restore contractile function in senescent rat hearts 
(Schmidt et a l, 2000), and the same technique has been shown to increase SR Ca 
uptake and accelerate diastolic Ca removal in rats (Meyer & Dillmann, 1998) and 
rabbits (Davia et al,2QQ\). Transfected animals have demonstrated improved survival 
following induction of HF (see del Monte & Hajjar, 2003). Transgenic mice 
overexpressing SERCA2a display enhanced contraction and relaxation (Meyer & 
Dillmann, 1998), and show preserved contractile function in the face of LVH induced 
by pressure overload, compared to similarly-treated wild-type mice (Ito et a l, 2 0 0 1 ). 
Knock-out of PLB has also been shown to increase SR Ca transport and reverse some 
of the abnormalities seen in LVH induced by calsequestrin overexpression (Sato et a l , 
2001). Thus, targeting of abnormal SR Ca uptake has shown promising results in 
animal studies. Similar improvements in contractile function have been shown for 
failing human cells in vitro (reviewed by del Monte & Hajjar, 2003), and some
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pharmacological compounds exist which can enhance SR Ca uptake (see Prestle et al., 
2003), but the application of such principles to patients with HF remains a distant 
prospect.
Experiments in Chapter 5 increased SR Ca content in LVD cells by raising the 
membrane potential during diastole, causing inhibition of NCX. However, this did not 
lead to larger Ca transients (see Figure 5.11), probably because of other effects of the 
elevated membrane potential on the cell. As discussed in section 5.4.2, reduced Ca flux 
via Ica was observed, which seemed to be a consequence of raised diastolic [Ca] (Table 
5.2). This emphasizes the fact that altering one aspect of Ca handling can lead to 
compensatory changes in other cellulai* processes, reversing some of the anticipated 
beneficial effects.
6.3.2 RyR function and SR Ca leak
The central role of the RyR in systolic Ca release and diastolic Ca leak has lead to 
interest in targeting its function in HF. One therapeutic possibility which has been 
considered is to stabilise the RyR cluster, through a similar mechanism to FKBP12.6. 
This could improve cooperative gating, leading to better synchronisation of Ca release 
in systole, and could also reduce Ca leak in diastole (discussed in Prestle et a l, 2003). 
However, the role of the RyR in HF remains under debate (see sections 1.4.1.4 &
5.4.1.1) and isolated changes in RyR function may not lead to lasting effects on the Ca 
transient (for reviews, see Eisner et a l, 1998; Eisner & Trafford, 2002). Also, RyR- 
specific pharmacological compounds with the necessary properties have not yet been 
isolated (see Prestle et a l , 2003). Thus, there are practical and theoretical reasons why 
targeting the RyR may not be fruitful.
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6.3.3 N C X
In Chapter 3, it was shown that NCX activity was reduced by around % in this model of 
HF, and this may be detrimental to Ca removal from the cytoplasm. It was also 
demonstrated that adenoviral transfection of NCX lead to a measurable increase in Incx 
in single cardiac myocytes (Figure 3.9). The consequences of this NCX upregulation 
on Ca handling would require further investigation. There has been some interest in 
targeting NCX in HF, however, a number of issues make modulation of NCX frinction 
less attractive as a therapeutic option. Firstly, NCX expression / activity does not 
change in a consistent direction in HF (see sections 1.4.1.6 & 3.4.5.3) and this 
variability is also seen from patient to patient (Hasenfuss et a l, 1999). Secondly, the 
ubiquitous nature of NCX means that changing its activity could have widespread side- 
effects on other tissues. Thirdly, some changes in NCX may be compensatoiy, for 
example increased NCX in some models of HF may offset reduced SERCA function 
and improve diastolic relaxation (e.g. see Fogwizd et a l, 1999). Inhibition of NCX in 
these circumstances could impair relaxation and increase diastolic [Ca]. Also, if 
reverse-mode NCX is important in contributing to SR Ca loading in HF (see Litwin & 
Bridge, 1997), then NCX inhibition could also impair systolic Ca handling.
One indirect way of affecting Ca efflux is thi'ough the use of cardiac glycosides such as 
digoxin. By inhibiting the sarcolemmal Na-K exchanger, digoxin leads to increased 
[Na]i and this will shift E^cx and reduce Ca efflux. A large multicentre trial of digoxin 
in patients with heart failure showed that it reduced hospitalisations due to HF, but did 
not improve mortality (The Digitalis Investigation Group, 1997).
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6.3.4 Potential problems with targeting Ca handling in heart failure
One danger of targeting the SR Ca content in HF is the theoretical risk of cellular Ca 
overload and triggered arrhythmias caused by spontaneous Ca release (see section
1.3.3.1). The threshold level of SR [Ca] where spontaneous release begins to occur 
may be the same in HF and control cells -  in their rabbit model of HF, Pogwizd et al 
showed that the threshold level was just above 100 p,mol/L cytosol in both cases 
(Pogwizd et a l,  2001). Thus, there may be a window within which the SR content 
could be entranced without triggering arrhythmias, although this [Ca] range may be 
relatively narrow.
As mentioned in section 6.1.1, additional factors also need taken into account when 
assessing arrhythmic risk — for example, the level of resting [Ca] and the P-adrenergic 
state are both important. Davia et a l showed that reduction of diastolic [Ca] by 
enhanced SERCA function could reduce arrhythmogenic Ca release even in the face of 
an almost doubled SR content (Davia et a l, 2001). Thus, targeting of SERCA still has 
its attractions. The presence of residual p-adrenergic responsiveness (Pogwizd et a l, 
2001) suggests that one of the beneficial effects of P-blockade in HF may be to limit 
catecholamine-induced Ca overload.
Finally, significant endocardial-epicardial differences in Ca handling were 
demonstrated in this thesis (Chapters 3 & 4), particularly for Sham cells, and others 
have shown regional differences across the epicardial surface in HF (Ng et a l,  1998). 
If any intervention affected cells in one part of the heart more than another then it 
would risk amplifying such inhomogeneities, increasing the risk of ventricular 
aiThythmias.
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6.4 Conclusions
The cellular response to left ventricular dysfunction is complex and depends on several 
factors including the species studied, the means of producing LVD, the timing of 
investigations and the region of the heart analysed. The work presented in this thesis 
has furthered the understanding of Ca handling in a rabbit model of heart failure, 8 
weeks after myocardial infarction. It is hoped that studies such as this will give 
insights into the underlying mechanisms of heart failure, and suggest potential future 
directions for the treatment of this prevalent, debilitating and often fatal condition.
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